Method of locating the tip of a central venous catheter

Abstract
Methods of locating a tip of a central venous catheter (“CVC”) relative to the superior vena cava, sino-atrial node, right atrium, and/or right ventricle using electrocardiogram data. The CVC includes at least one electrode. In particular embodiments, the CVC includes two or three pairs of electrodes. Further, depending upon the embodiment implemented, one or more electrodes may be attached to the patient's skin. The voltage across the electrodes is used to generate a P wave. A reference deflection value is determined for the P wave detected when the tip is within the proximal superior vena cava. Then, the tip is advanced and a new deflection value determined. A ratio of the new and reference deflection values is used to determine a tip location. The ratio may be used to instruct a user to advance or withdraw the tip.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The present invention is directed generally to devices for and methods of locating a catheter inside a body and more particularly to devices for and methods of locating the tip of a central venous catheter inside the superior vena cava, right atrium, and/or right ventricle using information obtained from an electrocardiogram.


2. Description of the Related Art


Central venous catheters (“CVC”) include any catheter designed to utilize the central veins (e.g., subclavian and superior vena cava) or right sided cardiac chambers for the delivery and/or withdrawal of blood, blood products, therapeutic agents, and/or diagnostic agents. CVCs also include catheters inserted into the central veins or right sided cardiac chambers for the acquisition of hemodynamic data. Standard central venous catheters for intravenous access, dialysis catheters, percutaneously introduced central catheters (“PICC” lines), and right heart (“Swan-Ganz™”) catheters are examples of CVCs.


The standard of care for placing a CVC (other than right heart catheters which generally terminate in the pulmonary artery) dictates that the tip of the CVC lie just above and not inside the right atrium. In fact, in 1989, the Food and Drug Administration issued a warning citing an increased risk of perforation of the right atrium, clot formation, and arrhythmias among other potential complications resulting from the tip of the CVC being placed inside the right atrium.


While CVCs have been used for many years, determining the position of the tip of the CVC has always been problematic. Currently, a chest x-ray is used to determine the position of the tip of the CVC. Because CVC may be a radiopaque and/or include radiopaque materials, the CVC is visible on an x-ray. However, this method has several drawbacks. For example, obtaining a chest x-ray is labor intensive and expensive. In recent years, CVCs, which were traditionally placed in a hospital in-patient setting, are being placed in an outpatient setting more frequently. In an outpatient setting, obtaining a chest x-ray to determine the position of the tip of the CVC can be very cumbersome and may not be obtained in a timely manner. Therefore, using a chest x-ray to determine the position of the tip of the CVC may introduce a considerable delay, prolonging the procedure. Generally, the operator will leave the patient to perform other duties while the x-ray is processed. If the tip is improperly placed, the operator must return to the patient's bedside to reposition the CVC. To reposition the CVC, the operator must open the sterile dressing, cut the sutures, re-suture, and redress the wound, all of which potentially expose the patient to discomfort and infection.


Recently, navigational systems principally used to guide peripherally placed lines have become available. Based upon the detection of magnetic fields between a stylet tip and a detector, these systems assume (and depend upon) a relationship between surface landmarks and anatomic locations. Unfortunately, these systems cannot be used to determine the location of the tip of a CVC with sufficient accuracy because the relationship between surface landmarks and anatomic locations is highly variable from one patient to another.


In addition to the need to know where the tip is during initial placement, the CVC may migrate or otherwise move after the initial placement and require re-positioning. Therefore, the operator must monitor or periodically reevaluate the location of the tip.


An electrocardiogram (“ECG”) measures electrical potential changes occurring in the heart. Referring to FIGS. 1A-1C, the ECG measurements may be visualized or displayed as an ECG trace, which includes ECG waveforms. As is appreciated by those of ordinary skill in the art, ECG waveforms are divided into portions that include a QRS complex portion and a P wave portion in addition to other wave portions. The QRS complex corresponds to the depolarization of the ventricular muscle. The P wave portion of the ECG waveforms represents atrial muscle depolarization: the first half is attributable to the right atrium and the second half to the left atrium. Under normal circumstances, atrial muscle depolarization is initiated by a release of an excitatory signal from the sino-atrial (“SA”) node, a specialized strip of tissue located at the juncture of the superior vena cava (“SVC”) and right atrium.


As is appreciated by those of ordinary skill in the art, an ECG may be obtained using different electrode configurations. For example, a standard configuration referred to as “Lead II” may used. In a bipolar Lead II configuration, one of the electrodes (the cathode) is attached to the left leg and the other electrode (the anode) is attached to the right shoulder. As is appreciated by those of ordinary skill in the art, using a different configuration could change the polarity and/or the shape of the P wave. Other standard bipolar configurations include a bipolar Lead I configuration where the cathode is attached to the left shoulder and the anode is attached to the right shoulder and a bipolar Lead III configuration where the cathode is attached to the left leg and the anode is attached to the right shoulder.


The waveforms depicted in FIGS. 1A-1C and 2B were obtained using the anode of a standardized bipolar ECG Lead II configuration attached to the right shoulder and the tip of the CVC as the cathode. While technically this configuration is not a standard Lead II configuration, the trace produced by the electrodes 114A and 114B may be displayed on a standard ECG monitor using the monitor's circuitry to display the trace as a bipolar Lead II trace.


Techniques of using ECG waveforms to locate the tip of a CVC have been available since the 1940's. Some of these prior art devices construct an intravascular ECG trace by placing an electrode near the tip of the CVC and using that electrode to measure the voltage near the tip of the CVC relative to a surface electrode(s) and/or a second electrode spaced from the first.


These techniques have shown that both the magnitude and shape of the P wave change depending upon the positioning or location of the electrode attached to the tip of the CVC. Referring to FIGS. 1A and 1B, two exemplary ECG traces are provided for illustrative purposes.



FIG. 1A is an ECG trace made when the electrode attached to the tip of the CVC is in the proximal SVC. This tip location corresponds to position “1” depicted in FIG. 2A. The portion of the ECG trace corresponding to an exemplary P wave produced when the electrode attached to the tip is located in position “1” is labeled “P1.”



FIG. 1B is an ECG trace made when the electrode attached to the tip of the CVC is approaching the SA node and stops at a location adjacent to the SA node. These tip locations correspond to moving the tip from a position “2” to position “3” depicted in FIG. 2A. The portion of the ECG trace corresponding to an exemplary P wave produced when the electrode attached to the tip is approaching the SA node is labeled “P2” and the portion of the ECG trace corresponding to an exemplary P wave produced when the electrode attached to the tip is located adjacent to the SA node is labeled “P3.”


Normally as the electrode attached to the tip of the CVC moves from the proximal SVC (position “1”) toward the SA node (position “3”), the maximum value of the absolute value of the voltage of the P wave increases dramatically. When the electrode attached to the tip of the CVC is adjacent to the SA node (position “3”), the voltage of the P wave (please see “P3” of FIG. 1B) reaches a maximum value that is more than twice the value experienced in the proximal SVC and may be as large as eight times the voltage in the proximal SVC. When this occurs, the tip of the CVC is considered to have entered into the right atrium. Because the magnitude of the P wave more than doubles when the electrode attached to the tip of the CVC is adjacent to the SA node, this information may be used to place the tip of the CVC within a few centimeters (e.g., about 1 cm to about 2 cm) proximal to the SA node. Additionally, as the electrode attached to the tip of the CVC moves from the proximal SVC toward the right atrium, the shape of the P wave changes from a “u” shape (FIG. 1A) to a spike-like shape (FIG. 1B).


Referring to FIG. 2B, another exemplary illustration of the P wave portion of the ECG trace produced when the electrode attached to the tip of the CVC is located at positions 1-5 depicted in FIG. 2A is provided. The P wave portions of the ECG traces of FIG. 2B are labeled with the letter “P” and occur between the vertical dashed lines. Each of the exemplary traces is numbered to correspond to positions “1” through “5.” Therefore, the ECG trace “1” was produced when the electrode attached to the tip was located in the proximal SVC. The trace “2” was produced when the electrode attached to the tip was in position “2” (distal SVC). The trace “3” was produced when the electrode attached to the tip was adjacent to the SA node.


As the electrode attached to the tip of the CVC is advanced further into the right atrium, the polarity of the P wave “P” changes from predominantly negative near the top of the right atrium (position “3”) to isoelectric (i.e., half has a positive polarity and half has a negative polarity) near the middle of the right atrium (position “4”) to almost entirely positive at the bottom of the right atrium (position “5”). These changes in the P wave “P” are illustrated in traces “3” through “5.”



FIG. 1C is an ECG trace made when the electrode attached to the tip of the CVC is in the right ventricle. The portion of the ECG trace corresponding to an exemplary P wave produced when the electrode attached to the tip is labeled “P6.” When the electrode attached to the tip of the CVC is advanced into the right ventricle, the maximum magnitude of the absolute value of the P wave “P6” approximates the maximum magnitude of the absolute value of the P wave “P1” when the electrode attached to the tip of the CVC was inside the proximal SVC above the SA node (i.e., located at position “1”). However, the polarity of the first half of P wave “P6,” which corresponds to the right atrium, is opposite.


The first technique developed for viewing the ECG waveform during the insertion of a CVC used a column of saline disposed within a hollow tube or lumen longitudinally traversing the CVC. The column of saline provides a conductive medium. Saline was inserted into the lumen by a saline filled syringe with a metal needle. The needle of the syringe remained within the entrance to the lumen or port in contact with the column of saline after the lumen was filled. One end of a double-sided alligator clip was attached to the needle and the other end was attached to an ECG lead, which in turn was attached to an ECG monitor. By using the saline solution filled CVC as a unipolar electrode and a second virtual electrode generated by ECG software from three surface electrodes, an intravascular ECG was obtained. The operator would adjust the position of the tip of the CVC based on the magnitude and shape of the P wave displayed by the ECG monitor.


Subsequently, this technique was modified by substituting an Arrow-Johans adapter for the metal needle. The Arrow-Johans adapter is a standard tubing connector with an embedded conductive ECG eyelet. The Arrow-Johans adapter may be placed in line with any conventional CVC. In a closed system, the tubing and CVC may be filled with saline, i.e., a conductive medium, and the CVC used as a unipolar electrode in conjunction with surface electrodes and a standard ECG monitor. The ECG eyelet is placed in contact with the saline in the lumen of the CVC. One end of the ECG lead is attached to the ECG eyelet and the other end to the ECG monitor for displaying the intravascular ECG waveforms. Because the system must be closed to prevent the saline from leaking out, this system works best after the guide wire used to thread the CVC forward has been withdrawn, i.e., after placement has been completed. Therefore, although the catheter may be withdrawn after initial placement, it may not be advanced into proper position.


B. Braun introduced its Certofix catheter to be used in conjunction with its CERTODYN adapter. In this system, a patch lead with two ends has an alligator clip connected to one end. The alligator clip is clipped to the CVC guide wire. The other end of the patch lead includes a connector that is plugged into the CERTODYN adapter. The ECG may be obtained during placement and the catheter may be advanced or withdrawn as desired. However, the CERTODYN adapter has many moving parts and is not sterile, making the procedure cumbersome to perform and the operative field more congested. Additionally, the sterile field may become contaminated by the non-sterile equipment.


The Alphacard, manufactured by B. Braun, merges the Arrow-Johans adapter and the CERTODYN adapter. The Alphacard consists of a saline filled syringe (used to flush the CVC with saline) and a connector to the CERTODYN. The Alphacard is used to obtain a ‘snapshot’ of the ECG trace from the saline column. If an atrial spike is seen in the ECG trace, the CVC is withdrawn.


With respect to all of these prior art methods of using an ECG trace to place the tip of the CVC, some degree of expertise is required to interpret the P waves measured because the user must advance the guide wire slowly and watch for changes in the P wave. If the catheter is inserted too far too quickly and the changes to the P wave go unnoticed (i.e., the operator fails to notice the increase or spike in the voltage experienced when the electrode attached to the tip is in the right atrium), the operator may mistakenly believe the tip is in the SVC when, in fact, the tip is in the right ventricle. If this occurs, advancing the tip may injure the patient.


U.S. Pat. Nos. 5,078,678 and 5,121,750 both issued to Katims teach a method of using the P wave portion of an ECG trace to guide placement of the tip of the CVC. The CVC includes two empty lumens into which a transmission line is fed or an electrolyte is added. Each of the lumens has a distal exit aperture located near the tip of the CVC. The two exit apertures are spaced from one another. In this manner, two spaced apart electrodes or a single anode/cathode pair are constructed near the tip of the CVC. The voltage or potential of one of the electrodes relative to the other varies depending upon the placement of the electrodes. The voltage of the electrodes is conducted to a catheter monitoring system. The catheter monitoring system detects increases and decreases in the voltage of the P wave. The voltage increases as the electrodes approach the SA node and decrease as the electrodes move away from the SA node. Based on whether the voltage is increasing or decreasing, the operator is instructed by messages on a screen to advance or withdraw the CVC.


While Katims teaches a method of locating the tip of a CVC relative to the SA node, Katims relies on advancing or withdrawing the CVC and observing the changes of the P wave. Katims does not disclose a method of determining the location of the tip of the CVC based on a single stationary position. Unless the entire insertion procedure is monitored carefully, the method cannot determine the position of the tip of the CVC. Further, the Katims method may be unsuitable for determining the location of a previously positioned stationary tip.


Other devices such as Bard's Zucker, Myler, Gorlin, and CVP/Pacing Lumen Electrode Catheters are designed primarily to pace. These devices include a pair of electrodes at their tip that are permanently installed and designed to contact the endocardial lining. These devices include a lumen, which may be used to deliver and/or withdraw medications or fluids as well as for pressure monitoring. These leads are not designed for tip location and do not include multi-lumen capability.


A method of obtaining an intravascular ECG for the purposes of placing a temporary pacing wire was described in U.S. Pat. No. 5,666,958 issued to Rothenberg et al. Rothenberg et al. discloses a bipolar pacing wire having a distal electrode. The distal electrode serves as a unipolar electrode when the pacing wire is inserted into the chambers of the heart. The pacing wire is connected to a bedside monitor through a specialized connector for the purposes of displaying the ECG waveforms detected by the distal electrode.


Given the volume of CVCs placed yearly and the increasing demand particularly for PICC lines (devices that permit the delivery of intravenous therapeutic agents in the outpatient setting, avoiding the need for hospitalization) a great need exists for methods and devices related to locating the tip of a CVC. Particularly, devices and methods are needed that are capable of determining the location of the tip before the operator leaves the bedside of the patient. Further, a method of determining the location (SVC, right atrium, or right ventricle) of the tip from a single data point rather than from a series of data points collected as the catheter is moved may be advantageous. Such a system may be helpful during initial placement and/or repositioning. A need also exists for a device for or a method of interpreting the ECG waveforms that does not require specialized expertise. Methods and devices that avoid the need for hospital and x-ray facilities are also desirable. A need also exists for devices and methods related to determining the position of the tip of the CVC that are less expensive, expose patients to fewer risks, and/or are less cumbersome than the x-ray method currently in use.





BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWING(S)


FIG. 1A is an exemplary ECG trace obtained from an electrode placed inside the proximal SVC.



FIG. 1B is an exemplary ECG trace obtained from an electrode approaching the sino-atrial node and stopping adjacent thereto.



FIG. 1C is an exemplary ECG trace obtained from an electrode placed inside the right ventricle.



FIG. 2A is an illustration of a partial cross-section of the heart providing five exemplary tip locations 1, 2, 3, 4, and 5.



FIG. 2B is a series of exemplary P wave traces 1, 2, 3, 4, and 5 obtained from an electrode placed in each of the exemplary tip locations 1, 2, 3, 4, and 5 depicted in FIG. 2A, respectively.



FIG. 3A is a signal analysis system configured to determine the position of the tip of a CVC using a single pair of electrodes.



FIG. 3B is an embodiment of a CVC including three pairs of electrodes.



FIG. 4 is a block diagram illustrating a method of using a single pair of electrodes to locate the tip of the CVC within the SVC.



FIG. 5 is a block diagram illustrating a method of using a single pair of electrodes to determine the tip of the CVC is located within the right ventricle.



FIG. 6 is a block diagram illustrating a method of using a single pair of electrodes to determine the location of the tip of the CVC within the right atrium.



FIG. 7 is an embodiment of a signal analysis system for use with the CVC of FIG. 3B.



FIG. 8 is a block diagram illustrating the components of the signal analysis system of FIG. 7.



FIG. 9 is block diagram illustrating the components of a monitor of the signal analysis system of FIG. 3A.



FIG. 10 is a block diagram illustrating a method of using at least two pairs of electrodes to locate the tip of the CVC relative to the SVC, right atrium, and right ventricle.



FIGS. 11A-11B are a block diagram illustrating an alternate method of using a single pair of electrodes to locate the tip of the CVC relative to the SA node.





DETAILED DESCRIPTION OF THE INVENTION
Central Venous Catheter 100

Aspects of the present invention are directed toward a device for locating the tip of a central venous catheter (“CVC”) and a method of determining the location of the tip of a CVC. The embodiments depicted in FIGS. 3A and 3B, include a CVC 100 constructed using any manner known in the art from a flexible nonconductive material, such as polyurethane or other suitable polymer material. It may also be desirable to use a radiopaque material to construct the CVC 100. As is appreciated by those of ordinary skill in the art, the material used to construct the CVC 100 may include materials and/or coatings that provide improved anti-thrombotic or anti-bacterial properties. The CVC 100 has a body 130 configured to be received within a central vein. The body 130 may include a distal end 110 having a tapered tip 112 and a proximal end 120 spaced longitudinally along the body 130 from the distal end 110.


Referring to FIG. 3A, the body 130 may include one or more lumens 132 that traverse the length of the body and may have one or more openings 134 at or spaced from the tip 112 and an open end portion 122 configured to permit access into the lumen 132. When the tip 112 of the CVC 100 is received within a central vein, the open end portion 122 may remain outside the central vein allowing materials (e.g., saline, mediations, etc.) to be inserted into the lumen 132 while the tip 112 is inside the central vein or another anatomical structure. The opening 134 permits the passage of materials between the lumen 132 and the environment outside the CVC 100. If one or more materials are inserted into the lumen 132 via the open end portion 122, those materials may exit the lumen 132 via the opening 134. If materials enter the lumen 132 via the opening 134, those materials may exit the lumen 132 via the open end portion 122.


The open end portion 122 is configured be coupled to a connector 124 through which materials may be introduced into or exit from the open end portion 122 of the lumen 132. The connector 124 may include any suitable connector known in the art including a Tuohy-Borst adapter, stop cock, and the like. In the embodiment depicted in FIG. 3A, the connector 124 is a Tuohy-Borst adapter, which includes a side port 125 through which materials (e.g., saline) may be introduced into the open end portion 122 of the lumen 132. The side port 125 may be used to flush the lumen 132 with normal saline or another material. The connector 124 is configured to maintain materials within the lumen 132 and to prevent those materials from leaking out of the CVC 100 through the open end portion 122.


The lumens 132 may be used as conduits for the passage of materials such as medications and/or other fluids to and from the environment outside the CVC 100. For example, the lumen 132 may be used to aspirate blood into the CVC 100 and/or provide a conduit through which pressure data may be collected and used to construct pressure waveforms. The environment outside the CVC 100 may include the inside of the SVC, right atrium, and/or right ventricle. The CVC 100 is provided for illustrative purposes and those of ordinary skill in the art appreciate that alternate embodiments of CVC 100 including embodiments with additional lumens, a flow directed balloon tip, thermistors, thermodilution ports, pacing wire ports, embedded pacing electrodes, and the like are within the scope of the present invention.


Deflection Value

The deflection of an ECG trace, (i.e., its vertical height relative to the baseline) may be used to compare two or more P waves. Because a P wave constitutes a voltage change over time, the deflection of the P wave is not constant. In particular embodiments, the P wave is represented by an array or series of discrete numerical values.


The deflection value may be calculated in several ways. For example, the maximum or peak deflection may be used. Alternatively, the deflection value may be calculated as the difference between the maximum deflection and the minimum deflection. The deflection value may also be calculated as the sum of the absolute value of the maximum and minimum deflections. If the P wave has two peaks, which may occur when the tip 112 is located within the right atrium and the P wave is biphasic (see position 4 of FIGS. 2A and 2B), the deflection value may be calculated by totaling the absolute value of the two peaks. When this method is used, the deflection value of the P wave measured at positions 3-5 may all be approximately equal. Further, if discrete data is being used, the deflection value may also be calculated as a total of the discrete deflection quantities. If continuous data is being used, the deflection value may also be calculated as the integral under the P wave. Further, the deflection value may also be calculated as the average P wave deflection. Because the polarity of portions of the P wave change depending upon the location of the tip 112, it may be beneficial to use the absolute value of the deflection of the P wave to calculate the deflection value.


For the purposes of this application, the term “deflection value” will be used hereafter to describe the metric used to compare two or more P waves, which depending upon the implementation details may be detected by one or more pairs of electrodes. It is appreciated by those of ordinary skill in the art that the deflection value may be determined in numerous ways including those listed above and others not listed and the invention is not limited by the method and manner of determining the deflection value of the P wave.


In the embodiments discussed below, unless otherwise indicated, the deflection value is calculated as the sum of the absolute value of the maximum and minimum deflections when the maximum and minimum deflections have opposite polarities. The deflection value is calculated as the larger of the absolute value of the maximum and minimum deflections when the maximum and minimum deflections have the same polarity. In other words, the vertical height of the P wave is used.


Embodiments Using a Single Pair of Electrodes

Referring to FIG. 3A, an embodiment of a system 121 using a single pair of electrodes 114 to determine the position of the tip 112 of the CVC 100 will be described. An electrolytic material or solution, such as saline, may be disposed inside the lumen 132. The electrolytic material inside the lumen 132 forms a continuous conductor or column of electrolytic material that may be used to conduct an electrical signal from the opening 134 in the tip 112, and up the continuous column. In other words, the opening 134 exposes the electrolytic material inside the lumen 132 to electrical activity occurring in the environment outside the tip 112. A first electrode 114A of the pair of electrodes 114 is placed in electrical communication with the continuous column inside the lumen 132. The first electrode 114A may be coupled by a wire 123 to a monitor 127.


A second or surface electrode 114B is placed in contact with the skin of a patient. By way of a non-limiting example, the surface electrode 114B may be affixed to the skin of the patient's chest using any method known in the art. The surface electrode 114B is coupled to the monitor 127 by a wire 129. The voltage at or near the opening 134 in the tip 112 may be measured using the pair of electrodes 114.


The voltages detected by the pair of electrodes 114 may be used to create an ECG trace of the electrical activity observed at or near the tip 112 of the CVC 100. Because the voltage across each of the pair of electrodes 114 may vary with time, the voltage across wires 123 and 129 may constitute a time-varying signal that can be analyzed using standard signal processing methods well known in the art. In a typical patient, the maximum voltage across the pair of electrodes 114 may range from about 0.2 mV to about 3 mV. The signal detected by the pair of electrodes 114 may be amplified and/or filtered to improve the signal quality.


In the embodiment depicted in FIG. 3A, the first electrode 114A is coupled to the connector 124. Alternatively, the first electrode 114A may be located inside at least a portion of the lumen 132. By way of another example, the first electrode 114A is coupled to the side port 125 through which the electrolytic material (e.g., saline) may be introduced into the open end portion 122 of the lumen 132. As is apparent to those of ordinary skill in the art, the first electrode 114A may be located anywhere that would place it in electrical continuity or communication with the electrolytic material (e.g., saline) exiting the tip 112 via the opening 134 or otherwise communicating electrically with the environment outside the opening 134 of the tip 112. By way of another example, the first electrode 114A may be incorporated into a guide wire (not shown), stylet, and the like that extends from, or near the tip 112 up the body 130 of the CVC 100 and is electrically coupled by the wire 123 to the monitor 127. The monitor 127 is described in detail below.


Method of Using a Single Electrode Pair to Determine the Position of the Tip of the CVC

Referring to FIG. 4, a method 140 of determining the location of the tip 112 using the pair of electrodes 114 will now be described. In block 141, the CVC 100 is inserted into the SVC. The CVC 100 may gain venous access to the SVC by any method known in the art including inserting the CVC 100 in a standard sterile fashion through the subclavian, one of the jugular veins, or a peripheral vein and directing the tip 112 of the CVC 100 through that vein toward the proximal SVC.


Next, in block 142, a reference deflection value is recorded in a storage location. The reference deflection value is the deflection value obtained from the pair of electrodes 114 when the tip 112 is located in the venous system proximal to or in the proximal SVC.


Then, in block 143, the tip 112 is advanced. As the tip 112 is advanced, a ratio of the deflection value of the currently observed P wave to the reference deflection value is calculated. Inside the SVC, as the tip 112 approaches the mid SVC, the deflection value of the P wave may increase by two to four times the reference deflection value. Further, as the tip 112 approaches the distal SVC, the deflection value of the P wave may increase by four to six times the reference deflection value. In the distal SVC near the SA node, the deflection value of the P wave may increase by six to eight times the reference deflection value.


In decision block 144, whether the ratio is less than or equal to a first predefined threshold value is determined. The first predefined threshold value should be large enough to ensure the tip 112 has left the proximal SVC and entered the mid SVC. Further, the first predefined threshold value should be small enough to prevent placement of the tip 112 in the distal SVC. Thus, the first predefined threshold value may be within a range of about 1.6 to about 3.9. By way of a non-limiting example, the first predefined threshold value may be about 2.0. If the ratio is less than or equal to the first predefined threshold value, in block 143, the tip 112 may be advanced and the ratio recalculated. Ratio values less than or equal to the first predefined threshold value indicate the tip 112 is in the proximal or mid SVC and has not yet reached either the distal SVC, caval-atrial junction adjacent to the SA node or the upper right atrium.


If decision block 144 determines the ratio is not less than or equal to the first predefined threshold value, the method 140 advances to decision block 145. In decision block 145, whether the ratio is less than or equal to a second predefined threshold value is determined. The second predefined threshold value should be large enough to ensure the tip 112 is in the distal SVC and small enough to avoid entry of the tip 112 into the right atrium. By way of a non-limiting example, the second predefined threshold value may within a range of about 4.0 to about 8.0. By way of a non-limiting example, the second predefined threshold value may be about 8.0. In other words, the block 144 determines whether the ratio is between the first and second threshold values or within a range defined between the first and second threshold values (e.g., about 2.0 to about 8.0). Nevertheless, ratio values within the range defined between the first and second threshold values may indicate the tip 112 is approaching or has reached the SA node, or the tip is located within the right atrium. In other words, any ratio value above the second predefined threshold value may indicate the tip 112 is located in the distal SVC or the upper atrium. If the ratio is within the range defined between the first and second threshold values, the decision in decision block 145 is “YES” and the method 140 ends.


If the ratio is greater than the second threshold value, the decision in decision block 145 is “NO,” and the method 140 advances to block 147. When the ratio is greater than the second threshold value, the tip 112 is in or near the right atrium and in block 147, the user or operator is advised to withdraw the tip 112. By way of a non-limiting example, the user or operator may be advised to withdraw the tip 112 about 0.5 cm to about 1 cm. Then, in block 147, advancement of the tip 112 is terminated and the tip 112 withdrawn. By way of a non-limiting example, the user or operator may withdraw the tip 112 about 0.5 cm to about 1 cm. In block 147, as the tip 112 is withdrawn, the ratio of the deflection value of the currently observed P wave to the reference deflection value is recalculated.


Then, the method 140 returns to decision block 144.


In particular embodiments, if at any time during the performance of method 140, the ratio is equal to the second predefined threshold value, the tip 112 is maintained in its current position without additional advancement or withdrawal and the method 140 ends. When the method 140 ends, the ratio is between the first and second threshold values and the tip 112 is located in the mid SVC or distal SVC.


The following table, Table 1, summarizes the relationship between the location of the tip 112 of the CVC 100 and the ratio of the deflection value of the currently observed P wave to the reference deflection value:











TABLE 1









Location of the tip 112















Very Distal



Proximal
Mid
Distal
SVC or Right



SVC
SVC
SVC
Atrium















Ratio: ratio of the
≦1.5
1.6-4.0
4.1-5.5
>5.5-8.0


deflection value of the


currently observed P


wave to the reference


deflection value









While Table 1 provides exemplary ranges and/or threshold values for use as a general guideline, those of ordinary skill in the art appreciate that these values may benefit from adjustment as additional anatomic or electrophysiologic data is acquired and such modified values are within the scope of the present invention.


As is apparent to those of ordinary skill, the pair of electrodes 114 may be used to detect the instantaneous location of the tip 112. Therefore, if the tip 112 migrates into the atrium, this movement may be detected immediately by calculating a ratio of the deflection value of the currently observed P wave to the recorded reference deflection value and comparing the ratio to the first and second threshold values. This calculation may be performed periodically or at random intervals. If the tip 112 migrates into the atrium, a medical professional may be alerted via a signal, such as an alarm, and the like, to reposition the tip 112.


Referring to FIG. 5, a method 450 may be used to determine the tip 112 is located within the ventricle. In first block 452, the tip 112 is located in the atrium. Then, in block 454, a reference atrium deflection value is recorded. The reference atrium deflection value is the deflection value obtained from the pair of electrodes 114 when the tip 112 is located in the atrium. Then, in block 456, a ratio of the deflection value of the current P wave detected by the pair of electrodes 114 to the reference atrium deflection value is determined. In decision block 457, whether the ratio is greater than a third predefined threshold value is determined. The third predefined threshold value may be about 0.5. If the decision is “YES,” the ratio is greater than the third predefined threshold value, and in block 458, the tip 112 is determined to be in the right atrium. Then, the method 450 ends. If the decision in decision block 457 is “NO,” the ratio is less than or equal to the third predefined threshold value, and in block 459, the tip 112 is determined to be in the right ventricle. Then, the method 450 ends.


Within at least a portion of the range defined between the first and second threshold values (e.g., about 2.0 to about 8.0), the P wave voltage measured using prior art techniques, such as those disclosed by U.S. Pat. Nos. 5,078,678 and 5,121,750 (both issued to Katims), has generally not yet reached its maximum value. Therefore, the present method indicates the tip 112 should be withdrawn before those techniques would signal withdrawal. For example, typically the P wave voltage within the proximal SVC is about 0.2 to about 0.3 mV. Near the SA node, the P wave voltage may increase about 8 fold (e.g., about 1.6 mV to about 2.4 mV. In other words, the ratio is about 8 near the SA node, which is the location of the maximum P wave voltage used in the prior art. However, prior art techniques advise to advance the tip until it can be clearly seen that the maximum P voltage has been reached. Therefore, the prior art techniques allow the tip 112 to advance further into the right atrium than the present technique before identifying the advancement should be halted and the tip withdrawn back into the SVC. Because the present technique halts the advancement of the tip 112 earlier (e.g., when the P wave voltage increases above the second predefined threshold value of about 8.0, which corresponds to about 1.6 mV to about 2.4 mV) than prior art techniques, the present teachings may avoid many of the risks associated with advancing the tip into the right atrium.


Further, the prior art teaches using a threshold percentage decrease to determine the tip 112 is in the correct location. However, using a threshold percentage decrease may be ineffective at locating the tip 112 within the SVC because the percentage decrease may vary from patient to patient. In other words, depending upon the anatomical structures of the patient, the tip 112 may have to be withdrawn until the percentage decreases differing amounts. On the other hand, if the tip 112 is withdrawn until the ratio is between about 2.0 and about 8.0 (e.g., the current P wave voltage is about 0.4 mV to about 2.4 mV), the tip will be located in the mid SVC or in some cases, the distal SVC. Therefore, the present technique more accurately positions the tip 112 than prior art techniques.


In addition to halting the advancement of the tip 112 when the ratio of the deflection value of the currently observed P wave to the reference deflection value has exceeded either of the first and second predefined threshold values, advancement of the tip 112 could also be halted when the deflection value of the currently observed P wave is approximately equivalent to the voltage (or deflection value) of the QRS complex.


As discussed above, when observed using a standard bipolar Lead II trace, the P wave voltage is almost entirely negative at the top of the right atrium (see trace 3 of FIG. 2B), biphasic in the mid right atrium (see trace 4 of FIG. 2B), and positive at the bottom of the right atrium (see trace 5 of FIG. 2B). A positive/total deflection ratio may be calculated and used to determine when advancement of the tip 112 should be halted. The positive/total deflection ratio is a ratio of the greatest positive deflection value (of an initial positive or upwardly deflecting portion that precedes a downwardly deflecting portion) to the total deflection value of the currently observed P wave. When the positive/total deflection ratio is greater than a predetermined fraction (e.g., one quarter, one eighth, etc.) advancement of the tip 112 should be halted. For example, the traces 3-5 illustrated in FIG. 2B each have an initial upwardly deflecting portion. However, in both cases, the greatest positive deflection value of the initial upwardly deflecting portion of the P wave is clearly greater than one quarter of the total deflection value of the currently observed P wave. As explained above, in these traces, the tip 112 is located in the right atrium. Thus, if the greatest positive deflection value is greater than the predetermined fraction of the total deflection value of the currently observed P wave, the tip 112 is in the right atrium and should be withdrawn.


Alternate Method of Using a Single Electrode Pair to Determine the Position of the Tip of the CVC


FIGS. 11A and 11B provide a block diagram of an alternate method 600 of advancing and locating the tip 112 of the CVC 100. A physical cathode-anode electrode pair is used in a standard bipolar lead setup. A bipolar lead setup means two physical leads are used (rather than one virtual lead and one physical lead, which are referred to as a unipolar lead setup).


For illustrative purposes, the method 600 is described using the first electrode 114A (see FIG. 3A) functions as a cathode at the tip 112 and the second electrode 114B (see FIG. 3A) functions as an anode attached to the patient's skin near his/her right shoulder. The continuous conductor or column inside the lumen 132, which is in electrical communication with both the first electrode 114A and the electrical activity occurring in the environment outside the tip 112 functions as a “wandering electrode,” which is the positive cathode. The second electrode 114B serves as the negative anode electrode. While technically this configuration is not a standard Lead II configuration, the trace produced by the electrodes 114A and 114B may be displayed on a standard ECG monitor using the monitor's circuitry to display the trace as a bipolar Lead II trace. Thus, an ECG trace is generated for the wandering electrode relative to the electrode “RA,” which is displayed as a Lead II trace. However, as is apparent to those of ordinary skill in the art, through application of ordinary skill in the art to the present teachings other ECG Lead traces could be used and are within the scope of the present disclosure.


As is apparent to those of ordinary skill in the art, in a standard unipolar lead setup, three surface electrodes (not shown) are attached to a patient's skin: an electrode “RA” is attached to the patient's right arm (or shoulder), an electrode “LA” is attached to the patient's left arm (or shoulder), and an electrode “LL” is attached to the patient's left leg. A virtual electrode may be created using ECG software, which calculates the virtual electrode as the electrical center of an Einthoven's triangle created by the electrodes “RA,” “LA,” and “LL” used in the Lead I, Lead II, and Lead III configurations. The continuous conductor or column inside the lumen 132, which is in electrical communication with both the first electrode 114A and the electrical activity occurring in the environment outside the tip 112 functions as a “wandering electrode.” The wandering electrode is the positive cathode, and the virtual electrode is the negative anode electrode. Thus, an ECG trace is derived for the wandering electrode relative to the virtual electrode. In addition to Leads I, II, and III (of the bipolar configurations), some ECG monitors display unipolar lead configurations, e.g., aVR, aVL, aVF derived from a composite of the electrodes “RA,” “LA” and “LL,” or a chest electrode, variably called a “V,” “MCL,” or “Chest” lead (hereafter referred to as the “V” lead). Some ECG monitors display this ECG trace as a unipolar “V” lead trace and some users particularly like to use the unipolar “V” lead trace to guide the tip 112 of the CVC 100. However, most users use the bipolar Lead II trace generated for the wandering electrode relative to the electrode “RA” (i.e., the ECG Lead II configuration discussed above). As is apparent to those of ordinary skill in the art, with respect to the method 600, any number of bipolar or unipolar lead configurations may be used with acceptable results. Further, either the unipolar “V” lead trace or the bipolar Lead II trace (among others) may be used to perform the method 140.


In method 600, the deflection values measured include only the negative polarity or downwardly extending portion of the P-wave. The upwardly extending positive polarity portion is not included in the measurement of the deflection values. Thus, the deflection value is calculated as the absolute value of the minimum deflection.


In first block 610, the CVC 100 is introduced into the venous system and advanced to an initial location estimated to place the tip 112 of the CVC 100 at or proximal to the proximal SVC. In next block 620, a deflection value of the P wave observed at the initial location is measured and stored as a reference deflection value.


Then, in block 630, the CVC 100 is advanced from the initial location to a second location. By way of a non-limiting example, the CVC 100 may be advanced from the initial location about 0.5 cm to about 1.0 cm in block 630. At the second location, a new deflection value is measured using of the P wave observed at the second location. A deflection ratio of the new deflection value to the reference deflection value is then calculated. As the method 600 is performed, a maximum deflection ratio observed is stored. Thus, in block 630, the maximum deflection value observed is equal to the deflection ratio observed at the second location.


In block 640, the CVC 100 is advanced from the second location by an incremental distance. By way of a non-limiting example, the incremental distance may be within a range of about 0.5 cm to about 1.0 cm. However, a smaller sized incremental distance may be used and is within the scope of the present teachings.


After the CVC 100 has been advanced by the incremental distance, in block 650, a current deflection value of the P wave observed at the new location is measured and a current deflection ratio of the current deflection value to the reference deflection value is calculated. If the current deflection ratio is greater than the maximum deflection ratio, the maximum deflection ratio is set equal to the current deflection ratio. Before the CVC 100 was advanced, the CVC was located a previous location. The deflection value measured at the previous location is a previous deflection value and the deflection ratio of the previous deflection value to the reference deflection value is a previous deflection ratio.


Then, in decision block 660, the current deflection ratio is compared to the previous deflection ratio. The decision in decision block 660 is “YES” when the current deflection ratio is less than the previous deflection ratio. Otherwise, the decision in decision block 660 is “NO.”


When the decision in decision block 660 is “YES,” in block 665, the CVC 100 is withdrawn from the current location to a new location. By way of a non-limiting example, in block 665, the CVC 100 may be withdrawn about 0.5 cm to about 1.0 cm. Then, a new deflection value of the P wave observed at the new location is measured and a new deflection ratio of the new deflection value to the reference deflection value is calculated. If the new deflection ratio is greater than the maximum deflection ratio, the maximum deflection ratio is set equal to the new deflection ratio. At this point, the location of the CVC 100 before withdrawal is a previous location and the deflection ratio calculated at the previous location is a previous deflection ratio. The location of the CVC 100 after withdrawal is a current location and the deflection ratio calculated at the current location is a current deflection ratio. By way of a non-limiting example, the CVC 100 may be withdrawn about 1 cm. Then, the method 600 advances to decision block 670.


In decision block 670 whether the CVC 100 has been withdrawn far enough is determined. In decision block 670, a positive/total deflection ratio of the greatest positive deflection value (of an initial positive or upwardly deflecting portion which precedes a downwardly deflecting portion) to the total deflection value of the currently observed P wave is calculated. The decision in decision block 670 is “YES” when the positive/total deflection ratio is less than a predetermined fraction (e.g., one quarter, one eighth, etc.). Otherwise, the decision in decision block 670 is “NO.”


Alternatively, in decision block 670, a negative/total deflection ratio of the smallest negative deflection value (of a negative polarity or downwardly deflecting portion of the currently observed P wave which follows an upwardly deflecting positive polarity portion of the currently observed P wave) to the total deflection value of the currently observed P wave is calculated. The decision in decision block 670 is “YES” when the negative/total deflection ratio is greater than or equal to a predetermined fraction (e.g., three quarters, seven eighths, etc.). Otherwise, the decision in decision block 670 is “NO.”


When the decision in decision block 670 is “YES,” the method 600 advances to decision block 675. When the decision in decision block 670 is “NO,” the method 600 returns to block 665.


In decision block 675, the current deflection ratio is compared to the maximum deflection ratio observed. The decision in decision block 675 is “YES” when the current deflection ratio is approximately equal to the maximum deflection ratio observed. By way of a non-limiting example, the current deflection ratio may be considered approximately equal to the maximum deflection ratio observed when the absolute value of the difference between the current deflection ratio and the maximum deflection ratio observed is less than 0.2. If the current deflection ratio is not approximately equal to the maximum deflection ratio observed, the decision in decision block 675 is “NO.”


When the decision in decision block 675 is “YES,” the method 600 ends. When the decision in decision block 675 is “NO,” the method 600 returns to block 640.


When the decision in decision block 660 is “NO,” the current deflection ratio (calculated after the CVC 100 was advanced by the current incremental distance) is greater than or equal to the previous deflection ratio (calculated after the CVC 100 was advanced by the previous incremental distance). When the decision in decision block 660 is “NO,” the method 600 advances to decision block 680.


The decision in decision block 680 is “YES,” when the current deflection ratio is less than a maximum threshold value. Otherwise, decision in decision block 680 is “NO.” By way of a non-limiting example, the maximum threshold value may be about 8.0.


When the decision in decision block 680 is “YES,” the current deflection ratio is less than the maximum threshold value (e.g., 8.0) and greater than the previous deflection ratio. When this is the case, the method 600 returns to block 640.


When the decision in decision block 680 is “NO,” the current deflection ratio is greater than or equal to the maximum threshold value (e.g., 8.0), and the method 600 advances to decision block 685 to determine whether the current deflection ratio is approximately equal to the maximum threshold value.


When the current deflection ratio is approximately equal to the maximum threshold value, the decision in decision block 685 is “YES.” Otherwise, decision in decision block 685 is “NO.” The current deflection ratio may be considered approximately equal to the maximum threshold value when the absolute value of the difference between the current deflection ratio and the maximum threshold value is less than 0.2.


When the decision in decision block 685 is “YES,” the method 600 ends. When the decision in decision block 685 is “NO,” the current deflection value is neither less than nor equal to the maximum threshold value. When this occurs, the method 600 progresses to block 686 whereat the CVC 100 is withdrawn from the current location to a new location. Then, a new deflection value of the P wave observed at the new location is measured and a new deflection ratio of the new deflection value to the reference deflection value is calculated. The location of the CVC 100 after withdrawal is a current location and the deflection ratio calculated at the current location is a current deflection ratio. By way of a non-limiting example, the CVC 100 may be withdrawn about 1 cm. Then, the method 600 advances to decision block 687.


In decision block 687, the current deflection ratio is compared to the maximum threshold value. The decision in decision block 670 is “YES” when the current deflection ratio is approximately equal to the maximum threshold value. By way of a non-limiting example, the current deflection ratio may be considered approximately equal to the maximum threshold value when the absolute value of the difference between the current deflection ratio and the previous deflection ratio is less than 0.2. When the current deflection ratio is not approximately equal to the maximum threshold value, the decision in decision block 687 is “NO.”


When the decision in decision block 687 is “YES,” the method 600 ends. When the decision in decision block 670 is “NO,” the method 600 advances to decision block 690. Decision block 690 determines whether the CVC 100 was withdrawn too far in block 686. The decision in decision block 690 is “YES” when the current deflection ratio is less than maximum threshold value. When this occurs, continuing to withdraw the CVC 100 will simply reduce the current deflection value. Thus, to make the current deflection ratio approximately equal to the maximum threshold value, the CVC 100 must be advanced.


The decision in decision block 690 is “NO” when the current deflection ratio is greater than the maximum threshold value. Thus, to make the current deflection ratio approximately equal to the maximum threshold value, the CVC 100 must be withdrawn. When the decision in decision block 690 is “NO,” the method 600 returns to block 686.


If at anytime during the performance of the method 600, the current deflection ratio is approximately equal to the previously observed maximum deflection ratio, advancement and withdrawal of the CVC 100 may be halted and performance of the method 600 terminated. Similarly, if at anytime during the performance of the method 600, the current deflection ratio is approximately equal to the maximum threshold value, advancement and withdrawal of the CVC 100 is halted and performance of the method 600 terminated.


Method of Using a Single Electrode Pair to Determine the Location of the Tip of the CVC within the Right Atrium

As discussed above, the P wave voltage is almost entirely negative at the top of the right atrium (see trace 3 of FIG. 2B), biphasic in the mid right atrium (see trace 4 of FIG. 2B), and positive at the bottom of the right atrium (see trace 5 of FIG. 2B). Referring to FIG. 6, a method 190 uses these characteristics of the P wave voltage to determine the location of the tip 112 of the CVC 100 within the atrium. As is apparent to those of ordinary skill in the art, with respect to the method 190, either the unipolar “V” lead trace or the bipolar Lead II trace may be used.


In block 191, any method known in the art or described herein is used to determine the tip 112 is located in the atrium. For example, the tip 112 is in the atrium when the ratio of the deflection value of the currently observed P wave to the reference deflection value is greater than a value that may vary from person to person but is within a range of about 4.0 to about 8.0. Alternatively, the tip 112 may be determined to be in the atrium when the P wave voltage has exceeded a predetermined amount (e.g., about 0.8 mV to about 2.4 mV). Further, the tip 112 may be determined to be in the atrium when the positive/total deflection ratio (i.e., a ratio of the greatest positive deflection value of the initial upwardly deflecting portion of the currently observed P wave, which precedes a downwardly deflecting portion, to the total deflection value) is greater than the predetermined fraction (e.g., one quarter, one eighth, etc.). By way of another example, the tip 112 may be determined to be in the atrium when the voltage (or deflection value) of the currently observed P wave is approximately equivalent to or greater than the voltage (or deflection value) of the QRS complex.


After it is determined the tip 112 is in the right atrium, in block 192, a positive/negative deflection ratio is calculated. The positive/negative deflection ratio is a ratio of the greatest positive deflection value to the smallest negative deflection value. As discussed above, the absolute value of the deflection values may used. Thus, the positive/negative deflection ratio may be calculated as a ratio of the deflection value having the largest absolute value within the portion of the P wave that has a positive polarity to the deflection value having the largest absolute value within the portion of the P wave having a negative polarity. If the P wave is entirely negative, the positive/negative ratio is zero (and the tip 112 is in the upper atrium). On the other hand, if the largest positive deflection value and the smallest negative deflection value are equal, the positive/negative deflection ratio is equal to one. In subsequent blocks 193-197, the positive/negative deflection ratio is used to determine whether the tip 112 is located in the upper, mid, or lower atrium.


In decision block 193, whether the positive/negative deflection ratio is less than a first predetermined threshold value is determined. The first predetermined threshold value may be about 0.80. If decision block 193 determines the ratio is less than the first predetermined threshold value, in block 194, the method 190 determines the tip 112 is in the upper atrium and the method 190 ends.


If decision block 193 determines the ratio is not less than the first predetermined threshold value, the method 190 advances to decision block 195. In decision block 195, whether the positive/negative deflection ratio is greater than a second predetermined threshold value is determined. The second predetermined threshold value may be about 1.20. If decision block 195 determines the ratio is greater than the second predetermined threshold value, in block 196, the method 190 determines the tip 112 is in the lower atrium and the method 190 ends.


If decision block 195 determines the ratio is not greater than the second predetermined threshold value, in block 197, the method 190 determines the tip 112 is in the mid atrium and the method 190 ends. In other words, if the positive/negative deflection ratio is between the first and second predetermined threshold values, the tip 112 is in the mid atrium. Further, if the positive/negative deflection ratio is equal to the first predetermined threshold value or the second predetermined threshold value, the tip 112 is in the mid atrium.


The following table summarizes the relationship between the location of the tip 112 of the CVC 100 and the positive/negative deflection ratio:











TABLE 2









Location of the tip 112











Upper
Mid
Lower



Atrium
Atrium
Atrium














Positive/Negative Deflection Ratio:
<0.80
0.80-1.20
>1.20


ratio of the greatest positive


deflection value to the smallest


negative deflection value









While Table 2 provides exemplary ranges and/or threshold values for use as a general guideline, those of ordinary skill in the art appreciate that these values may benefit from adjustment as additional anatomic or electrophysiologic data is acquired and such modified values are within the scope of the present invention.


Embodiments Using Two or More Pairs of Electrodes

In the embodiment depicted in FIG. 3B, the CVC 100 includes four longitudinally spaced apart electrodes 150, 152, 154, and 156. Each electrode 150, 152, 154, and 156 is in electrical communication with a wire 160, 162, 164, and 166, respectively. In particular embodiments, the electrodes 150, 152, 154, and 156 are constructed from the distal end of each of the wires 160, 162, 164, and 166. In another embodiment, the electrodes 150, 152, 154, and 156 are attached to the ends of the wires 160, 162, 164, and 166 by any method known in the art for attaching an electrode to a wire, including soldering. The wires 160, 162, 164, and 166 are electrically isolated from one another. The wires 160, 162, 164, and 166 may be insulated from the environment outside the body 130 by the body 130.


The electrodes 150, 152, 154, and 156 and the wires 160, 162, 164, and 166 may be constructed from any suitable materials known in the art such as stainless steel or platinum. Alternatively, a column of conductive material such as an electrolytic material (e.g., saline) may be used to construct one or more of the electrodes 150, 152, 154, and 156 and/or the wires 160, 162, 164, and 166. The electrodes 150, 152, 154, and 156 may be about 6 mm to about 12 mm long, about 6 mm to about 12 mm wide, and about 1 mm to about 4 mm thick. The wires 160, 162, 164, and 166 may be constructed using any electrical lead wire suitable for obtaining an ECG trace.


Optionally, the invention may include two longitudinally spaced apart electrodes 157 and 158. Each of the electrodes 157 and 158 may be electrical communication with a wire 167 and 168, respectively. The electrodes 157 and 158 and wires 167 and 168 may be constructed in a manner substantially similar to that used to construct the electrodes 150, 152, 154, and 156 and the wires 160, 162, 164, and 166, respectively. In particular embodiments, the electrode 157 and 158 are positioned proximal to the electrodes 150, 152, 154, and 156.


Electrodes 150, 152, 154, and 156 may form two anode/cathode pairs. For example, electrodes 150 and 152 may form a first or proximal anode/cathode pair 180 and electrodes 154 and 156 may form a second or distal anode/cathode pair 182. Optional electrodes 157 and 158 may form an optional third or reference anode/cathode pair 184. A pair of electrodes forming an anode/cathode pair may be attached to a pair of insulated wires housed within a single cable. In particular embodiments, a pair of bipolar lead wires are used. In this manner, the four electrodes of the proximal and distal anode/cathode pairs 180 and 182 may be attached to two lead wires. A third bipolar lead wire may be included for use with the reference anode/cathode pair 184. Alternatively, the proximal and distal anode/cathode pairs 180 and 182 may be attached to four insulated wires housed within a single cable such a dual bipolar lead wire.


The wires 160, 162, 164, and 166 and electrodes 150, 152, 154, and 156 may be permanently embedded into the body 130 of the CVC 100 or removably inserted into one or more channels or lumens 132 formed in the CVC 100 for potential future removal and/or replacement. The wires 167 and 168 and electrodes 157 and 158 may be incorporated into the CVC 100 in any manner described with respect to wires 160, 162, 164, and 166 and electrodes 150, 152, 154, and 156, respectively.


The electrodes 150, 152, 154, and 156 are in electrical communication with the environment outside the CVC 100. In particular embodiments, a portion of each of the electrodes 150, 152, 154, and 156 are exposed to the environment outside the CVC 100 by apertures 170, 172, 174, and 176 formed in the body 130 adjacent to the electrodes 150, 152, 154, and 156, respectively. In embodiments including optional electrodes 157 and 158, a portion of each of the electrodes 157 and 158 may be exposed to the environment outside the CVC 100 by apertures 177 and 178 formed in the body 130 adjacent to the electrodes 157 and 158, respectively. The apertures 177 and 178 may be constructed in any manner suitable for constructing apertures 170, 172, 174, and 176. The apertures 170, 172, 174, and 176 may be formed in the body 130 by any method known in the art and the invention is not limited by the method used to construct the apertures 170, 172, 174, and 176. While the electrodes 150, 152, 154, and 156 depicted in the drawings extend outwardly from the body 130 through the apertures 170, 172, 174, and 176, it is understood by those of ordinary skill in the art, that electrodes 150, 152, 154, and 156 may reside at the bottom of the apertures 170, 172, 174, and 176 which may provide a passageway for fluids in the outside environment to the electrodes 150, 152, 154, and 156. Alternatively, the portion of the electrodes 150, 152, 154, and 156 in electrical communication with the environment outside the CVC 100 may be flush with the outside surface of the CVC 100.


The electrode 156 may be located at or spaced from the tip 112. In particular embodiments, the electrode 156 is less than about 5 mm from the tip 112. The spacing between an anode and cathode of the anode/cathode pairs 180 and 182 may be about 1 mm to about 4 mm. In particular embodiments, the spacing between an anode and cathode of the anode/cathode pairs 180 and 182 is about 3 mm.


In particular embodiments, the distance between the electrodes 154 and 152 is less than the height of the right atrium. In an adult, the height of the right atrium may be approximately equal to or greater than about 4 cm. In one exemplary embodiment, the distance between the electrode 154 and 152 may be about 3 cm. In embodiments including optional electrodes 157 and 158, the distance between the electrodes 150 and 158 may be about 10 cm to about 18 cm.


Those of ordinary skill in the art appreciate that the size and spacing of the electrodes provided herein may require modification for use with patients that are larger or smaller than a typical adult and such embodiments are within the scope of the present invention. For example, smaller electrodes with a closer spacing may be required for use with a pediatric patient.


Referring to FIG. 7, the CVC 100 may gain venous access to the SVC by any method known in the art including inserting the CVC 100 in a standard sterile fashion through the subclavian, one of the jugular veins, or a peripheral vein and directing the tip 112 of the CVC 100 through that vein to the SVC.


Each of the anode/cathode pairs 180 and 182 may be used to generate an ECG trace. In this manner, the ECG waveforms detected by the proximal pair 180 may be compared to the ECG waveform detected by the distal pair 182. In particular embodiments, the P wave portion of each trace is compared to determine the position of the tip 112 of the CVC 100 within the SVC, right atrium, and right ventricle.


In embodiments including the reference anode/cathode pair 184, the reference anode/cathode pair 184 may be used to generate an ECG trace. Referring to FIG. 7, because the reference anode/cathode pairs 184 may be located substantially proximally from the proximal and distal anode/cathode pairs 180 and 182, the reference anode/cathode pair 184 may remain in the venous system proximal to or in the proximal SVC after the proximal and distal anode/cathode pairs 180 and 182 have entered the heart. In particular embodiments, the spacing between the anode/cathode pair 184 and the proximal pair 180 is large enough to insure the reference anode/cathode pair 184 remains proximal to or inside the proximal SVC when the distal anode/cathode pair 182 is inside the right ventricle. In this manner, the reference anode/cathode pair 184 may be used to detect the ECG waveform within venous system proximal to or in the proximal SVC while the catheter is being placed.


The ECG waveforms detected by the proximal anode/cathode pair 180 and/or distal anode/cathode pair 182 may be compared to the ECG waveform detected by the reference anode/cathode pair 184. In particular embodiments, the P wave portion of the ECG trace detected by the proximal anode/cathode pair 180 and/or distal anode/cathode pair 182 is compared to P wave portion of the ECG trace detected by the reference anode/cathode pair 184 to determine whether the tip 112 of the CVC 100 is located within the SVC, right atrium, or right ventricle.


Methods of Determining the Location of the Tip of the CVC Using Two or More Electrode Pairs

As is apparent to those of ordinary skill in the art, the methods 140, 450, 190, and 600 described above may be performed using the CVC 100 with two or three pairs of electrodes. With respect to each of the methods 140, 450, 190, and 600, the electrode 156 of the distal anode/cathode pair 182 may be substituted for the first electrode 114A (see FIG. 3A) and the electrode 154 of the distal anode/cathode pair 182 may be substituted for the second electrode 114B (see FIG. 3A). By way of another non-limiting example, any one of the electrodes 156, 154, or 152 may be used as the cathode and any one of the electrodes 154, 152, or 150 proximal to the one used as the cathode may be used as the anode. Alternatively, with respect to each of the methods 140, 450, 190, and 600, one or both of the distal anode/cathode pair 182 may be substituted for the first electrode 114A (see FIG. 3A) and one or both of the proximal anode/cathode pair 180 may be substituted for the second electrode 114B (see FIG. 3A). However, as is appreciated by those of ordinary skill in the art, it may be desirable to use the distal most electrode as the cathode.


Referring to FIG. 10, an alternate method 500 of determining the location of the tip 112 of the CVC 100 using two or three pairs of electrodes will now be described. With respect to method 500, unless otherwise indicated, the deflection value is calculated as the sum of the absolute value of the maximum and minimum deflections when the maximum and minimum deflections have opposite polarities. The deflection value is calculated as the larger of the absolute value of the maximum deflection and the absolute value of the minimum deflection when the maximum and minimum deflections have the same polarity.


In first block 510, both the distal anode/cathode pair 182 and the proximal anode/cathode pair 180 are located in the venous system proximal to or in the proximal SVC. A D/P ratio of the deflection value of the distal anode/cathode pair 182 to the deflection value of the proximal anode/cathode pair 180 may be calculated and used to verify the locations of the distal anode/cathode pair 182 and the proximal anode/cathode pair 180 within the venous system proximal to or in the proximal SVC. When both of the anode/cathode pairs 180 and 182 are within the venous system proximal to or in the proximal SVC, the deflection value of the P wave detected by each of them is substantially identical and the D/P ratio of their P wave deflection values equals approximately one. Optionally, the deflection value of one or both of the P waves may be stored or otherwise recorded. For example, the deflection value of the P wave detected by the distal anode/cathode pair 182 or the proximal anode/cathode pair 180 may be stored as a reference deflection value.


In next block 518, the user advances the CVC 100. By way of a non-limiting example, the user may advance the CVC 100 about 0.5 cm to about 1.0 cm. Then, in block 520, the D/P ratio of the deflection value of the distal anode/cathode pair 182 to the deflection value of the proximal anode/cathode pair 180 is calculated. Optionally, the deflection value of one or both of the P waves may be stored or otherwise recorded. Then, the method 500 advances to decision block 524.


The user or operator may wish to continue advancing the CVC 100 until the SA node is detected. When an anode/cathode pair 180 or 182 is approximately 4 cm proximal to the SA node and therefore, by inference, approximately 4 cm proximal to the entrance of the right atrium (or “caval-atrial junction,” which is the location of the SA node), the deflection value of the P wave detected by that anode/cathode pair may increase.


When the distal anode/cathode pair 182 enters the right atrium and the proximal anode/cathode pair 180 is still in the venous system proximal to or in the proximal SVC, the deflection value of the P wave detected by the distal anode/cathode pair 182 may be at least four times the deflection value of the P wave detected by the proximal anode/cathode pair 180. Therefore, when the D/P ratio of the P wave deflection values of the distal anode/cathode pair 182 to the proximal anode/cathode pair 180 is greater than or equal to about 4.0 to about 8.0, the user or operator should withdraw the CVC 100. By way of a non-limiting example, the user may withdraw the CVC 100 about 0.5 cm to about 1.0 cm.


In decision block 524, a predetermined maximum threshold value “TR1” may be used to determine whether the user or operator should withdraw the CVC 100. If the D/P ratio exceeds the maximum threshold value “TR1,” the decision in decision block 524 is “YES,” and in block 528, the CVC 100 is withdrawn. In particular embodiments, the maximum threshold value “TR1” may range from approximately 4.0 to approximately 8.0. By way of a non-limiting example, the maximum threshold value “TR1” may be about 8.0. If the D/P ratio does not exceed the maximum threshold value “TR1,” the decision in decision block 524 is “NO,” and the method 500 advances to decision block 532.


When the distal anode/cathode pair 182 enters the right ventricle, the proximal anode/cathode pair 180 may be in the right atrium. Because the deflection value of the P wave experienced in the right ventricle is approximately equal to the deflection value of the P wave experienced in the proximal SVC, the D/P ratio of the P wave deflection values of the distal anode/cathode pair 182 to the proximal anode/cathode pair 180 (which is now in the upper atrium) is less than or equal to about one half. Therefore, when the D/P ratio is less than about one half, the user or operator should withdraw the CVC 100.


In decision block 532, a predetermined minimum threshold value “TMIN” may be used to determine whether the user or operator should withdraw the CVC 100. If the D/P ratio is less than the predetermined minimum threshold value “TMIN,” the decision in decision block 532 is “YES,” and in block 528, the CVC 100 is withdrawn. In particular embodiments, the predetermined minimum threshold value “TMIN” may be approximately one half.


If the D/P ratio is not less than the minimum threshold value “TMIN,” the decision in decision block 532 is “NO,” and the distal anode/cathode pair 182 and the proximal anode/cathode pair 180 may both be in the right atrium at the same time. When this occurs, the deflection value of the P waves detected by each would be very similar if not identical making their D/P ratio approximately equal to one. Therefore, in block 536, a P/R ratio or D/R ratio (described below) may be calculated to determine the location of the tip 112 of the CVC 100.


The P/R ratio may include the ratio of the deflection value of the P wave detected by the proximal anode/cathode pair 180 to the stored reference deflection value of the P wave detected in the proximal SVC. In particular embodiments, the P/R ratio may include the ratio of the deflection value of the P wave detected by the proximal anode/cathode pair 180 to a reference deflection value of the P wave detected by the reference anode/cathode pair 184. In embodiments that include a reference anode/cathode pair 184, the reference anode/cathode pair 184 may be used to detect the P wave in the proximal SVC. Because the proximal anode/cathode pair 180 is inside the right atrium, the deflection value of its P wave is greater than or equal to about four times to about eight times the deflection value of the P wave observed in the proximal SVC. When the P/R ratio is equal to or greater than a threshold value “TR2” within a range of about 4.0 to about 8.0, the user or operator should withdraw the CVC 100. By way of a non-limiting example, the threshold value “TR2” may be about 4.0. By way of a non-limiting example, the threshold value “TR2” may be equal to the predetermined maximum threshold value “TR1.” Alternatively, the threshold value “TR2” could be set equal the largest D/R ratio observed thus far.


After the P/R ratio is calculated, in decision block 540, the threshold value “TR2” may be used to determine whether the user or operator should withdraw the CVC 100. If the P/R ratio exceeds the threshold value “TR2,” the decision in decision block 540 is “YES,” and in block 528, the CVC 100 is withdrawn. Otherwise, if the P/R ratio does not exceed the threshold value “TR2,” the user does not need to withdraw the CVC 100, and the decision in decision block 540 is “NO.” Then, the method 500 ends.


Alternatively, in block 536, a D/R ratio may be calculated to determine the location of the tip 112 of the CVC 100. The D/R ratio may include the ratio of the deflection value of the P wave detected by the distal anode/cathode pair 182 to the stored reference deflection value of the P wave detected in the proximal SVC. In particular embodiments, the D/R ratio may include the ratio of the deflection value of the P wave detected by the distal anode/cathode pair 182 to the reference deflection value of the P wave detected by the reference anode/cathode pair 184. In embodiments that include a reference pair 184, the reference pair 184 may be used to detect the P wave in the proximal SVC. Because the distal anode/cathode pair 182 is inside the right atrium, the deflection value of its P wave is greater than or equal to about four times to about eight times the deflection value of the P wave observed in the proximal SVC.


When D/R ratio is equal to or greater than a threshold value “TR3” within a range of about 4.0 to about 8.0, the user or operator should withdraw the CVC 100. By way of a non-limiting example, the threshold value “TR3” may be about 4.0. By way of a non-limiting example, the threshold value “TR3” may be equal to the predetermined maximum threshold value “TR1.” Alternatively, the threshold value “TR3” could be set equal the largest D/R ratio observed thus far. Under these circumstances, in decision block 540, the threshold value “TR3” may be used to determine whether the user or operator should withdraw the CVC 100, i.e., if the D/R ratio exceeds the threshold value “TR3,” the decision in decision block 540 is “YES,” and the CVC 100 is withdrawn in block 528. Otherwise, if the D/R ratio does not exceed the threshold value “TR3,” the user does not need to withdraw the CVC 100, and the decision in decision block 540 is “NO.” Then, the method 500 ends.


After the CVC 100 is withdrawn in block 528, the method 500 may return to block 520 to recalculate the D/P ratio.


In method 500, determining when to withdraw the CVC 100 is unaffected by wide anatomic variability between individual people because instead of using predetermined threshold deflection values, the D/P ratio, P/R ratio, and/or D/R ratio of deflection values obtained from each individual is used.


The following table summarizes the relationship between the location of the tip 112 of the CVC 100 and the deflection values of the P waves detected by the proximal and distal anode/cathode pairs 180 and 182:











TABLE 3









Location of the distal



anode/cathode pair 182












Proximal
Right
Right
Right



SVC
Atrium
Atrium
Ventricle









Location of the proximal



anode/cathode pair 180












Proximal
Proximal
Right
Right



SVC
SVC
Atrium
Atrium















D/P ratio: Ratio of the
≈1
≧TR1
≈1
≦TMIN


deflection value of the


distal anode/cathode pair


182 to the deflection


value of the proximal


anode/cathode pair 180


P/R ratio: Ratio of the
≈1
≈1
≧TR2
≧TR2


deflection value of the


P wave detected by the


proximal anode/cathode


pair 180 and the


deflection value of


the P wave detected


in the proximal SVC


D/R ratio: Ratio of the
≈1
≧TR3
≧TR3
≈1


deflection value of the


P wave detected by the


distal anode/cathode


pair 182 and the


deflection value of


the P wave detected


in the proximal SVC









As mentioned above, each of the threshold values “TR1,” “TR2,” and “TR3” in Table 3 may be within a range of about 4.0 to about 8.0 and the minimum threshold value “TMIN” may be about 0.5. Alternatively, the threshold values “TR1,” “TR2,” and “TR3” in Table 3 may be set equal the largest D/R ratio observed during the performance of the method 500. By way of another example, the threshold values “TR1,” “TR2,” and “TR3” in Table 3 may be set equal the largest D/R ratio observed for the patient during the performance of any of the methods described herein and recorded for use with the method 500. While exemplary threshold values “TR1,” “TR2,” “TR3,” and “TMIN” have been provided for use as a general guideline, those of ordinary skill in the art appreciate that these values may benefit from adjustment as additional anatomic or electrophysiologic data is acquired and such modified values are within the scope of the present invention.


As is apparent from Table 3, either of the P/R ratio and the D/R ratio may be calculated first and used instead of the D/P ratio. For example, if the P/R ratio is calculated first, it may be compared to the threshold value “TR2.” If the P/R ratio is greater than or equal to the threshold value “TR2,” the tip 112 is in the right atrium or right ventricle and should be withdrawn. If the P/R ratio is less than the threshold value “TR2,” the tip 112 is in the right atrium or proximal SVC. When this occurs, either the D/P ratio or the D/R ratio may be calculated. If the D/P ratio is calculated, it may be compared to the predetermined maximum threshold value “TR1.” If the D/P ratio is greater than or equal to the predetermined maximum threshold value “TR1,” the tip 112 should be withdrawn. If the D/R ratio is calculated, it may be compared to the threshold value “TR3.” If the D/R ratio is greater than or equal to the threshold value “TR3,” the tip 112 should be withdrawn.


Alternatively, if the D/R ratio is calculated first, it may be compared to the threshold value “TR3.” If the D/R ratio is greater than or equal to the threshold value “TR3,” the tip 112 is in the right atrium and should be withdrawn. If the D/R ratio is less than the threshold value “TR3,” the tip 112 is in the right ventricle or proximal SVC. When this occurs, either the D/P ratio or the P/R ratio may be calculated. If the D/P ratio is calculated, it may be compared to the predetermined minimum threshold value “TMIN.” If the D/P ratio is less than or equal to the predetermined minimum threshold value “TMIN,” the tip 112 should be withdrawn. If the P/R ratio is calculated, it may be compared to the threshold value “TR2.” If the P/R ratio is greater than or equal to the threshold value “TR2,” the tip 112 should be withdrawn.


In addition to using the method 500 to determine when to withdraw the CVC 100, the QRS complex portion of the ECG waveforms detected by the distal anode/cathode pair 182 and/or the proximal anode/cathode pair 180 may be used to determine when the tip 112 of the CVC 100 is in the right atrium. Specifically, the tip 112 should be withdrawn because it is in the right atrium when the deflection value of the P wave detected by either the distal anode/cathode pair 182 or the proximal anode/cathode pair 180 is approximately equivalent to or greater than the voltage (or deflection value) of the QRS complex detected simultaneously by the same anode/cathode pair. The P wave and QRS complex typically look similar and deflect in the same direction. The CVC 100 may be advanced until the deflection value of the P wave is slightly less than or approximately equal to the deflection value of the QRS complex.


Further, a positive/total deflection ratio of the largest positive deflection value (of an initial positive or upwardly deflecting portion preceding a downwardly deflecting portion of a P wave detected by the distal anode/cathode pair 182 and/or the proximal anode/cathode pair 180) to the total deflection value (of the P wave detected by the distal anode/cathode pair 182 and/or the proximal anode/cathode pair 180) may be used to determine when the tip 112 of the CVC 100 is in the right atrium. As discussed above, the P wave voltage is almost entirely negative at the top of the right atrium (see trace 3 of FIG. 2B), biphasic in the mid right atrium (see trace 4 of FIG. 2B), and positive at the bottom of the right atrium (see trace 5 of FIG. 2B). Thus, advancement of the tip 112 may be halted when the positive/total deflection ratio is greater than a predetermined fraction (e.g., one quarter, one eighth, etc.). As mentioned above, with respect to the single electrode pair embodiments, when the positive/total deflection ratio exceeds the predetermined fraction, the tip 112 is in the right atrium.


As is apparent to those of ordinary skill, the proximal and distal anode/cathode pairs 180 and 182 may be used to detect the instantaneous location of the tip 112. Therefore, if the tip 112 migrates into the atrium or ventricle, this movement may be detected immediately. Following such an occurrence, a medical professional may be alerted via a signal, such as an alarm, and the like, to reposition the tip 112.


If the tip 112 is determined to be in the atrium, the method 190 described above may be used to determine the position of the tip 112 inside the atrium. Specifically, the electrode 114B (see FIG. 3A) may be attached to the skin of the patient. Then, the method 190 may be used to determine a positive/negative deflection ratio for the P wave detected by the electrode 114B and one of the electrodes 154 and 156 of the distal anode/cathode pair 182. The positive/negative deflection ratio may be compared to the first and second threshold values (see Table 2) and the location of the tip 112 within the atrium determined. Alternatively, instead of attaching the electrode 114B to the skin of the patient, one of the electrodes 157 and 158 of the reference anode/cathode pair 184 may be used. In such embodiments, the positive/negative deflection ratio is determined for the P wave detected by one of the electrodes 157 and 158 of the reference anode/cathode pair 184 and one of the electrodes 154 and 156 of the distal anode/cathode pair 182. As mentioned above, it may desirable to use the most distal electrode 156 of the distal anode/cathode pair 182. The positive/negative deflection ratio may be compared to the first and second threshold values (see Table 2) and the location of the tip 112 within the atrium determined.


Because the voltage across each of the anode/cathode pairs 180 and 182 may vary depending over time, the voltage across wires 164 and 166 and wires 160 and 162 may each constitute a time-varying signal that can be analyzed using standard signal processing methods well known in the art. In a typical patient, the maximum of voltage across the anode/cathode pairs 180 and 182 may range from about 0.2 mV to about 3 mV. The signal from each anode/cathode pairs 180 and 182 may be amplified and/or filtered to improve the signal quality. A distal signal may be detected by the distal anode/cathode pair 182 and a proximal signal may be detected by the proximal anode/cathode pair 180. Similarly, an optional reference signal may be detected by the reference anode/cathode pair 184.


A separate ECG trace may be constructed for distal and proximal signals. In some embodiments, an ECG trace may also be constructed for the reference signal. The P wave portion of one or more of these ECG traces may be identified and analyzed. For example, the ECG trace of the distal signal may be visualized by connecting wires 164 and 166 of the distal anode/cathode pair 182 to a device such as a PACERVIEW® signal conditioner designed specifically to construct and display an ECG trace from a time varying low voltage signal. Similarly, the ECG trace of the proximal signal may be viewed by connecting the wires 160 and 162 of the proximal anode/cathode pair 180 to a PACERVIEW® signal conditioner. The ECG trace of the reference signal may be viewed by connecting the wires 167 and 168 of the proximal anode/cathode pair 184 to a PACERVIEW® signal conditioner.


In particular embodiments, each of the four wires 160, 162, 164, and 166 may be coupled to a signal analysis system for analysis of the voltage information detected by the electrodes 150, 152, 154, and 156, respectively. In embodiments including electrodes 157 and 158, the wires 167 and 168 may be coupled to the signal analysis system for analysis of the voltage information detected by the electrodes 157 and 158, respectively. An exemplary signal analysis system 200 for analyzing the signals carried by wires 160, 162, 164, and 166 and alerting the user or operator when to withdraw the tip 112 of the CVC 100 may be viewed in FIG. 7. In an alternate embodiment, the system 200 may also analyze the signals carried by wires 167 and 168.


System 200


FIG. 8 is a block diagram of the components of the exemplary system 200. The system 200 may include a programmable central processing unit (CPU) 210 which may be implemented by any known technology, such as a microprocessor, microcontroller, application-specific integrated circuit (ASIC), digital signal processor (DSP), or the like. The CPU 200 may be integrated into an electrical circuit, such as a conventional circuit board, that supplies power to the CPU 210. The CPU 210 may include internal memory or memory 220 may be coupled thereto. The memory 220 may be coupled to the CPU 210 by an internal bus 264.


The memory 220 may comprise random access memory (RAM) and read-only memory (ROM). The memory 220 contains instructions and data that control the operation of the CPU 210. The memory 220 may also include a basic input/output system (BIOS), which contains the basic routines that help transfer information between elements within the system 200. The present invention is not limited by the specific hardware component(s) used to implement the CPU 210 or memory 220 components of the system 200.


All or a portion of the deflection values and/or deflection ratios calculated by the methods 140, 190, 450, 500, and 600, including the reference deflection value, may be stored in the memory 220 for use by the methods.


Optionally, the memory 220 may include external or removable memory devices such as floppy disk drives and optical storage devices (e.g., CD-ROM, R/W CD-ROM, DVD, and the like). The system 200 may also include one or more I/O interfaces (not shown) such as a serial interface (e.g., RS-232, RS-432, and the like), an IEEE-488 interface, a universal serial bus (USB) interface, a parallel interface, and the like, for the communication with removable memory devices such as flash memory drives, external floppy disk drives, and the like.


The system 200 may also include a user interface 240 such as a standard computer monitor, LCD, colored lights 242 (see FIG. 7), PACERVIEW® signal conditioner, ECG trace display device 244 (see FIG. 7), or other visual display including a bedside display. In particular embodiments, a monitor or handheld LCD display may provide an image of a heart and a visual representation of the estimated location of the tip 112 of the CVC 100. The user interface 240 may also include an audio system capable of playing an audible signal. In particular embodiments, the user interface 240 includes a red light indicating the CVC 100 should be withdrawn and a green light indicating the CVC 100 may be advanced. In another embodiment, the user interface 240 includes an ECG trace display device 244 capable of displaying the ECG trace of the distal and proximal signals. In the embodiment depicted in FIG. 7, the user interface 240 includes a pair of lights 242, one red and the other green, connected in series with a ECG trace display device 244. In some embodiments, a display driver may provide an interface between the CPU 210 and the user interface 240. Because an ultrasound machine is typically used when placing peripherally inserted central catheters (“PICC” lines), the system 200 may be incorporated into an ultrasound unit (not shown).


The user interface 240 may permit the user to enter control commands into the system 200. For example, the user may command the system 200 to store information such as the deflection value of the P wave inside the SVC. The user may also use the user interface 240 to identify which portion of the ECG trace corresponds to the P wave. The user interface 240 may also allow the user or operator to enter patient information and/or annotate the data displayed by user interface 240 and/or stored in memory 220 by the CPU 210. The user interface 240 may include a standard keyboard, mouse, track ball, buttons, touch sensitive screen, wireless user input device and the like. The user interface 240 may be coupled to the CPU 210 by an internal bus 268.


Optionally, the system 200 may also include an antenna or other signal receiving device (not shown) such as an optical sensor for receiving a command signal such as a radio frequency (RF) or optical signal from a wireless user interface device such as a remote control. The system 200 may also include software components for interpreting the command signal and executing control commands included in the command signal. These software components may be stored in memory 220.


The system 200 includes an input signal interface 250 for receiving the distal and proximal signals. The input signal interface 250 may also be configured to receive the reference signal. The input signal interface 250 may include any standard electrical interface known in the art for connecting a double dipole lead wire to a conventional circuit board as well as any components capable of communicating a low voltage time varying signal from a pair of wires through an internal bus 262 to the CPU 210. The input signal interface 250 may include hardware components such as memory as well as standard signal processing components such as an analog to digital converter, amplifiers, filters, and the like.


The various components of the system 200 may be coupled together by the internal buses 262, 264, and 268. Each of the internal buses 262, 264, and 268 may be constructed using a data bus, control bus, power bus, I/O bus, and the like.


The system 200 may include instructions 300 executable by the CPU 210 for processing and/or analyzing the distal and/or proximal signals. These instructions may include computer readable software components or modules stored in the memory 220. In particular embodiments, the instructions 300 include instructions for performing the method 500 (see FIG. 10).


The instructions 300 may include an ECG Trace Generator Module 310 that generates a traditional ECG trace from the distal and/or proximal signals. In some embodiments, the ECG Trace Generator Module 310 may generate a traditional ECG trace from the reference signal. As is appreciated by those of ordinary skill in the art, generating an ECG trace from an analog signal, such as the distal and proximal signals, may require digital or analog hardware components, such as an analog to digital converter, amplifiers, filters, and the like and such embodiments are within the scope of the present invention. In particular embodiments, some or all of these components may be included in the input signal interface 250. In an alternate embodiment, some or all of these components may be implemented by software instructions included in the ECG Trace Generator Module 310. The ECG Trace Generator 310 may include any method known in the art for generating an ECG trace from a time varying voltage signal.


The ECG Trace Generator 310 may record one or more of the ECG traces generated. Presently, a chest x-ray is used to document the location of the tip 112. This documentation may be used to prove the tip 112 of the CVC was placed correctly. Using the present techniques, the recorded ECG trace(s) may be used in addition to or instead of the chest x-ray to document tip 112 location. For example, the recorded ECG trace(s) may demonstrate that the tip 112 has migrated from the proximal SVC into the right atrium. Further, the recorded ECG trace(s) could document the repositioning of the tip 112 back into proximal SVC. Additionally, the recorded ECG trace(s) could document that the tip 112 was initially placed correctly and did not migrate from its initial position. In this manner, the ECG trace(s) could be used to document the correct or incorrect placement of the tip 112 and could be included in the patient's medical record, replacing or supplementing the prior art chest x-ray. Further, if the tip 112 does migrate, the recorded ECG trace(s) could be used to determine whether the tip entered the atrium, how far into the atrium the tip migrated, and/or whether the tip entered the ventricle.


The instructions 300 may include a P Wave Detection Module 320 for detecting or identifying the P wave portion of the ECG trace. The P wave portion of the ECG trace may be detected using any method known in the art. In particular embodiments, the P Wave Detection Module 320 receives input from the user or operator via the user interface 240. The input received may identify the P wave portion of the ECG trace. Optionally, the P Wave Detection Module 320 may include instructions for identifying the QRS complex as well as the P wave portion of the ECG trace. Further, the P Wave Detection Module 320 may include instructions for determining a deflection value for an initial upwardly deflecting portion of a single P wave preceding a downwardly deflecting portion. The P Wave Detection Module 320 may also include instructions for determining a positive/total deflection ratio of the largest positive deflection value for the initial upwardly deflecting portion of the P wave to the deflection value for the entire P wave.


The instructions 300 may include an Interpretive Module 330 for comparing the P wave generated for the distal, proximal, and/or reference signals. In particular embodiments, the Interpretive Module 330 determines the deflection value of the P wave generated for the distal and/or proximal signals. In some embodiments, the Interpretive Module 330 determines the deflection value of the P wave generated for the reference signal. The Interpretive Module 330 may direct the CPU 210 to store the deflection value of the distal, proximal, and/or reference signals in memory 220. In particular, it may be desirable to store the deflection value of the P wave encountered in the proximal SVC. The Interpretive Module 330 may receive input from the user or operator via the user interface 240 instructing the Interpretive Module 330 to store the deflection value. This information could be stored under a unique patient identifier such as a medical record number so that tip location information could be accessed anytime during the life of the CVC 100, potentially avoiding the need for a chest x-ray to document current location.


With respect to performing the method 500 illustrated in FIG. 10, the Interpretive Module 330 may also determine the D/P ratio by calculating the ratio of the deflection value of the distal signal to the deflection value of the proximal signal. If the D/P ratio is approximately equal to or greater than the maximum threshold value “TR1,” the tip 112 of the CVC 100 may be in the right atrium. The Interpretive Module 330 may alert the user or operator that the tip 112 is in the right atrium and the CVC 100 should be withdrawn from the right atrium. On the other hand, if the D/P ratio is approximately equal to or less than the minimum threshold value “TMIN,” the tip 112 of the CVC 100 may be in the right ventricle. The Interpretive Module 330 may alert the user or operator that the tip 112 is in the right ventricle and the CVC 100 should be withdrawn therefrom.


If the D/P ratio is less than the maximum threshold value “TR1” and greater than the minimum threshold value “TMIN,” the tip 112 may be in either the right atrium or the proximal SVC. When this happens, the Interpretive Module 330 may calculate the P/R ratio and/or the D/R ratio. For example, if the D/R ratio is approximately equal to or greater than the threshold value “TR3,” the tip may be in the right atrium and should be withdrawn therefrom. When this occurs, the Interpretive Module 330 may alert the user or operator that the tip 112 is in the right atrium. If the D/R ratio is approximately less than the threshold value “TR3,” the tip 112 is in the SVC and may be advanced if the operator so chooses. The Interpretive Module 330 may communicate to the user or operator that the tip 112 may be advanced.


On the other hand, if the P/R ratio is approximately equal to or greater than the threshold value “TR2,” the tip may be in the right atrium or right ventricle and should be withdrawn therefrom. When this occurs, the Interpretive Module 330 may alert the user or operator to withdraw the tip 112. If the P/R ratio is approximately less than the threshold value“TR2,” the tip 112 is in the SVC (because the D/P ratio is less than the maximum threshold value “TR1”) and may be advanced if the operator so chooses. The Interpretive Module 330 may communicate to the user or operator that the tip 112 may be advanced.


In an alternate embodiment, the P/R ratio is used instead of the D/P ratio. Whenever the P/R ratio is approximately equal to or greater than the threshold value “TR2,” the user or operator may be alerted to withdraw the CVC 100. If the P/R ratio is approximately less than the threshold value “TR2,” the D/P ratio or D/R ratio may be calculated and used to determine the position of the tip 112 of the CVC 100.


In another alternate embodiment, the D/R ratio is used instead of the D/P ratio. Whenever the D/R ratio is approximately equal to or greater than the threshold value “TR3,” the user or operator may be alerted to withdraw the CVC 100. If the D/R ratio is approximately less than the threshold value “TR3,” the D/R ratio or P/R ratio may be calculated and used to determine the position of the tip 112 of the CVC 100.


In particular embodiments, the instructions in the Interpretive Module 330 direct the CPU 210 to use the user interface 240 to communicate whether the tip 112 should be withdrawn to the user. The CPU 210 may use the user interface 240 to communicate the tip 112 may be advanced. Because the Interpretive Module 330 may interpret the P wave to obtain the deflection values of the distal and proximal signals, compare the deflection values, and provide the operator with immediate real-time feedback, the operator need not interpret the actual ECG waveforms.


Monitor 127

The monitor 127 of the system 121 for use with single pair of electrode embodiments will now be described. Returning to FIG. 3A, for illustrative purposes, the monitor 127 is described as coupled to each of the electrodes 114A and 114B by wires 123 and 129, respectively. However, in alternate embodiments, the monitor 127 is coupled to the electrodes 176 and 174 of the distal anode/cathode pair 182 (see FIG. 3B) by wires 123 and 129, respectively. By way of another alternate embodiment, one or both of the distal anode/cathode pair 182 may be coupled to the monitor 127 by wire 123 and one or both of the proximal anode/cathode pair 180 may be may be coupled to the monitor 127 by wire 129.


Referring to FIG. 9, the monitor 127 includes a signal analysis system 400 that may be substantially similar to the signal analysis system 200 described above. Specifically, the system 400 may construct an ECG trace for the electrical signals detected by the pair of electrodes 114, and identify and analyze the P wave portion of the ECG trace using any method discussed above with respect to the system 200. Further, the system 400 is configured to display information to the user or operator communicating the current position of the tip 112 of the CVC 100.


Like reference numerals are used to identify substantially identical components in FIGS. 8 and 9. The system 400 includes the CPU 210, the memory 220, the input signal interface 250 for receiving the signals detected by the pair of electrodes 114, and a user interface 410. Like system 200, the various components of the system 400 may be coupled together by the internal buses 262, 264, and 268.


All or a portion of the deflection values and/or deflection ratios calculated by the methods 140, 190, 450, and 600, including the reference deflection value, may be stored in the memory 220 for use by the methods.


The system 400 differs from the system 200 with respect to the user interface 410 and at least a portion of the computer-executable instructions stored in memory 220. Returning to FIG. 3A, in some embodiments, the user interface 410 includes an array of lights 412, a first portion 412A of which corresponds to ratio values below or equal to the first predefined threshold value of the method 140 (see FIG. 4), a second portion 412B of which corresponds to the range of ratio values greater than the first predefined threshold value and less than or equal to the second threshold value of the method 140, and a third portion 412C of which indicates the second predefined threshold value has been exceeded.


By way of a non-limiting example, the first portion 412A may include an array of green lights. The number of green lights lit may indicate the magnitude of the ratio of the deflection value of the currently observed P wave to the reference deflection value. For example, the first portion may include eight lights. The first light may indicate the ratio is less than or equal to 0.8. For each 0.2 increase in the ratio, another green light may be lit until all eight green lights are lit and the ratio is approximately equal to 4.0. If the ratio decreases to less than 4.0, for each 0.2 decrease in the ratio, a green light may be turned off until only a single green light is lit.


By way of a non-limiting example, the second portion of lights may include an array of yellow lights. The number of yellow lights lit may indicate the magnitude of the ratio of the deflection value of the currently observed P wave to the reference deflection value. For example, the second portion may include eight yellow lights. The first yellow light may indicate the ratio is approximately equal to about 4.4 to about 4.5. For each 0.2 increase in the ratio above 4.4, another yellow light may be lit until all eight yellow lights are lit and the ratio is approximately equal to 6.0. If the ratio decreases to less than 6.0, for each 0.2 decrease in the ratio, a yellow light may be turned off until the ratio is less than 4.4 and none of the yellow lights are lit.


By way of a non-limiting example, the third portion may include a single red light indicating the magnitude of the ratio of the deflection value of the currently observed P wave to the reference deflection value has exceeded 6.0. If the ratio decreases to less than 6.0, the red light may be turned off. In this manner, the user interface 410 provides greater resolution for ratio values less than or equal to the first predefined threshold value than for ratio values between the first and second predefined threshold values.


While the above example has been described as including lights (such as LEDs, conventional light bulbs, and the like), those of ordinary skill in the art appreciate that any indicator may used and such embodiments are within the scope of the present teachings. For example, a monitor displaying a graphical representation of lights, a figure, such as a bar, that increases or decreases in size to reflect an increase or decrease in the ratio, and the like may be used in place of the array of lights. Optionally, the user interface 410 may include a screen 420 (see FIG. 3A) configured to display information to the user or operator. For example, the screen 420 may display an image of a heart and a visual representation of the estimated location of the tip 112 of the CVC 100. Alternatively, the screen 420 may display the words “ADVANCE,” “HOLD,” or “WITHDRAW” as appropriate.


The user interface 410 may also indicate when the tip 112 is located in the ventricle. By way of a non-limiting example, the user interface 410 may include a light, audio signal, or other indicator configured to indicate the tip 112 has entered the ventricle.


In some embodiments, a display driver may provide an interface between the CPU 210 and the user interface 410. Optionally, the user interface 410 includes an audio system capable of playing an audible signal. For example, the audio system may produce a tone that increases in pitch as the ratio increases and decreases in pitch as the ratio decreases may be used. Alternatively, the audio system may produce one tone when the ratio is greater than the first predefined threshold value, indicating the tip 112 should be withdrawn. In such embodiments, the audio system may produce another more urgent or annoying tone when the ratio is above the second predefined threshold value. Further, the audio system may be silent when the ratio is below the first predefined threshold value.


The user interface 410 may permit the user to enter control commands into the system 200. For example, the user may command the system 200 to store information such as the deflection value of the P wave inside the proximal SVC (e.g., the reference deflection value), atrium (e.g., the reference atrium deflection value), and the like. The user may also use the user interface 410 to identify manually which portion of the ECG trace corresponds to the P wave. The user interface 410 may also allow the user or operator to enter patient information (such as a patient identifier number) and/or annotate the data displayed by user interface 410 and/or stored in memory 220 by the CPU 210. The user interface 410 may include a standard keyboard, mouse, track ball, buttons 416, touch sensitive screen, wireless user input device and the like. The user interface 410 may be coupled to the CPU 210 by an internal bus 268.


By way of a non-limiting example, a patient's reference deflection value (detected when the tip 112 was located in the proximal SVC) and/or reference atrium deflection value (detected when the tip 112 was located in the atrium) could be stored in the memory 220 and associated with the patient's patient identifier number or some other identification number. In this manner, the patient's recorded reference deflection value could be used anytime during the life of the CVC 100 by recalling the reference deflection value from memory 220 using the patient's patient identifier number, which could be entered manually using the user interface 410.


Optionally, the system 400 may also include an antenna or other signal receiving device (not shown) such as an optical sensor for receiving a command signal such as a radio frequency (RF) or optical signal from a wireless user interface device such as a remote control. The system 400 may also include software components for interpreting the command signal and executing control commands included in the command signal. These software components may be stored in memory 220.


The system 400 includes instructions 300 executable by the CPU 210 for processing and/or analyzing the electrical signals detected by the pair of electrodes 114. The instructions 300 may include the ECG Trace Generator Module 310 that generates a traditional ECG trace from the signals detected by the pair of electrodes 114, the P Wave Detection Module 320 for detecting or identifying the P wave portion of the ECG trace, and the Interpretive Module 330. As discussed above with respect to the system 200, the ECG Trace Generator Module 310 may record the ECG trace generated thereby.


Optionally, the P Wave Detection Module 320 may include instructions for identifying the QRS complex as well as the P wave portion of the ECG trace. Further, the P Wave Detection Module 320 may include instructions for determining a deflection value for an initial upwardly deflecting portion of a single P wave preceding a downwardly deflecting portion. The P Wave Detection Module 320 may also include instructions for determining a positive/total deflection ratio of the largest positive deflection value for the initial upwardly deflecting portion of the P wave to the deflection value for the entire P wave.


Like the Interpretive Module 330 of the system 200, the Interpretive Module 330 of the system 400 determines the deflection value of the P wave detected by a pair of electrodes (i.e., the pair of electrodes 114). However, other functions performed by the Interpretive Module 330 may differ in system 400 from those performed by the Interpretive Module 330 in system 200. The Interpretive Module 330 directs the CPU 210 to store the deflection value of the P wave detected by the pair of electrodes 114 in the proximal SVC in memory 220. The Interpretive Module 330 may receive input from the user or operator via the user interface 410 instructing the Interpretive Module 330 to store the deflection value.


The Interpretive Module 330 also includes instructions for performing the method 140, 190, and/or the method 600. With respect to the method 140 (see FIG. 4), the Interpretive Module 330 may determine the ratio of the deflection value of the currently observed P wave to the reference deflection value. The Interpretive Module 330 may compare this ratio to the first predefined threshold (e.g., about 1.5). If the ratio is less than or equal to the first predefined threshold, the Interpretive Module 330 determines the tip 112 is in the SVC. Further, if the determination is made in block 143, the Interpretive Module 330 may signal the user or operator to advance the tip 112. If the determination is made in block 145, the Interpretive Module 330 may signal the user or operator to stop withdrawing the tip 112.


If the ratio is greater than the first predefined threshold, the Interpretive Module 330 determines the tip 112 is not in a desired location and instructs the user interface 410 to signal the user or operator to withdraw the tip.


The Interpretive Module 330 may compare the ratio to the second predefined threshold value (e.g., about 2.0). If the ratio is less than or equal to the second predefined threshold value, the Interpretive Module 330 determines the tip 112 is in the distal SVC near the SA node or in the atrium near the SA node. If the ratio is greater than the second predefined threshold value, the Interpretive Module 330 determines the tip 112 is in the atrium.


Optionally, the Interpretive Module 330 may determine the ratio of the deflection value of the current P wave detected by the pair of electrodes 114 to the reference atrium deflection value. The Interpretive Module 330 may compare this ratio to the third predefined threshold value (e.g., about 0.5) to determine whether the tip 112 is in the atrium or the ventricle.


With respect to the method 190 (see FIG. 6), the Interpretive Module 330 may determine the tip 112 is located within the right atrium using any method known in the art or disclosed herein. The Interpretive Module 330 then calculates the positive/negative deflection ratio and compares this ratio to the first predetermined threshold value (e.g., about 0.30). If the positive/negative deflection ratio is less than the first predetermined threshold value, the Interpretive Module 330 determines the tip 112 is in the upper right atrium. On the other hand, if the positive/negative deflection ratio is greater than or equal to the first predetermined threshold value, the Interpretive Module 330 compares positive/negative deflection ratio to the second predetermined threshold value (e.g., about 1.30). If the positive/negative deflection ratio is greater than the second predetermined threshold value, the Interpretive Module 330 determines the tip 112 is in the lower atrium. Otherwise, if the positive/negative deflection ratio is greater than or equal to the first predetermined threshold value and less than or equal to the second predetermined threshold value, the Interpretive Module 330 determines the tip 112 is in the mid atrium.


With respect to the method 600 (see FIGS. 11A and 11B), the Interpretive Module 330 may store a reference deflection value and determine the deflection ratio of the deflection value of the currently observed P wave to the reference deflection value. After the tip 112 is withdrawn or advanced, the Interpretive Module 330 may determine the current deflection ratio of the deflection value of the currently observed P wave to the reference deflection value. The deflection ratio determined before the tip 112 was withdrawn or advanced is stored by the Interpretive Module 330 as a previous deflection ratio.


Each time the tip 112 is moved (e.g., advanced or withdrawn), the Interpretive Module 330 determines whether the current deflection ratio is the largest observed since the CVC 100 was inserted into the venous system, and if the current deflection ratio is the largest deflection ratio observed, stores the current deflection ratio as the maximum deflection ratio.


The Interpretive Module 330 compares the current deflection ratio to the previous deflection ratio. If the current deflection ratio is less than or equal to the previous deflection ratio, the Interpretive Module 330 determines the tip 112 has been advanced too far and may signal the user to withdraw the CVC 100. Then, the Interpretive Module 330 determines whether the tip 112 has been withdrawn far enough. The Interpretive Module 330 may determine the tip 112 has been withdrawn far enough when the positive/total deflection ratio is less than a predetermined fraction (e.g., one quarter, one eighth, etc.). Otherwise, the tip 112 has not been withdrawn far enough. If the tip 112 has not been withdrawn far enough, the Interpretive Module 330 signals the user to withdraw the tip 112.


If the tip 112 has been withdrawn far enough, the Interpretive Module 330 determines whether the current deflection ratio is approximately equal to the maximum deflection ratio. If the current deflection ratio is not approximately equal to the maximum deflection ratio, the Interpretive Module 330 determines the tip 112 has been withdrawn too far and signals the user to advance the CVC 100.


As mentioned above, the Interpretive Module 330 may compare current deflection ratio to the previous deflection ratio. If the current deflection ratio is greater than the previous deflection ratio, the Interpretive Module 330 determines whether the current deflection ratio is less than a maximum threshold value (e.g., 8.0). If the current deflection ratio is less than the maximum threshold value, the Interpretive Module 330 determines the tip 112 has not been advanced far enough and signals the user to advance the CVC 100.


If instead the current deflection ratio is greater than or equal to the maximum threshold value, the Interpretive Module 330 determines whether the current deflection ratio is approximately equal to the maximum threshold value. If the current deflection ratio is not approximately equal to the maximum threshold value, the Interpretive Module 330 determines the tip 112 has been advanced too far and signals the user to withdraw the CVC 100. After the tip 112 is withdrawn, the Interpretive Module 330 determines whether the current deflection ratio is approximately equal to the maximum threshold value.


If the current deflection ratio is not approximately equal to the maximum threshold value, the Interpretive Module 330 determines whether the current deflection ratio is less than the maximum threshold value (indicating the tip 112 has been withdrawn too far). If the current deflection ratio is less than the maximum threshold value, the Interpretive Module 330 determines the tip 112 has been withdrawn too far and signals the user to advance the CVC 100. On the other hand, if the current deflection ratio is still greater than the maximum threshold value, the Interpretive Module 330 determines the tip 112 has not been withdrawn far enough and signals the user to withdraw the CVC 100.


Optionally, whenever the current deflection ratio is approximately equal to the maximum deflection ratio or the maximum threshold value, the Interpretive Module 330 may signal the user to stop moving (e.g., advancing or withdrawing) the CVC 100.


With respect to the methods 140, 190, and 600, the instructions in the Interpretive Module 330 direct the CPU 210 to use the user interface 410 to communicate whether the tip 112 should be withdrawn to the user. Further, the instructions in the Interpretive Module 330 direct the CPU 210 to use the user interface 410 to communicate the tip 112 may be advanced. Because the Interpretive Module 330 may interpret the P wave to obtain the deflection values, compare the deflection values, and provide the operator with immediate real-time feedback, the operator need not interpret the actual ECG waveforms.


Optionally, the system 400 could be coupled to a prior art navigational system, such as a VIASYS MedSystems NAVIGATØR® BioNavigation® system, manufactured by VIASYS Healthcare Inc. of Conshohocken, Pa., which is principally used to guide peripherally placed lines, such as a peripherally inserted central catheter (“PICC”). Such systems determine the location of a PICC line using magnetic fields that are generated by a detector, and detected by a magnetically activated position sensor located in the tip of a stylet inserted inside the PICC near its tip. By way of a non-limiting example, the detector may include a NAVIGATØR® electronic locating instrument configured to emit low-level, high-frequency magnetic fields. Also by way of a non-limiting example, the stylet may include a MAPCath® Sensor Stylet also manufactured by VIASYS Healthcare Inc.


The sensor in the tip of the stylet is activated by the magnetic field emitted by the detector. The sensor is operable to output its location via a wire coupled to the sensor and extending longitudinally along the PICC to the detector, which is configured to interpret the signal and communicate the location of the tip to the user or operator. As mentioned above, because such navigational systems depend upon a relationship between surface landmarks and anatomic locations, they cannot be used to determine the location of the tip 112 of the CVC 100 with sufficient accuracy. However, the system 400 may be used, in conjunction with a navigational system to improve the accuracy of the navigational system.


By way of non-limiting examples, additional prior art navigational systems include the Sherlock Tip Location System used with the stylet provided in Bard Access Systems PICC kits both of which are manufactured by C. R. Bard, Inc. of Salt Lake City, Utah, the CathRite™ system manufactured by Micronix Pty. Ltd. of Australia, and the like. As is apparent to those of ordinary skill in the art, the present teaching may be combined with one or more of these additional exemplary navigational systems and used to improve the accuracy of those systems.


In further embodiments, the teachings provided herein may be expanded to use electrophysiology procedures for navigating other bodily channels. For example, in the prior art, ECG guidance techniques have been used to place feeding tubes. Because the QRS complex measured in the stomach is upright but in a post pyloric area (first part of the duodenum, beyond the stomach) the QRS complex is down-going, one or more threshold deflection values may be determined and used to determine the placement of the tip of the feeding tube.


The foregoing described embodiments depict different components contained within, or connected with, different other components. It is to be understood that such depicted architectures are merely exemplary, and that in fact many other architectures can be implemented which achieve the same functionality. In a conceptual sense, any arrangement of components to achieve the same functionality is effectively “associated” such that the desired functionality is achieved. Hence, any two components herein combined to achieve a particular functionality can be seen as “associated with” each other such that the desired functionality is achieved, irrespective of architectures or intermedial components. Likewise, any two components so associated can also be viewed as being “operably connected”, or “operably coupled”, to each other to achieve the desired functionality.


While particular embodiments of the present invention have been shown and described, it will be obvious to those skilled in the art that, based upon the teachings herein, changes and modifications may be made without departing from this invention and its broader aspects and, therefore, the appended claims are to encompass within their scope all such changes and modifications as are within the true spirit and scope of this invention. Furthermore, it is to be understood that the invention is solely defined by the appended claims. It will be understood by those within the art that, in general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to inventions containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” should typically be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should typically be interpreted to mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, typically means at least two recitations, or two or more recitations).


Accordingly, the invention is not limited except as by the appended claims.

Claims
  • 1. A monitor electrically couplable to an electrode attached to a tip of a central venous catheter that is insertable into a venous system of a subject, the monitor comprising: a processor;a withdraw indicator coupled to the processor configured to indicate when the tip of the central venous catheter should be withdrawn; anda memory coupled to the processor and having instructions executable by the processor, when executed, the instructions instructing the processor to:store an identifier identifying the subject,determine and store a reference deflection value of a P wave detected by the electrode attached to the tip of the central venous catheter,associate the reference deflection value with the identifier identifying the subject,determine a current deflection value of a current P wave detected by the electrode attached to the tip of the central venous catheter,calculate a current ratio of the current deflection value to the stored reference deflection value, andactuate the withdraw indicator to indicate the tip of the central venous catheter should be withdrawn based on the current ratio.
  • 2. The monitor of claim 1, wherein the instructions executable by the processor further instruct the processor to: store a maximum ratio comprising a largest ratio of the current deflection value to the stored reference deflection value calculated for the subject,associate the maximum ratio with the identifier identifying the subject,compare the current ratio to the maximum ratio, andactuate the withdraw indicator to indicate the tip of the central venous catheter should be withdrawn based on the comparison.
  • 3. The monitor of claim 1, wherein the instructions executable by the processor further instruct the processor to compare the current ratio to a threshold value and actuate the withdraw indicator to indicate the tip of the central venous catheter should be withdrawn based on the comparison.
  • 4. The monitor of claim 1, wherein the instructions executable by the processor further instruct the processor to store at least one of the current deflection value and the current ratio.
CROSS REFERENCE TO RELATED APPLICATION(S)

This application is a division of U.S. patent application Ser. No. 13/737,806, filed Jan. 9, 2013, now U.S. Pat. No. 8,774,907, which is a division of U.S. patent application Ser. No. 12/427,244, filed Apr. 21, 2009, now U.S. Pat. No. 8,388,546, which is: 1) a continuation of International Application No. PCT/US2009/033116, filed Feb. 4, 2009, claiming priority under 35 U.S.C. §119(e) to U.S. Provisional Application No. 61/026,372, filed Feb. 5, 2008; and 2) a continuation-in-part of U.S. patent application Ser. No. 11/552,094, filed Oct. 23, 2006, now U.S. Pat. No. 7,794,407. Each of the aforementioned applications is incorporated by reference in its entirety into this application.

US Referenced Citations (1465)
Number Name Date Kind
3133244 Wojtulewicz May 1964 A
3297020 Mathiesen Jan 1967 A
3625200 Muller Dec 1971 A
3674014 Tillander et al. Jul 1972 A
3817241 Grausz Jun 1974 A
3847157 Caillouette et al. Nov 1974 A
3868565 Kuipers Feb 1975 A
3896373 Zelby Jul 1975 A
3902501 Citron et al. Sep 1975 A
3986373 Goodlaxson Oct 1976 A
3995623 Blake et al. Dec 1976 A
4003369 Heilman et al. Jan 1977 A
4063561 McKenna Dec 1977 A
4072146 Howes Feb 1978 A
4114601 Abels Sep 1978 A
4149535 Volder et al. Apr 1979 A
4173228 Steenwyk et al. Nov 1979 A
4175566 Millar Nov 1979 A
4181120 Kunii et al. Jan 1980 A
4224949 Scott et al. Sep 1980 A
4244362 Anderson Jan 1981 A
4289139 Enjoji et al. Sep 1981 A
4317078 Weed et al. Feb 1982 A
4327722 Groshong et al. May 1982 A
4327723 Frankhouser May 1982 A
4362166 Furler et al. Dec 1982 A
4365639 Goldreyer Dec 1982 A
4380237 Newbower Apr 1983 A
4407294 Vilkomerson Oct 1983 A
4417886 Frankhouser et al. Nov 1983 A
4429693 Blake et al. Feb 1984 A
4431005 McCormick Feb 1984 A
4431214 Buffington Feb 1984 A
4445501 Bresler May 1984 A
4459854 Richardson et al. Jul 1984 A
4469106 Harui Sep 1984 A
4483343 Beyer et al. Nov 1984 A
4491137 Jingu Jan 1985 A
4565201 Lass Jan 1986 A
4572198 Codrington Feb 1986 A
4577634 Gessman Mar 1986 A
4582067 Silverstein et al. Apr 1986 A
4587975 Salo et al. May 1986 A
4588394 Schulte et al. May 1986 A
4593687 Gray Jun 1986 A
4595012 Webler et al. Jun 1986 A
4601706 Aillon Jul 1986 A
4608989 Drue Sep 1986 A
4608992 Hakim et al. Sep 1986 A
4619247 Inoue et al. Oct 1986 A
4622644 Hansen Nov 1986 A
4644960 Johans Feb 1987 A
4652820 Maresca Mar 1987 A
4660571 Hess et al. Apr 1987 A
4665925 Millar May 1987 A
4667230 Arakawa et al. May 1987 A
4674518 Salo Jun 1987 A
4676249 Arenas et al. Jun 1987 A
4681106 Kensey et al. Jul 1987 A
4681117 Brodman et al. Jul 1987 A
4688578 Takano et al. Aug 1987 A
4692148 Kantrowitz et al. Sep 1987 A
4697595 Breyer et al. Oct 1987 A
4700997 Strand Oct 1987 A
4706681 Breyer et al. Nov 1987 A
4710708 Rorden et al. Dec 1987 A
4733669 Segal Mar 1988 A
4737794 Jones Apr 1988 A
4741356 Letzo et al. May 1988 A
4742356 Kuipers May 1988 A
4753247 Kirsner et al. Jun 1988 A
4770185 Silverstein et al. Sep 1988 A
4771788 Millar Sep 1988 A
4781685 Lehmann et al. Nov 1988 A
4784646 Feingold Nov 1988 A
4787070 Suzuki et al. Nov 1988 A
4787396 Pidorenko Nov 1988 A
4790809 Kuntz Dec 1988 A
4793361 DuFault Dec 1988 A
4794930 Machida et al. Jan 1989 A
4796632 Boyd et al. Jan 1989 A
4798588 Aillon Jan 1989 A
4798598 Bonello et al. Jan 1989 A
4809681 Kantrowitz et al. Mar 1989 A
4809713 Grayzel Mar 1989 A
4813729 Speckhart Mar 1989 A
4821731 Martinelli et al. Apr 1989 A
4836214 Sramek Jun 1989 A
4840182 Carlson Jun 1989 A
4840622 Hardy Jun 1989 A
4841977 Griffith et al. Jun 1989 A
4849692 Blood Jul 1989 A
4850358 Millar Jul 1989 A
4852580 Wood Aug 1989 A
4856317 Pidorenko et al. Aug 1989 A
4856529 Segal Aug 1989 A
4860757 Lynch et al. Aug 1989 A
4867169 Machida et al. Sep 1989 A
4869263 Segal et al. Sep 1989 A
4869718 Brader Sep 1989 A
4873987 Djordjevich et al. Oct 1989 A
4887606 Yock et al. Dec 1989 A
4887615 Taylor Dec 1989 A
4889128 Millar Dec 1989 A
4899756 Sonek Feb 1990 A
4901725 Nappholz et al. Feb 1990 A
4905698 Strohl, Jr. et al. Mar 1990 A
4911173 Terwilliger Mar 1990 A
4911174 Pederson et al. Mar 1990 A
4917669 Bonaldo Apr 1990 A
4924870 Wlodarczyk et al. May 1990 A
4943770 Ashley-Rollman et al. Jul 1990 A
4945305 Blood Jul 1990 A
4947852 Nassi et al. Aug 1990 A
4957110 Vogel et al. Sep 1990 A
4957111 Millar Sep 1990 A
4961433 Christian Oct 1990 A
4966148 Millar Oct 1990 A
4967753 Haase et al. Nov 1990 A
4977886 Takehana et al. Dec 1990 A
4989608 Ratner Feb 1991 A
4995396 Inaba et al. Feb 1991 A
4998916 Hammerslag et al. Mar 1991 A
5004456 Botterbusch et al. Apr 1991 A
5005592 Cartmell Apr 1991 A
5016173 Kenet et al. May 1991 A
5025799 Wilson Jun 1991 A
5029585 Lieber et al. Jul 1991 A
5040548 Yock Aug 1991 A
5042486 Pfeiler et al. Aug 1991 A
5045071 McCormick et al. Sep 1991 A
5046497 Millar Sep 1991 A
5050607 Bradley et al. Sep 1991 A
5057095 Fabian Oct 1991 A
5058583 Geddes et al. Oct 1991 A
5058595 Kern Oct 1991 A
5067489 Lind Nov 1991 A
5076278 Vilkomerson et al. Dec 1991 A
5078140 Kwoh Jan 1992 A
5078148 Nassi et al. Jan 1992 A
5078149 Katsumata et al. Jan 1992 A
5078678 Katims Jan 1992 A
5078714 Katims Jan 1992 A
5084022 Claude Jan 1992 A
5092341 Kelen Mar 1992 A
5099845 Besz et al. Mar 1992 A
5099850 Matsui et al. Mar 1992 A
5100387 Ng Mar 1992 A
5105829 Fabian et al. Apr 1992 A
5109862 Kelen et al. May 1992 A
5114401 Stuart et al. May 1992 A
5121750 Katims Jun 1992 A
5125410 Misono et al. Jun 1992 A
5134370 Jefferts et al. Jul 1992 A
5144955 O'Hara Sep 1992 A
5156151 Imran Oct 1992 A
5158086 Brown et al. Oct 1992 A
5160342 Reger et al. Nov 1992 A
5161536 Vilkomerson et al. Nov 1992 A
5174295 Christian et al. Dec 1992 A
5174299 Nelson Dec 1992 A
5184601 Putman Feb 1993 A
5190045 Frazin Mar 1993 A
5202985 Goyal Apr 1993 A
5205830 Dassa et al. Apr 1993 A
5211165 Dumoulin et al. May 1993 A
5211636 Mische May 1993 A
5212988 White et al. May 1993 A
5214615 Bauer et al. May 1993 A
5217026 Stoy et al. Jun 1993 A
5220924 Frazin Jun 1993 A
5233994 Shmulewitz Aug 1993 A
5235987 Wolfe Aug 1993 A
5239464 Blair et al. Aug 1993 A
5240004 Walinsky et al. Aug 1993 A
5243995 Maier Sep 1993 A
5246007 Frisbie et al. Sep 1993 A
5246426 Lewis et al. Sep 1993 A
5247171 Wlodarczyk et al. Sep 1993 A
5251635 Dumoulin et al. Oct 1993 A
5255680 Darrow et al. Oct 1993 A
5257636 White Nov 1993 A
5257979 Jagpal Nov 1993 A
5261409 Dardel Nov 1993 A
5265610 Darrow et al. Nov 1993 A
5265614 Hayakawa et al. Nov 1993 A
5267569 Lienhard Dec 1993 A
5270810 Nishimura Dec 1993 A
5271404 Corl et al. Dec 1993 A
5273025 Sakiyama et al. Dec 1993 A
5273042 Lynch et al. Dec 1993 A
5274551 Corby, Jr. Dec 1993 A
5275053 Wlodarczyk et al. Jan 1994 A
5279129 Ito Jan 1994 A
5279607 Schentag et al. Jan 1994 A
5280786 Wlodarczyk et al. Jan 1994 A
5287331 Schindel et al. Feb 1994 A
5289373 Zarge et al. Feb 1994 A
5292342 Nelson et al. Mar 1994 A
5307072 Jones, Jr. Apr 1994 A
5311871 Yock May 1994 A
5313949 Yock May 1994 A
5318025 Dumoulin et al. Jun 1994 A
5325860 Seward et al. Jul 1994 A
5325873 Hirschi et al. Jul 1994 A
5330496 Alferness Jul 1994 A
5331966 Bennett et al. Jul 1994 A
5333614 Feiring Aug 1994 A
5337678 Grout et al. Aug 1994 A
5341807 Nardella Aug 1994 A
5343865 Gardineer et al. Sep 1994 A
5345940 Seward et al. Sep 1994 A
5348020 Hutson Sep 1994 A
5350352 Buchholtz et al. Sep 1994 A
5357961 Fields et al. Oct 1994 A
5365935 Righter et al. Nov 1994 A
5366443 Eggers et al. Nov 1994 A
5368048 Stoy et al. Nov 1994 A
5375596 Twiss et al. Dec 1994 A
5376083 Mische Dec 1994 A
5377678 Dumoulin et al. Jan 1995 A
5385053 Wlodarczyk et al. Jan 1995 A
5391199 Ben-Haim Feb 1995 A
5394876 Ma Mar 1995 A
5394877 Orr et al. Mar 1995 A
5395366 D'Andrea et al. Mar 1995 A
5398683 Edwards et al. Mar 1995 A
5398691 Martin et al. Mar 1995 A
5411485 Tennican et al. May 1995 A
5413107 Oakley et al. May 1995 A
5417208 Winkler May 1995 A
5422478 Wlodarczyk et al. Jun 1995 A
5423334 Jordan Jun 1995 A
5423877 Mackey Jun 1995 A
5425367 Shapiro et al. Jun 1995 A
5425370 Vilkomerson Jun 1995 A
5425382 Golden et al. Jun 1995 A
5427114 Colliver et al. Jun 1995 A
5429132 Guy et al. Jul 1995 A
5429617 Hammersmark et al. Jul 1995 A
5431641 Grozinger et al. Jul 1995 A
5433729 Adams et al. Jul 1995 A
5437276 Takada et al. Aug 1995 A
5437277 Dumoulin et al. Aug 1995 A
5438873 Wlodarczyk et al. Aug 1995 A
5443066 Dumoulin et al. Aug 1995 A
5443489 Ben-Haim Aug 1995 A
5445150 Dumoulin et al. Aug 1995 A
5445166 Taylor Aug 1995 A
5450846 Goldreyer Sep 1995 A
5453575 O'Donnell et al. Sep 1995 A
5453576 Krivitski Sep 1995 A
5456256 Schneider Oct 1995 A
5456718 Szymaitis Oct 1995 A
5464016 Nicholas et al. Nov 1995 A
5474065 Meathrel et al. Dec 1995 A
5476090 Kishi Dec 1995 A
5480422 Ben-Haim Jan 1996 A
5487729 Avellanet et al. Jan 1996 A
5490522 Dardel Feb 1996 A
5492538 Johlin, Jr. Feb 1996 A
5494038 Wang et al. Feb 1996 A
5500011 Desai Mar 1996 A
5500012 Brucker et al. Mar 1996 A
5505205 Solomon et al. Apr 1996 A
5509822 Negus et al. Apr 1996 A
5513637 Twiss et al. May 1996 A
5515160 Schulz et al. May 1996 A
5515853 Smith et al. May 1996 A
5517989 Frisbie et al. May 1996 A
5522878 Montecalvo et al. Jun 1996 A
5522880 Barone et al. Jun 1996 A
5526812 Dumoulin et al. Jun 1996 A
5531664 Adachi et al. Jul 1996 A
5536248 Weaver et al. Jul 1996 A
5540230 Vilkomerson Jul 1996 A
5540681 Strul et al. Jul 1996 A
5542938 Avellanet et al. Aug 1996 A
5546949 Frazin et al. Aug 1996 A
5546951 Ben-Haim Aug 1996 A
5555618 Winkler Sep 1996 A
5558091 Acker et al. Sep 1996 A
5568809 Ben-haim Oct 1996 A
D375450 Bidwell et al. Nov 1996 S
5570671 Hickey Nov 1996 A
5575291 Hayakawa et al. Nov 1996 A
5588442 Scovil et al. Dec 1996 A
5592939 Martinelli Jan 1997 A
5598846 Peszynski Feb 1997 A
5599299 Weaver et al. Feb 1997 A
5600330 Blood Feb 1997 A
5603333 Konings Feb 1997 A
5610967 Moorman et al. Mar 1997 A
5617866 Marian, Jr. Apr 1997 A
5622169 Golden et al. Apr 1997 A
5622170 Schulz Apr 1997 A
5622184 Ashby et al. Apr 1997 A
5623931 Wung et al. Apr 1997 A
5624430 Eton et al. Apr 1997 A
5626554 Ryaby et al. May 1997 A
5626870 Monshipouri et al. May 1997 A
5630419 Ranalletta May 1997 A
5638819 Manwaring et al. Jun 1997 A
5644612 Moorman et al. Jul 1997 A
5645065 Shapiro et al. Jul 1997 A
5651047 Moorman et al. Jul 1997 A
5654864 Ritter et al. Aug 1997 A
D383968 Bidwell et al. Sep 1997 S
5662115 Torp et al. Sep 1997 A
5665103 Lafontaine et al. Sep 1997 A
5665477 Meathrel et al. Sep 1997 A
5666473 Wallace Sep 1997 A
5666958 Rothenberg et al. Sep 1997 A
5669383 Johnson Sep 1997 A
5669388 Vilkomerson Sep 1997 A
5676159 Navis Oct 1997 A
5676673 Ferre et al. Oct 1997 A
5682890 Kormos et al. Nov 1997 A
5691898 Rosenberg et al. Nov 1997 A
5694945 Ben-Haim Dec 1997 A
5695479 Jagpal Dec 1997 A
5697377 Wittkampf Dec 1997 A
5699801 Atalar et al. Dec 1997 A
5700889 Blair Dec 1997 A
5701898 Adam et al. Dec 1997 A
5702433 Taylor et al. Dec 1997 A
5711299 Manwaring et al. Jan 1998 A
5713362 Vilkomerson Feb 1998 A
5713363 Seward et al. Feb 1998 A
5713858 Heruth et al. Feb 1998 A
5713946 Ben-Haim Feb 1998 A
5715817 Stevens-Wright et al. Feb 1998 A
5716389 Walinsky et al. Feb 1998 A
5718241 Ben-Haim et al. Feb 1998 A
D391838 Bidwell et al. Mar 1998 S
5722412 Pflugrath et al. Mar 1998 A
5727550 Montecalvo Mar 1998 A
5727552 Ryan Mar 1998 A
5727553 Saad Mar 1998 A
5729055 Manning Mar 1998 A
5729129 Acker Mar 1998 A
5729584 Moorman et al. Mar 1998 A
5730129 Darrow et al. Mar 1998 A
5731996 Gilbert Mar 1998 A
5733323 Buck et al. Mar 1998 A
5738096 Ben-Haim Apr 1998 A
5740808 Panescu et al. Apr 1998 A
5742394 Hansen Apr 1998 A
5744953 Hansen Apr 1998 A
5748767 Raab May 1998 A
5749835 Glantz May 1998 A
5749938 Coombs May 1998 A
5751785 Moorman et al. May 1998 A
5752513 Acker et al. May 1998 A
5758650 Miller et al. Jun 1998 A
5762064 Polvani Jun 1998 A
5767669 Hansen et al. Jun 1998 A
5767960 Orman et al. Jun 1998 A
5769786 Wiegel Jun 1998 A
5769843 Abela et al. Jun 1998 A
5769881 Schroeppel et al. Jun 1998 A
5771896 Sliwa, Jr. et al. Jun 1998 A
5775322 Silverstein et al. Jul 1998 A
5775332 Goldman Jul 1998 A
5776064 Kalfas et al. Jul 1998 A
5776080 Thome et al. Jul 1998 A
5779638 Vesely et al. Jul 1998 A
5782767 Pretlow, III Jul 1998 A
5785657 Breyer et al. Jul 1998 A
5792055 McKinnon et al. Aug 1998 A
5795297 Daigle Aug 1998 A
5795298 Vesely et al. Aug 1998 A
5795632 Buchalter Aug 1998 A
5797849 Vesely et al. Aug 1998 A
5800352 Ferre et al. Sep 1998 A
5800410 Gawreluk Sep 1998 A
5800497 Bakels et al. Sep 1998 A
5803089 Ferre et al. Sep 1998 A
5810733 Van Creveld et al. Sep 1998 A
RE35924 Winkler Oct 1998 E
5817022 Vesely Oct 1998 A
5817024 Ogle et al. Oct 1998 A
5820549 Marian, Jr. Oct 1998 A
5824031 Cookston et al. Oct 1998 A
5827192 Gopakumaran et al. Oct 1998 A
5829444 Ferre et al. Nov 1998 A
5830145 Tenhoff Nov 1998 A
5831260 Hansen Nov 1998 A
5833608 Acker Nov 1998 A
5833622 Meathrel et al. Nov 1998 A
5835561 Moorman et al. Nov 1998 A
5836882 Frazin Nov 1998 A
5836990 Li Nov 1998 A
5840024 Taniguchi et al. Nov 1998 A
5840025 Ben-Haim Nov 1998 A
5840030 Ferek-Petric et al. Nov 1998 A
5840031 Crowley Nov 1998 A
5842986 Avrin et al. Dec 1998 A
5842998 Gopakumaran et al. Dec 1998 A
5843076 Webster, Jr. et al. Dec 1998 A
5843153 Johnston et al. Dec 1998 A
5844140 Seale Dec 1998 A
5846198 Killmann Dec 1998 A
5855553 Tajima et al. Jan 1999 A
5859893 Moorman et al. Jan 1999 A
5865748 Co et al. Feb 1999 A
5868673 Vesely Feb 1999 A
5873822 Ferre et al. Feb 1999 A
5876328 Fox et al. Mar 1999 A
5879297 Haynor et al. Mar 1999 A
5893363 Little et al. Apr 1999 A
5897495 Aida et al. Apr 1999 A
5899860 Pfeiffer et al. May 1999 A
5902238 Golden et al. May 1999 A
5907487 Rosenberg et al. May 1999 A
5908385 Chechelski et al. Jun 1999 A
5910113 Pruter Jun 1999 A
5910120 Kim et al. Jun 1999 A
5913820 Bladen et al. Jun 1999 A
5913830 Miles Jun 1999 A
5919141 Money et al. Jul 1999 A
5919170 Woessner Jul 1999 A
5928145 Ocali et al. Jul 1999 A
5929607 Rosenberg et al. Jul 1999 A
5931788 Keen et al. Aug 1999 A
5931818 Werp et al. Aug 1999 A
5931863 Griffin, III et al. Aug 1999 A
5941858 Johnson Aug 1999 A
5941889 Cermak Aug 1999 A
5941904 Johnston et al. Aug 1999 A
5944022 Nardella et al. Aug 1999 A
5944023 Johnson et al. Aug 1999 A
5951598 Bishay et al. Sep 1999 A
5953683 Hansen et al. Sep 1999 A
5957857 Hartley Sep 1999 A
5961923 Nova et al. Oct 1999 A
5967978 Littmann et al. Oct 1999 A
5967980 Ferre et al. Oct 1999 A
5967991 Gardineer et al. Oct 1999 A
5969722 Palm Oct 1999 A
5971933 Gopakumaran et al. Oct 1999 A
5978705 KenKnight et al. Nov 1999 A
5983126 Wittkampf Nov 1999 A
5984908 Davis et al. Nov 1999 A
5991693 Zalewski Nov 1999 A
5997473 Taniguchi et al. Dec 1999 A
5997481 Adams et al. Dec 1999 A
6006123 Nguyen et al. Dec 1999 A
6011988 Lynch et al. Jan 2000 A
6014473 Hossack et al. Jan 2000 A
6014580 Blume et al. Jan 2000 A
6015414 Werp et al. Jan 2000 A
6017496 Nova et al. Jan 2000 A
6019724 Gronningsaeter et al. Feb 2000 A
6019725 Vesely et al. Feb 2000 A
6023638 Swanson Feb 2000 A
6026312 Shemwell et al. Feb 2000 A
6031765 Lee et al. Feb 2000 A
6032070 Flock et al. Feb 2000 A
6039694 Larson et al. Mar 2000 A
6050718 Schena et al. Apr 2000 A
6052610 Koch Apr 2000 A
6052618 Dahlke et al. Apr 2000 A
D424693 Pruter May 2000 S
6059718 Taniguchi et al. May 2000 A
6064905 Webster, Jr. et al. May 2000 A
6066094 Ben-Haim May 2000 A
6068599 Saito et al. May 2000 A
6073043 Schneider Jun 2000 A
6074367 Hubbell Jun 2000 A
6075442 Welch Jun 2000 A
6076007 England et al. Jun 2000 A
6081737 Shah Jun 2000 A
6082366 Andra et al. Jul 2000 A
6083170 Ben-Haim Jul 2000 A
6099524 Lipson et al. Aug 2000 A
6100026 Nova et al. Aug 2000 A
6102044 Naidyhorski Aug 2000 A
6107699 Swanson Aug 2000 A
6112111 Glantz Aug 2000 A
6112115 Feldman et al. Aug 2000 A
6113504 Kuesters Sep 2000 A
6115624 Lewis et al. Sep 2000 A
6120445 Grunwald Sep 2000 A
6122538 Sliwa, Jr. et al. Sep 2000 A
6128174 Ritter et al. Oct 2000 A
6129668 Haynor et al. Oct 2000 A
6132378 Marino Oct 2000 A
6132379 Patacsil et al. Oct 2000 A
6135961 Pflugrath et al. Oct 2000 A
6136274 Nova et al. Oct 2000 A
6138681 Chen et al. Oct 2000 A
6139496 Chen et al. Oct 2000 A
6139502 Fredriksen Oct 2000 A
6144300 Dames et al. Nov 2000 A
6148823 Hastings Nov 2000 A
6152933 Werp et al. Nov 2000 A
6157853 Blume et al. Dec 2000 A
6165144 Talish et al. Dec 2000 A
6165977 Mochly-Rosen Dec 2000 A
6166496 Lys et al. Dec 2000 A
6166806 Tjin Dec 2000 A
6167765 Weitzel Jan 2001 B1
6172499 Ashe Jan 2001 B1
6173199 Gabriel Jan 2001 B1
6173715 Sinanan et al. Jan 2001 B1
6175756 Ferre et al. Jan 2001 B1
6176829 Vilkomerson Jan 2001 B1
6187744 Rooney Feb 2001 B1
6190370 Tsui Feb 2001 B1
6191136 Marban Feb 2001 B1
6193743 Brayton et al. Feb 2001 B1
6200305 Berthiaume et al. Mar 2001 B1
6203499 Imling et al. Mar 2001 B1
6208884 Kumar et al. Mar 2001 B1
6211626 Lys et al. Apr 2001 B1
6211666 Acker Apr 2001 B1
6212426 Swanson Apr 2001 B1
6216027 Willis et al. Apr 2001 B1
6216028 Haynor et al. Apr 2001 B1
6216029 Paltieli Apr 2001 B1
6223087 Williams Apr 2001 B1
6226547 Lockhart et al. May 2001 B1
6230042 Slettenmark May 2001 B1
6230046 Crane et al. May 2001 B1
6231518 Grabek et al. May 2001 B1
6233476 Strommer et al. May 2001 B1
6233994 Roy et al. May 2001 B1
6236883 Ciaccio et al. May 2001 B1
6238344 Gamelsky et al. May 2001 B1
6241673 Williams Jun 2001 B1
6246231 Ashe Jun 2001 B1
6246898 Vesely et al. Jun 2001 B1
6248072 Murkin Jun 2001 B1
6248074 Ohno et al. Jun 2001 B1
6248075 McGee et al. Jun 2001 B1
6253770 Acker et al. Jul 2001 B1
6258035 Hoeksel et al. Jul 2001 B1
6259941 Chia et al. Jul 2001 B1
6261231 Damphousse et al. Jul 2001 B1
6263230 Haynor et al. Jul 2001 B1
6266550 Selmon et al. Jul 2001 B1
6266551 Osadchy et al. Jul 2001 B1
6266552 Slettenmark Jul 2001 B1
6266563 KenKnight et al. Jul 2001 B1
6270493 Lalonde et al. Aug 2001 B1
6271833 Rosenberg et al. Aug 2001 B1
6272371 Shlomo Aug 2001 B1
6272374 Flock et al. Aug 2001 B1
6275258 Chim Aug 2001 B1
6275724 Dickinson et al. Aug 2001 B1
6277077 Brisken et al. Aug 2001 B1
6284459 Nova et al. Sep 2001 B1
6285898 Ben-Haim Sep 2001 B1
6287260 Hascoet et al. Sep 2001 B1
6288704 Flack et al. Sep 2001 B1
6292678 Hall et al. Sep 2001 B1
6292680 Somogyi et al. Sep 2001 B1
6292901 Lys et al. Sep 2001 B1
6293955 Houser et al. Sep 2001 B1
6296604 Garibaldi et al. Oct 2001 B1
6298261 Rex Oct 2001 B1
6304768 Blume et al. Oct 2001 B1
6306097 Park et al. Oct 2001 B1
6306105 Rooney et al. Oct 2001 B1
6311082 Creighton, IV et al. Oct 2001 B1
6315709 Garibaldi et al. Nov 2001 B1
6315727 Coleman et al. Nov 2001 B1
6319668 Nova et al. Nov 2001 B1
6323769 Dames et al. Nov 2001 B1
6323770 Dames et al. Nov 2001 B1
6324416 Seibert Nov 2001 B1
6325540 Lounsberry et al. Dec 2001 B1
6325762 Tjin Dec 2001 B1
6329139 Nova et al. Dec 2001 B1
6329916 Dames et al. Dec 2001 B1
6330467 Creighton, IV et al. Dec 2001 B1
6332089 Acker et al. Dec 2001 B1
6332874 Eliasen et al. Dec 2001 B1
6340588 Nova et al. Jan 2002 B1
6340868 Lys et al. Jan 2002 B1
6341231 Ferre et al. Jan 2002 B1
6346081 Vilkomerson Feb 2002 B1
6348911 Rosenberg et al. Feb 2002 B1
6350160 Feuersanger et al. Feb 2002 B1
6352363 Munger et al. Mar 2002 B1
6354999 Dgany et al. Mar 2002 B1
6355026 Mick Mar 2002 B1
6356791 Westlund et al. Mar 2002 B1
6360123 Kimchi et al. Mar 2002 B1
6361499 Bates et al. Mar 2002 B1
6364823 Garibaldi et al. Apr 2002 B1
6364839 Little et al. Apr 2002 B1
6366804 Mejia Apr 2002 B1
6368285 Osadchy et al. Apr 2002 B1
6370411 Osadchy et al. Apr 2002 B1
6373240 Govari Apr 2002 B1
6373388 Dames et al. Apr 2002 B1
6374134 Bladen et al. Apr 2002 B1
6374670 Spelman et al. Apr 2002 B1
6375606 Garibaldi et al. Apr 2002 B1
6375639 Duplessie et al. Apr 2002 B1
6377857 Brayton et al. Apr 2002 B1
6379302 Kessman et al. Apr 2002 B1
6379303 Seitz et al. Apr 2002 B1
6379307 Filly et al. Apr 2002 B1
6381485 Hunter et al. Apr 2002 B1
6385472 Hall et al. May 2002 B1
6385476 Osadchy et al. May 2002 B1
6398736 Seward Jun 2002 B1
6398738 Millar Jun 2002 B1
6401723 Garibaldi et al. Jun 2002 B1
6406422 Landesberg Jun 2002 B1
6406442 McFann et al. Jun 2002 B1
6412978 Watanabe et al. Jul 2002 B1
6412980 Lounsberry et al. Jul 2002 B1
6417839 Odell Jul 2002 B1
6418332 Mastrototaro et al. Jul 2002 B1
6418335 Avrin et al. Jul 2002 B2
6423002 Hossack Jul 2002 B1
6423050 Twardowski Jul 2002 B1
6427079 Schneider et al. Jul 2002 B1
6428551 Hall et al. Aug 2002 B1
6430315 Makram-Ebeid Aug 2002 B1
6432069 Godo et al. Aug 2002 B1
6438411 Guttman et al. Aug 2002 B1
6442416 Schultz Aug 2002 B1
6445943 Ferre et al. Sep 2002 B1
6456874 Hafer et al. Sep 2002 B1
6459919 Lys et al. Oct 2002 B1
6463121 Milnes Oct 2002 B1
6466815 Saito et al. Oct 2002 B1
6471656 Shalman et al. Oct 2002 B1
6471658 Daniels et al. Oct 2002 B1
6471700 Burbank et al. Oct 2002 B1
6473167 Odell Oct 2002 B1
6474341 Hunter et al. Nov 2002 B1
6475152 Kelly, Jr. et al. Nov 2002 B1
6475223 Werp et al. Nov 2002 B1
6477402 Lynch et al. Nov 2002 B1
6484118 Govari et al. Nov 2002 B1
6487916 Gomm et al. Dec 2002 B1
6491671 Larson, III et al. Dec 2002 B1
6493573 Martinelli et al. Dec 2002 B1
6494832 Feldman et al. Dec 2002 B1
6496715 Lee et al. Dec 2002 B1
6498944 Ben-Haim et al. Dec 2002 B1
6500141 Irion et al. Dec 2002 B1
6505062 Ritter et al. Jan 2003 B1
6506159 Hascoet et al. Jan 2003 B2
6507751 Blume et al. Jan 2003 B2
6508802 Rosengart et al. Jan 2003 B1
6511413 Landesberg Jan 2003 B2
6512958 Swoyer et al. Jan 2003 B1
6514226 Levin et al. Feb 2003 B1
6514249 Maguire et al. Feb 2003 B1
6515657 Zanelli Feb 2003 B1
6516212 Bladen et al. Feb 2003 B1
6516231 Flammang Feb 2003 B1
6516807 Panescu et al. Feb 2003 B1
6517520 Chang et al. Feb 2003 B2
6522906 Salisbury, Jr. et al. Feb 2003 B1
6522907 Bladen et al. Feb 2003 B1
6522909 Garibaldi et al. Feb 2003 B1
6524303 Garibaldi Feb 2003 B1
6528954 Lys et al. Mar 2003 B1
6528991 Ashe Mar 2003 B2
6529761 Creighton, IV et al. Mar 2003 B2
6529766 Guendel Mar 2003 B1
6534982 Jakab Mar 2003 B1
6535625 Chang et al. Mar 2003 B1
6537192 Elliott et al. Mar 2003 B1
6537196 Creighton, IV et al. Mar 2003 B1
6538634 Chui et al. Mar 2003 B1
6540699 Smith et al. Apr 2003 B1
6542766 Hall et al. Apr 2003 B2
6544251 Crawford Apr 2003 B1
6545678 Ohazama Apr 2003 B1
6546270 Goldin et al. Apr 2003 B1
6546279 Bova et al. Apr 2003 B1
6546787 Schiller et al. Apr 2003 B1
6552841 Lasser et al. Apr 2003 B1
6556858 Zeman Apr 2003 B1
6562019 Sell May 2003 B1
6564087 Pitris et al. May 2003 B1
6569101 Quistgaard et al. May 2003 B2
6569103 Hoeksel et al. May 2003 B2
6569160 Goldin et al. May 2003 B1
6569862 Marban May 2003 B1
6571004 Florent et al. May 2003 B1
6574518 Lounsberry et al. Jun 2003 B1
6575908 Barnes et al. Jun 2003 B2
6577080 Lys et al. Jun 2003 B2
6577896 Werner et al. Jun 2003 B2
6584343 Ransbury et al. Jun 2003 B1
6593754 Steber et al. Jul 2003 B1
6593884 Gilboa et al. Jul 2003 B1
6597943 Taha et al. Jul 2003 B2
6599249 Nordgren et al. Jul 2003 B1
6607488 Jackson et al. Aug 2003 B1
6610058 Flores Aug 2003 B2
6611141 Schulz et al. Aug 2003 B1
6615071 Casscells, III et al. Sep 2003 B1
6615155 Gilboa Sep 2003 B2
6616610 Steininger et al. Sep 2003 B2
6618612 Acker et al. Sep 2003 B1
6626832 Paltieli et al. Sep 2003 B1
6626834 Dunne et al. Sep 2003 B2
6626902 Kucharczyk et al. Sep 2003 B1
6630879 Creighton, IV et al. Oct 2003 B1
6635027 Cragg et al. Oct 2003 B1
6645148 Nguyen-Dinh et al. Nov 2003 B2
6648875 Simpson et al. Nov 2003 B2
6649914 Moorman et al. Nov 2003 B1
6652505 Tsugita Nov 2003 B1
6652506 Bowe et al. Nov 2003 B2
6660024 Flaherty et al. Dec 2003 B1
6662034 Segner et al. Dec 2003 B2
6663661 Boneau Dec 2003 B2
6666828 Greco et al. Dec 2003 B2
6672308 Gaspari Jan 2004 B1
6677752 Creighton, IV et al. Jan 2004 B1
6679857 Bastia et al. Jan 2004 B1
6684176 Willins et al. Jan 2004 B2
6685644 Seo Feb 2004 B2
6687531 Ferre et al. Feb 2004 B1
6689119 Di Caprio et al. Feb 2004 B1
6690963 Ben-Haim et al. Feb 2004 B2
6690964 Bieger et al. Feb 2004 B2
6690968 Mejia Feb 2004 B2
6694167 Ferre et al. Feb 2004 B1
6695786 Wang et al. Feb 2004 B2
6701179 Martinelli et al. Mar 2004 B1
6701918 Fariss et al. Mar 2004 B2
6702804 Ritter et al. Mar 2004 B1
6704590 Haldeman Mar 2004 B2
6709390 Marie Pop Mar 2004 B1
6711429 Gilboa et al. Mar 2004 B1
6711431 Sarin et al. Mar 2004 B2
6719699 Smith Apr 2004 B2
6719724 Walker et al. Apr 2004 B1
6719756 Muntermann Apr 2004 B1
6720745 Lys et al. Apr 2004 B2
6733458 Steins et al. May 2004 B1
6733511 Hall et al. May 2004 B2
6736782 Pfeiffer et al. May 2004 B2
6738656 Ferre et al. May 2004 B1
6740103 Hall et al. May 2004 B2
6743177 Ito Jun 2004 B2
6754596 Ashe Jun 2004 B2
6755789 Stringer et al. Jun 2004 B2
6755816 Ritter et al. Jun 2004 B2
6755822 Reu et al. Jun 2004 B2
6757557 Bladen et al. Jun 2004 B1
6763261 Casscells, III et al. Jul 2004 B2
6764449 Lee et al. Jul 2004 B2
6768496 Bieger et al. Jul 2004 B2
6772001 Maschke et al. Aug 2004 B2
6774624 Anderson et al. Aug 2004 B2
6783536 Vilsmeier et al. Aug 2004 B2
6784660 Ashe Aug 2004 B2
6785571 Glossop et al. Aug 2004 B2
6786219 Garibaldi et al. Sep 2004 B2
6786870 Miyaki et al. Sep 2004 B2
6788967 Ben-Haim et al. Sep 2004 B2
6794667 Noshi Sep 2004 B2
6799066 Steines et al. Sep 2004 B2
6815651 Odell Nov 2004 B2
6816266 Varshneya et al. Nov 2004 B2
6817364 Garibaldi Nov 2004 B2
6834201 Gillies et al. Dec 2004 B2
6844713 Steber et al. Jan 2005 B2
6845142 Ohishi Jan 2005 B2
6856823 Ashe Feb 2005 B2
6860422 Hull et al. Mar 2005 B2
6862467 Moore et al. Mar 2005 B2
6869390 Elliott et al. Mar 2005 B2
6875179 Ferguson et al. Apr 2005 B2
6879160 Jakab Apr 2005 B2
6887206 Hoeksel et al. May 2005 B2
6889091 Hine et al. May 2005 B2
6895268 Rahn et al. May 2005 B1
6902528 Garibaldi et al. Jun 2005 B1
6905469 Hascoet et al. Jun 2005 B2
6908433 Pruter Jun 2005 B1
6911026 Hall et al. Jun 2005 B1
6923782 O'Mahony et al. Aug 2005 B2
6926673 Roberts et al. Aug 2005 B2
6926674 Tenerz et al. Aug 2005 B2
6934575 Ferre et al. Aug 2005 B2
6936010 Fang et al. Aug 2005 B2
6939313 Saadat et al. Sep 2005 B2
6940379 Creighton Sep 2005 B2
6941166 MacAdam et al. Sep 2005 B2
6947788 Gilboa et al. Sep 2005 B2
6950689 Willis et al. Sep 2005 B1
6953754 Machida et al. Oct 2005 B2
6958677 Carter Oct 2005 B1
6959214 Pape et al. Oct 2005 B2
6962566 Quistgaard et al. Nov 2005 B2
6968846 Viswanathan Nov 2005 B2
6975197 Creighton, IV Dec 2005 B2
6976962 Bullis Dec 2005 B2
6976987 Flores Dec 2005 B2
6980843 Eng et al. Dec 2005 B2
6980852 Jersey-Willuhn et al. Dec 2005 B2
6980921 Anderson et al. Dec 2005 B2
6986739 Warren et al. Jan 2006 B2
6986744 Krivitski Jan 2006 B1
6999821 Jenney et al. Feb 2006 B2
7001355 Nunomura et al. Feb 2006 B2
7008418 Hall et al. Mar 2006 B2
7010338 Ritter et al. Mar 2006 B2
7015393 Weiner et al. Mar 2006 B2
7017584 Garibaldi et al. Mar 2006 B2
7019610 Creighton, IV et al. Mar 2006 B2
7020512 Ritter et al. Mar 2006 B2
D518574 Chaggares Apr 2006 S
7022075 Grunwald et al. Apr 2006 B2
7022082 Sonek Apr 2006 B2
7026927 Wright et al. Apr 2006 B2
7027634 Odell Apr 2006 B2
7028387 Huynh et al. Apr 2006 B1
7029446 Wendelken et al. Apr 2006 B2
7033603 Nelson et al. Apr 2006 B2
D520139 Chaggares May 2006 S
D520140 Chaggares May 2006 S
7038398 Lys et al. May 2006 B1
7038657 Rosenberg et al. May 2006 B2
7043293 Baura May 2006 B1
7048733 Hartley et al. May 2006 B2
7054228 Hickling May 2006 B1
7065403 Mouchawar et al. Jun 2006 B1
7066914 Andersen Jun 2006 B2
7066924 Garibaldi et al. Jun 2006 B1
7069072 Jansen et al. Jun 2006 B2
D525363 Chaggares Jul 2006 S
7070565 Vaezy et al. Jul 2006 B2
7072704 Bucholz Jul 2006 B2
7082325 Hashimshony et al. Jul 2006 B2
7090639 Govari Aug 2006 B2
7096059 Geddes et al. Aug 2006 B2
7096148 Anderson et al. Aug 2006 B2
7096870 Lamprich et al. Aug 2006 B2
7098907 Houston et al. Aug 2006 B2
7103205 Wang et al. Sep 2006 B2
7104980 Laherty et al. Sep 2006 B1
7106043 Da Silva et al. Sep 2006 B1
7106431 Odell Sep 2006 B2
7106479 Roy et al. Sep 2006 B2
7107105 Bjorklund et al. Sep 2006 B2
7112197 Hartley et al. Sep 2006 B2
7128734 Wilson et al. Oct 2006 B1
7132804 Lys et al. Nov 2006 B2
7137976 Ritter et al. Nov 2006 B2
7141019 Pearlman Nov 2006 B2
7141812 Appleby et al. Nov 2006 B2
7142905 Slayton et al. Nov 2006 B2
7148970 de Boer Dec 2006 B2
7153291 Bierman Dec 2006 B2
7161453 Creighton, IV Jan 2007 B2
7162291 Nachaliel Jan 2007 B1
7167738 Schweikard et al. Jan 2007 B2
7169107 Jersey-Willuhn et al. Jan 2007 B2
7169109 Jansen et al. Jan 2007 B2
7174201 Govari et al. Feb 2007 B2
7175646 Brenneman et al. Feb 2007 B2
7180252 Lys et al. Feb 2007 B2
7184820 Jersey-Willuhn et al. Feb 2007 B2
7189198 Harburn et al. Mar 2007 B2
7189205 McMorrow et al. Mar 2007 B2
7189208 Beatty et al. Mar 2007 B1
7190819 Viswanathan Mar 2007 B2
7194295 Vilsmeier Mar 2007 B2
7204798 Zdeblick et al. Apr 2007 B2
7206064 Rogers et al. Apr 2007 B2
7207941 Sharf Apr 2007 B2
7211082 Hall et al May 2007 B2
7214191 Stringer et al. May 2007 B2
7215326 Rosenberg May 2007 B2
7221104 Lys et al. May 2007 B2
7223256 Bierman May 2007 B2
7229400 Elliott et al. Jun 2007 B2
7231243 Tearney et al. Jun 2007 B2
7236157 Schena et al. Jun 2007 B2
7236816 Kumar et al. Jun 2007 B2
7236820 Mabary et al. Jun 2007 B2
7237313 Skujins et al. Jul 2007 B2
7241267 Furia Jul 2007 B2
7244234 Ridley et al. Jul 2007 B2
7248032 Hular et al. Jul 2007 B1
7248914 Hastings et al. Jul 2007 B2
7252633 Obata et al. Aug 2007 B2
7264584 Ritter et al. Sep 2007 B2
7270662 Visram et al. Sep 2007 B2
7276044 Ferry et al. Oct 2007 B2
7286034 Creighton Oct 2007 B2
7291146 Steinke et al. Nov 2007 B2
7297140 Orlu et al. Nov 2007 B2
7300430 Wilson et al. Nov 2007 B2
7302288 Schellenberg Nov 2007 B1
7308296 Lys et al. Dec 2007 B2
7310150 Guillermo et al. Dec 2007 B2
7311702 Tallarida et al. Dec 2007 B2
7321228 Govari Jan 2008 B2
7326241 Jang Feb 2008 B2
7327872 Vaillant et al. Feb 2008 B2
7342058 Peppmoller et al. Mar 2008 B2
7355716 de Boer et al. Apr 2008 B2
7360427 Drinkwater et al. Apr 2008 B2
7366376 Shishkov et al. Apr 2008 B2
7366562 Dukesherer et al. Apr 2008 B2
7366563 Kleen et al. Apr 2008 B2
7373271 Schneider May 2008 B1
7381204 Wilson et al. Jun 2008 B2
7382949 Bouma et al. Jun 2008 B2
7384407 Rodriguez et al. Jun 2008 B2
7418169 Tearney et al. Aug 2008 B2
7447408 Bouma et al. Nov 2008 B2
7452331 Pruter Nov 2008 B1
7452358 Stern et al. Nov 2008 B2
7454244 Kassab et al. Nov 2008 B2
D585556 Kosaku Jan 2009 S
7479141 Kleen et al. Jan 2009 B2
7519424 Dennis et al. Apr 2009 B2
7529584 Laske et al. May 2009 B2
7534223 Boutilette et al. May 2009 B2
7538859 Tearney et al. May 2009 B2
7543239 Viswanathan et al. Jun 2009 B2
7547282 Lo et al. Jun 2009 B2
7551293 Yelin et al. Jun 2009 B2
D603050 Chen Oct 2009 S
7599730 Hunter et al. Oct 2009 B2
7606615 Makower et al. Oct 2009 B2
7616992 Dennis et al. Nov 2009 B2
7627376 Dennis et al. Dec 2009 B2
7635336 Pruter Dec 2009 B1
7637163 Fetzer et al. Dec 2009 B2
7640053 Verin Dec 2009 B2
7651469 Osborne et al. Jan 2010 B2
7652080 Peppmoller et al. Jan 2010 B2
7660623 Hunter et al. Feb 2010 B2
7665893 Buchalter Feb 2010 B2
7668583 Fegert et al. Feb 2010 B2
7697972 Verard et al. Apr 2010 B2
7699782 Angelsen et al. Apr 2010 B2
7699829 Harris et al. Apr 2010 B2
7715925 Hafer et al. May 2010 B2
7727192 Tokumoto et al. Jun 2010 B2
7729743 Sabczynski et al. Jun 2010 B2
7751865 Jascob et al. Jul 2010 B2
7766839 Rogers et al. Aug 2010 B2
7771437 Hogg et al. Aug 2010 B2
7774051 Voth Aug 2010 B2
7774055 Min Aug 2010 B1
7794407 Rothenberg Sep 2010 B2
7798970 Lo et al. Sep 2010 B2
7819810 Stringer et al. Oct 2010 B2
7828528 Estes et al. Nov 2010 B2
7831294 Viswanathan Nov 2010 B2
7833168 Taylor et al. Nov 2010 B2
7833214 Wilson et al. Nov 2010 B2
D629526 Ladwig et al. Dec 2010 S
D629527 Crunkilton Dec 2010 S
7846157 Kozel Dec 2010 B2
7850613 Stribling Dec 2010 B2
D630756 Kitayama Jan 2011 S
D630757 Kitayama Jan 2011 S
7869854 Shachar et al. Jan 2011 B2
7873402 Shachar Jan 2011 B2
7909815 Whitmore, III et al. Mar 2011 B2
7931596 Rachlin et al. Apr 2011 B2
7947040 Davies et al. May 2011 B2
7976469 Bonde et al. Jul 2011 B2
7976518 Shaughnessy et al. Jul 2011 B2
7981038 Kanade et al. Jul 2011 B2
7988633 Hossack et al. Aug 2011 B2
8016814 Blakstvedt et al. Sep 2011 B2
8046052 Verard et al. Oct 2011 B2
8057394 Dala-Krishna Nov 2011 B2
8060185 Hunter et al. Nov 2011 B2
8078274 Kassab Dec 2011 B2
8078279 Dennis et al. Dec 2011 B2
8082032 Kassab et al. Dec 2011 B2
8088072 Munrow et al. Jan 2012 B2
8090430 Makower et al. Jan 2012 B2
8099161 Kassab Jan 2012 B2
8114143 Kassab et al. Feb 2012 B2
8118743 Park et al. Feb 2012 B2
8123691 Mine et al. Feb 2012 B2
8133698 Silver Mar 2012 B2
8142417 Pajunk et al. Mar 2012 B2
8150522 Echauz et al. Apr 2012 B2
8152724 Ridley et al. Apr 2012 B2
8204582 Zantos et al. Jun 2012 B2
8214018 Markowitz et al. Jul 2012 B2
8221402 Francischelli et al. Jul 2012 B2
8240211 Zeitner et al. Aug 2012 B2
8241274 Keogh et al. Aug 2012 B2
8244339 Shen et al. Aug 2012 B2
8255035 Cao et al. Aug 2012 B2
8260395 Markowitz et al. Sep 2012 B2
8262577 Munrow et al. Sep 2012 B2
8298149 Hastings et al. Oct 2012 B2
8303502 Washburn et al. Nov 2012 B2
8303505 Webler et al. Nov 2012 B2
8326419 Rosenberg et al. Dec 2012 B2
8340751 Markowitz et al. Dec 2012 B2
8369922 Paul et al. Feb 2013 B2
8388541 Messerly et al. Mar 2013 B2
8388546 Rothenberg Mar 2013 B2
8391956 Zellers et al. Mar 2013 B2
8401616 Verard et al. Mar 2013 B2
8409103 Grunwald et al. Apr 2013 B2
8425425 Hagy et al. Apr 2013 B2
8437833 Silverstein May 2013 B2
8439873 Donovan May 2013 B1
8442621 Gorek et al. May 2013 B2
8447384 Xu et al. May 2013 B2
D684265 Cadera Jun 2013 S
8456182 Bar-Tal et al. Jun 2013 B2
8478382 Burnside et al. Jul 2013 B2
8485980 Sinderby et al. Jul 2013 B2
8494608 Markowitz et al. Jul 2013 B2
8496592 Ridley et al. Jul 2013 B2
8512256 Rothenberg Aug 2013 B2
8527036 Jalde et al. Sep 2013 B2
8538509 Harlev et al. Sep 2013 B2
8774907 Rothenberg Jul 2014 B2
8781555 Burnside et al. Jul 2014 B2
8784336 Bown et al. Jul 2014 B2
8801693 He et al. Aug 2014 B2
8849382 Cox et al. Sep 2014 B2
8858455 Rothenberg Oct 2014 B2
9125578 Grunwald Sep 2015 B2
20020010392 Desai Jan 2002 A1
20020019447 Renn et al. Feb 2002 A1
20020022777 Crieghton et al. Feb 2002 A1
20020032391 McFann et al. Mar 2002 A1
20020049488 Boneau Apr 2002 A1
20020055680 Miele et al. May 2002 A1
20020082559 Chang et al. Jun 2002 A1
20020113555 Lys et al. Aug 2002 A1
20020123679 Dominguez Sep 2002 A1
20020128554 Seward Sep 2002 A1
20020129952 Matsudate et al. Sep 2002 A1
20020133079 Sandhu Sep 2002 A1
20020156363 Hunter et al. Oct 2002 A1
20020156376 Wang et al. Oct 2002 A1
20020165448 Ben-Haim et al. Nov 2002 A1
20020165534 Hayzelden et al. Nov 2002 A1
20020165537 Kelley et al. Nov 2002 A1
20020198568 Hafer et al. Dec 2002 A1
20030009132 Schwartz et al. Jan 2003 A1
20030011359 Ashe Jan 2003 A1
20030013966 Barnes et al. Jan 2003 A1
20030013986 Saadat Jan 2003 A1
20030036696 Willis et al. Feb 2003 A1
20030040671 Somogyi et al. Feb 2003 A1
20030040743 Cosman et al. Feb 2003 A1
20030072805 Miyazawa et al. Apr 2003 A1
20030073901 Simon et al. Apr 2003 A1
20030076281 Morgan et al. Apr 2003 A1
20030083698 Whitehurst et al. May 2003 A1
20030088195 Vardi et al. May 2003 A1
20030100849 Jang May 2003 A1
20030114742 Lewkowicz et al. Jun 2003 A1
20030114777 Griffin et al. Jun 2003 A1
20030120150 Govari Jun 2003 A1
20030120154 Sauer et al. Jun 2003 A1
20030139661 Kimchy et al. Jul 2003 A1
20030149328 Elliott et al. Aug 2003 A1
20030149368 Hennemann et al. Aug 2003 A1
20030152290 Odell Aug 2003 A1
20030160721 Gilboa et al. Aug 2003 A1
20030163037 Bladen et al. Aug 2003 A1
20030163142 Paltieli et al. Aug 2003 A1
20030171691 Casscells et al. Sep 2003 A1
20030173953 Ashe Sep 2003 A1
20030181892 Pajunk et al. Sep 2003 A1
20030184544 Prudent Oct 2003 A1
20030191392 Haldeman Oct 2003 A1
20030191460 Hobbs et al. Oct 2003 A1
20030195420 Mendlein et al. Oct 2003 A1
20030199746 Fuimaono et al. Oct 2003 A1
20030208142 Boudewijn et al. Nov 2003 A1
20030216639 Gilboa et al. Nov 2003 A1
20030220557 Cleary et al. Nov 2003 A1
20030220578 Ho et al. Nov 2003 A1
20030229298 Iwami et al. Dec 2003 A1
20030233042 Ashe Dec 2003 A1
20040010189 van Sloun et al. Jan 2004 A1
20040015070 Liang et al. Jan 2004 A1
20040024301 Hockett et al. Feb 2004 A1
20040030319 Korkor et al. Feb 2004 A1
20040054278 Kimchy et al. Mar 2004 A1
20040059237 Narayan et al. Mar 2004 A1
20040082916 Jenkins Apr 2004 A1
20040087877 Besz et al. May 2004 A1
20040088136 Ashe May 2004 A1
20040092962 Thornton et al. May 2004 A1
20040097803 Panescu May 2004 A1
20040097804 Sobe May 2004 A1
20040097805 Verard et al. May 2004 A1
20040097806 Hunter et al. May 2004 A1
20040116809 Chow et al. Jun 2004 A1
20040127805 MacAdam et al. Jul 2004 A1
20040131998 Marom et al. Jul 2004 A1
20040133111 Szczech et al. Jul 2004 A1
20040133130 Ferry et al. Jul 2004 A1
20040135069 Odell Jul 2004 A1
20040138557 Le et al. Jul 2004 A1
20040138564 Hwang et al. Jul 2004 A1
20040138570 Nita et al. Jul 2004 A1
20040147837 Macaulay et al. Jul 2004 A1
20040150963 Holmberg et al. Aug 2004 A1
20040152972 Hunter Aug 2004 A1
20040155609 Lys et al. Aug 2004 A1
20040158140 Fuimaono et al. Aug 2004 A1
20040171924 Mire et al. Sep 2004 A1
20040176688 Haldeman Sep 2004 A1
20040186461 DiMatteo Sep 2004 A1
20040199069 Connelly et al. Oct 2004 A1
20040210289 Wang et al. Oct 2004 A1
20040225233 Frankowski et al. Nov 2004 A1
20040230131 Kassab et al. Nov 2004 A1
20040230271 Wang et al. Nov 2004 A1
20040234453 Smith Nov 2004 A1
20040243018 Organ et al. Dec 2004 A1
20040243116 Joye et al. Dec 2004 A1
20040243118 Ayers et al. Dec 2004 A1
20040253365 Warren et al. Dec 2004 A1
20040254470 Drinkwater et al. Dec 2004 A1
20040254495 Mabary et al. Dec 2004 A1
20040260174 Keene Dec 2004 A1
20040267086 Anstadt et al. Dec 2004 A1
20050004450 Ben-Haim et al. Jan 2005 A1
20050021019 Hashimshony et al. Jan 2005 A1
20050033150 Takahashi et al. Feb 2005 A1
20050038355 Gellman et al. Feb 2005 A1
20050043640 Chang Feb 2005 A1
20050049486 Urquhart et al. Mar 2005 A1
20050049510 Haldeman et al. Mar 2005 A1
20050063194 Lys et al. Mar 2005 A1
20050070788 Wilson et al. Mar 2005 A1
20050075561 Golden Apr 2005 A1
20050085716 Hamm et al. Apr 2005 A1
20050085718 Shahidi Apr 2005 A1
20050085720 Jascob et al. Apr 2005 A1
20050090746 Ohtake Apr 2005 A1
20050101868 Ridley et al. May 2005 A1
20050101869 Burba et al. May 2005 A1
20050105081 Odell May 2005 A1
20050105101 Duling et al. May 2005 A1
20050112135 Cormier et al. May 2005 A1
20050113669 Helfer et al. May 2005 A1
20050113676 Weiner et al. May 2005 A1
20050113700 Yanagihara et al. May 2005 A1
20050113873 Weiner et al. May 2005 A1
20050113874 Connelly et al. May 2005 A1
20050113876 Weiner et al. May 2005 A1
20050148836 Kleen et al. Jul 2005 A1
20050149002 Wang et al. Jul 2005 A1
20050151489 Lys et al. Jul 2005 A1
20050154308 Quistgaard et al. Jul 2005 A1
20050159644 Takano Jul 2005 A1
20050159790 Shalev Jul 2005 A1
20050165301 Smith et al. Jul 2005 A1
20050165313 Byron et al. Jul 2005 A1
20050175665 Hunter et al. Aug 2005 A1
20050175703 Hunter et al. Aug 2005 A1
20050178395 Hunter et al. Aug 2005 A1
20050178396 Hunter et al. Aug 2005 A1
20050182295 Soper et al. Aug 2005 A1
20050197674 McCabe et al. Sep 2005 A1
20050203368 Verin Sep 2005 A1
20050203396 Angelsen et al. Sep 2005 A1
20050205081 Barker et al. Sep 2005 A1
20050215901 Anderson et al. Sep 2005 A1
20050215945 Harris et al. Sep 2005 A1
20050222532 Bertolero et al. Oct 2005 A1
20050240102 Rachlin et al. Oct 2005 A1
20050245811 Scheffler Nov 2005 A1
20050256398 Hastings et al. Nov 2005 A1
20050256451 Adams et al. Nov 2005 A1
20050256521 Kozel Nov 2005 A1
20050256541 Stypulkowski Nov 2005 A1
20050283216 Pyles Dec 2005 A1
20050288586 Ferek-Petric Dec 2005 A1
20060009759 Chrisitian et al. Jan 2006 A1
20060015003 Moaddes et al. Jan 2006 A1
20060025677 Verard et al. Feb 2006 A1
20060058633 Hoshino et al. Mar 2006 A1
20060068074 Stefandl Mar 2006 A1
20060084867 Tremblay et al. Apr 2006 A1
20060106306 Essner et al. May 2006 A1
20060116571 Maschke et al. Jun 2006 A1
20060116576 McGee et al. Jun 2006 A1
20060116578 Grunwald et al. Jun 2006 A1
20060149134 Soper et al. Jul 2006 A1
20060173251 Govari et al. Aug 2006 A1
20060173329 Irioka et al. Aug 2006 A1
20060173407 Shaughnessy et al. Aug 2006 A1
20060176242 Jaramaz et al. Aug 2006 A1
20060184074 Vaezy et al. Aug 2006 A1
20060206037 Braxton Sep 2006 A1
20060211944 Mauge et al. Sep 2006 A1
20060217655 Vitullo et al. Sep 2006 A1
20060224188 Libbus et al. Oct 2006 A1
20060247746 Danek et al. Nov 2006 A1
20060276867 Viswanathan Dec 2006 A1
20070010753 MacAdam Jan 2007 A1
20070016007 Govari et al. Jan 2007 A1
20070016013 Camus Jan 2007 A1
20070016068 Grunwald et al. Jan 2007 A1
20070016069 Grunwald et al. Jan 2007 A1
20070016070 Grunwald et al. Jan 2007 A1
20070016072 Grunwald et al. Jan 2007 A1
20070032746 Sell Feb 2007 A1
20070038113 Oonuki et al. Feb 2007 A1
20070049822 Bunce et al. Mar 2007 A1
20070049846 Bown et al. Mar 2007 A1
20070055141 Kruger et al. Mar 2007 A1
20070055142 Webler Mar 2007 A1
20070060992 Pappone Mar 2007 A1
20070062544 Rauk Bergstrom et al. Mar 2007 A1
20070066888 Maschke Mar 2007 A1
20070073155 Park et al. Mar 2007 A1
20070087038 Richardson et al. Apr 2007 A1
20070093710 Maschke Apr 2007 A1
20070100236 McMorrow et al. May 2007 A1
20070100285 Griffin et al. May 2007 A1
20070112282 Skujins et al. May 2007 A1
20070123805 Shireman et al. May 2007 A1
20070129770 Younis Jun 2007 A1
20070135803 Belson Jun 2007 A1
20070135886 Maschke Jun 2007 A1
20070156205 Larson et al. Jul 2007 A1
20070161853 Yagi et al. Jul 2007 A1
20070161914 Zdeblick et al. Jul 2007 A1
20070161915 Desai Jul 2007 A1
20070167738 Timinger et al. Jul 2007 A1
20070167762 Kim et al. Jul 2007 A1
20070167769 Ikuma et al. Jul 2007 A1
20070167801 Webler et al. Jul 2007 A1
20070167997 Forsberg et al. Jul 2007 A1
20070197905 Timinger et al. Aug 2007 A1
20070208255 Ridley et al. Sep 2007 A1
20070219453 Kremliovsky et al. Sep 2007 A1
20070225589 Viswanathan Sep 2007 A1
20070225610 Mickley et al. Sep 2007 A1
20070232882 Glossop et al. Oct 2007 A1
20070232896 Gilboa et al. Oct 2007 A1
20070238984 Maschke et al. Oct 2007 A1
20070239018 Fetzer et al. Oct 2007 A1
20070244413 Biggins Oct 2007 A1
20070247454 Rahn et al. Oct 2007 A1
20070249911 Simon Oct 2007 A1
20070255270 Carney Nov 2007 A1
20070265526 Govari et al. Nov 2007 A1
20070280974 Son et al. Dec 2007 A1
20070282196 Birk et al. Dec 2007 A1
20070282197 Bill et al. Dec 2007 A1
20070299352 Harlev et al. Dec 2007 A1
20070299353 Harlev et al. Dec 2007 A1
20080004652 Abboud et al. Jan 2008 A1
20080008745 Stinchcomb et al. Jan 2008 A1
20080009720 Schefelker et al. Jan 2008 A1
20080015442 Watson et al. Jan 2008 A1
20080027320 Bolorforosh et al. Jan 2008 A1
20080033283 Dellaca et al. Feb 2008 A1
20080033316 Kassab et al. Feb 2008 A1
20080033350 Wilson et al. Feb 2008 A1
20080045908 Gould et al. Feb 2008 A1
20080051626 Sato et al. Feb 2008 A1
20080077158 Haider et al. Mar 2008 A1
20080081958 Denison et al. Apr 2008 A1
20080082136 Gaudiani Apr 2008 A1
20080097232 Rothenberg Apr 2008 A1
20080108949 Beasley et al. May 2008 A1
20080114095 Peppmoller et al. May 2008 A1
20080125772 Stone et al. May 2008 A1
20080139944 Weymer et al. Jun 2008 A1
20080146939 McMorrow et al. Jun 2008 A1
20080146940 Jenkins et al. Jun 2008 A1
20080146942 Dala-Krishna Jun 2008 A1
20080154100 Thalmeier et al. Jun 2008 A1
20080166453 Steele et al. Jul 2008 A1
20080171934 Greenan et al. Jul 2008 A1
20080183075 Govari et al. Jul 2008 A1
20080188830 Rosenblatt et al. Aug 2008 A1
20080190438 Harlev et al. Aug 2008 A1
20080195169 Pinter et al. Aug 2008 A1
20080200754 Buchalter Aug 2008 A1
20080228082 Scheirer et al. Sep 2008 A1
20080236598 Gobel Oct 2008 A1
20080255404 Nogawa et al. Oct 2008 A1
20080255475 Kondrosky et al. Oct 2008 A1
20080269581 Wood et al. Oct 2008 A1
20080269611 Pedrizzetti et al. Oct 2008 A1
20080275465 Paul et al. Nov 2008 A1
20080275765 Kuchar Nov 2008 A1
20080288038 Paul et al. Nov 2008 A1
20080294041 Kassab Nov 2008 A1
20080319350 Wallace et al. Dec 2008 A1
20090005674 Saadat et al. Jan 2009 A1
20090005675 Grunwald et al. Jan 2009 A1
20090018497 Birchard et al. Jan 2009 A1
20090024018 Boyden et al. Jan 2009 A1
20090030380 Binmoeller Jan 2009 A1
20090043205 Pelissier et al. Feb 2009 A1
20090062684 Gregersen et al. Mar 2009 A1
20090082661 Saladin et al. Mar 2009 A1
20090084382 Jalde et al. Apr 2009 A1
20090101577 Fulkerson et al. Apr 2009 A1
20090118612 Grunwald et al. May 2009 A1
20090118637 Kassab et al. May 2009 A1
20090118706 Schweikert et al. May 2009 A1
20090124901 Fink et al. May 2009 A1
20090143736 Mittermeyer et al. Jun 2009 A1
20090156926 Messerly et al. Jun 2009 A1
20090163810 Kanade et al. Jun 2009 A1
20090171217 Kim et al. Jul 2009 A1
20090177083 Matsumura Jul 2009 A1
20090177090 Grunwald et al. Jul 2009 A1
20090203989 Burnside et al. Aug 2009 A1
20090204113 MacAdam et al. Aug 2009 A1
20090209872 Pop Aug 2009 A1
20090209950 Starksen Aug 2009 A1
20090221908 Glossop Sep 2009 A1
20090227952 Blakstvedt et al. Sep 2009 A1
20090234328 Cox et al. Sep 2009 A1
20090258171 Uang Oct 2009 A1
20090259124 Rothenberg Oct 2009 A1
20090262982 Markowitz et al. Oct 2009 A1
20090270729 Corbucci et al. Oct 2009 A1
20090270746 Min Oct 2009 A1
20090275828 Shachar et al. Nov 2009 A1
20090297441 Canham et al. Dec 2009 A1
20100004543 Ahlund et al. Jan 2010 A1
20100004547 Scholz et al. Jan 2010 A1
20100010355 Kassab Jan 2010 A1
20100010444 Bettuchi Jan 2010 A1
20100010612 Gelbart et al. Jan 2010 A1
20100016726 Meier Jan 2010 A1
20100036227 Cox et al. Feb 2010 A1
20100036284 Laynes et al. Feb 2010 A1
20100041973 Vu et al. Feb 2010 A1
20100041984 Shapland et al. Feb 2010 A1
20100049062 Ziv Feb 2010 A1
20100055153 Majmudar Mar 2010 A1
20100055184 Zeitels et al. Mar 2010 A1
20100057157 Govari et al. Mar 2010 A1
20100060472 Kimura et al. Mar 2010 A1
20100063401 Nishina et al. Mar 2010 A1
20100076305 Maier-Hein et al. Mar 2010 A1
20100076328 Matsumura et al. Mar 2010 A1
20100081934 Soltani et al. Apr 2010 A1
20100083719 Peppmoller et al. Apr 2010 A1
20100094116 Silverstein Apr 2010 A1
20100106011 Byrd et al. Apr 2010 A1
20100114573 Huang et al. May 2010 A1
20100117659 Osadchy et al. May 2010 A1
20100143119 Kooijman et al. Jun 2010 A1
20100152596 Griffiths et al. Jun 2010 A1
20100168557 Deno et al. Jul 2010 A1
20100185097 Hall Jul 2010 A1
20100198048 Togawa Aug 2010 A1
20100198346 Keogh et al. Aug 2010 A1
20100204569 Burnside et al. Aug 2010 A1
20100210938 Verard et al. Aug 2010 A1
20100210950 Dunbar et al. Aug 2010 A1
20100217116 Eck et al. Aug 2010 A1
20100222664 Lemon et al. Sep 2010 A1
20100222786 Kassab Sep 2010 A1
20100234733 Wahlheim Sep 2010 A1
20100249598 Smith et al. Sep 2010 A1
20100258033 Yang et al. Oct 2010 A1
20100268059 Ryu et al. Oct 2010 A1
20100273895 Stinchcomb et al. Oct 2010 A1
20100291521 Simon Nov 2010 A1
20100298702 Rogers et al. Nov 2010 A1
20100298704 Pelissier et al. Nov 2010 A1
20100298705 Pelissier et al. Nov 2010 A1
20100298712 Pelissier et al. Nov 2010 A1
20100312086 Beatty et al. Dec 2010 A9
20100317981 Grunwald Dec 2010 A1
20100318026 Grunwald Dec 2010 A1
20100331712 Rothenberg Dec 2010 A1
20110015527 Heasty et al. Jan 2011 A1
20110015533 Cox et al. Jan 2011 A1
20110034823 Gelbart et al. Feb 2011 A1
20110034940 Payner Feb 2011 A1
20110040212 Dietz et al. Feb 2011 A1
20110052694 Stinchcomb et al. Mar 2011 A1
20110087105 Ridley et al. Apr 2011 A1
20110087106 Ridley et al. Apr 2011 A1
20110087107 Lindekugel et al. Apr 2011 A1
20110112396 Shachar et al. May 2011 A1
20110136242 Marx et al. Jun 2011 A1
20110196235 Dunbar et al. Aug 2011 A1
20110196248 Grunwald Aug 2011 A1
20110196255 Kassab Aug 2011 A1
20110237935 Kalpin et al. Sep 2011 A1
20110245659 Ma et al. Oct 2011 A1
20110282187 Harlev et al. Nov 2011 A1
20110282188 Burnside et al. Nov 2011 A1
20110295108 Cox et al. Dec 2011 A1
20110306867 Gopinathan et al. Dec 2011 A1
20110313293 Lindekugel et al. Dec 2011 A1
20120004564 Dobak, III Jan 2012 A1
20120035460 Stangenes et al. Feb 2012 A1
20120046562 Powers et al. Feb 2012 A1
20120059249 Verard et al. Mar 2012 A1
20120059270 Grunwald Mar 2012 A1
20120071751 Sra et al. Mar 2012 A1
20120071759 Hagy et al. Mar 2012 A1
20120071782 Patil et al. Mar 2012 A1
20120078342 Vollkron et al. Mar 2012 A1
20120095319 Kondrosky et al. Apr 2012 A1
20120108950 He et al. May 2012 A1
20120143029 Silverstein et al. Jun 2012 A1
20120143078 Kassab et al. Jun 2012 A1
20120172727 Hastings et al. Jul 2012 A1
20120220854 Messerly et al. Aug 2012 A1
20120283582 Mahapatra et al. Nov 2012 A1
20120296200 Shachar et al. Nov 2012 A1
20120310052 Mahapatra et al. Dec 2012 A1
20120310066 Shachar et al. Dec 2012 A1
20120316440 Munrow et al. Dec 2012 A1
20130006102 Wilkes et al. Jan 2013 A1
20130018248 Hurezan Jan 2013 A1
20130035590 Ma et al. Feb 2013 A1
20130041269 Stahmann et al. Feb 2013 A1
20130060116 Messerly et al. Mar 2013 A1
20130085416 Mest Apr 2013 A1
20130102890 Dib Apr 2013 A1
20130123597 Rothenberg May 2013 A1
20130217999 Burnside et al. Aug 2013 A1
20130245434 Messerly et al. Sep 2013 A1
20130303896 Kalpin et al. Nov 2013 A1
20130317338 Silverstein Nov 2013 A1
20130324841 Kamen et al. Dec 2013 A1
20130338503 Cohen et al. Dec 2013 A1
20130338517 Rothenberg Dec 2013 A1
20130345555 Kanade et al. Dec 2013 A1
20140031674 Newman et al. Jan 2014 A1
20140046261 Newman et al. Feb 2014 A1
20140094694 Moctezuma de la Barrera Apr 2014 A1
20140107475 Cox et al. Apr 2014 A1
20140163356 Burnside et al. Jun 2014 A2
20140180074 Green et al. Jun 2014 A1
20140188133 Misener Jul 2014 A1
20140228689 Ishikawa et al. Aug 2014 A1
20140275957 Lupotti Sep 2014 A1
20140275990 Hagy et al. Sep 2014 A1
20140303492 Burnside et al. Oct 2014 A1
20140309624 Bown et al. Oct 2014 A1
20140343398 He et al. Nov 2014 A1
20150005621 Liu Jan 2015 A1
20150018701 Cox et al. Jan 2015 A1
20150025402 Rothenberg Jan 2015 A1
20150051489 Caluser et al. Feb 2015 A1
20150080716 Powers et al. Mar 2015 A1
20150297114 Cox et al. Oct 2015 A1
Foreign Referenced Citations (189)
Number Date Country
642647 Nov 1990 AU
1860597 Jun 1999 AU
20009592 Sep 2000 AU
20015250 Jun 2001 AU
768362 Dec 2003 AU
2001229024 Sep 2005 AU
2001283703 May 2006 AU
2006202149 Jun 2006 AU
2006904933 Sep 2006 AU
2006283022 Feb 2012 AU
2420676 Feb 2002 CA
2619909 Jan 2014 CA
2031655 Feb 1989 CN
1672649 Sep 2005 CN
102209490 Oct 2011 CN
102802514 Nov 2012 CN
102821679 Dec 2012 CN
103037761 Apr 2013 CN
103037762 Apr 2013 CN
103118591 May 2013 CN
4319033 Jun 1994 DE
0359697 Mar 1990 EP
0362821 Apr 1990 EP
0399536 Nov 1990 EP
0823261 Feb 1998 EP
0928976 Jul 1999 EP
1025805 Aug 2000 EP
1311226 May 2003 EP
1504713 Feb 2005 EP
1932477 Jun 2008 EP
2313143 Apr 2011 EP
2440122 Apr 2012 EP
2464407 Jun 2012 EP
2482719 Aug 2012 EP
2575610 Apr 2013 EP
2575611 Apr 2013 EP
2603145 Jun 2013 EP
2605699 Jun 2013 EP
2618727 Jul 2013 EP
2632360 Sep 2013 EP
2219526 Mar 2014 EP
2712547 Apr 2014 EP
2545349 Nov 1984 FR
9721DELNP2011 Jan 2013 IN
01097440 Apr 1989 JP
03173542 Jul 1991 JP
4090741 Aug 1992 JP
9-503054 Mar 1997 JP
09-094298 Apr 1997 JP
10043310 Feb 1998 JP
10290839 Nov 1998 JP
11128237 May 1999 JP
2001161683 Jun 2001 JP
2001-514533 Sep 2001 JP
2001-524339 Dec 2001 JP
2001340334 Dec 2001 JP
2002-529133 Sep 2002 JP
2002-541947 Dec 2002 JP
2003-010138 Jan 2003 JP
2003501127 Jan 2003 JP
2003061752 Mar 2003 JP
2003299654 Oct 2003 JP
2003334191 Nov 2003 JP
2002520893 Feb 2004 JP
2004505748 Feb 2004 JP
2004515298 May 2004 JP
2006508744 Mar 2006 JP
2006-338526 Dec 2006 JP
2007-000226 Jan 2007 JP
2007-068989 Mar 2007 JP
2009271123 Nov 2009 JP
5010604 Jun 2012 JP
2012-529929 Nov 2012 JP
2013-518676 May 2013 JP
2013-526959 Jun 2013 JP
2013-526961 Jun 2013 JP
8002376 Nov 1980 WO
9112836 Sep 1991 WO
9203090 Mar 1992 WO
9403159 Feb 1994 WO
9404938 Mar 1994 WO
9605768 Feb 1996 WO
9607352 Mar 1996 WO
9641119 Dec 1996 WO
9729683 Aug 1997 WO
9743989 Nov 1997 WO
9825159 Jun 1998 WO
9835611 Aug 1998 WO
9916495 Apr 1999 WO
9927837 Jun 1999 WO
9949407 Sep 1999 WO
0019906 Apr 2000 WO
0027281 May 2000 WO
0040155 Jul 2000 WO
0063658 Oct 2000 WO
0074775 Dec 2000 WO
0113792 Mar 2001 WO
0139683 Jun 2001 WO
0176479 Oct 2001 WO
0215973 Feb 2002 WO
0219905 Mar 2002 WO
0225277 Mar 2002 WO
02085442 Oct 2002 WO
03061752 Jul 2003 WO
03077759 Sep 2003 WO
03091495 Nov 2003 WO
2004002303 Jan 2004 WO
2004049970 Jun 2004 WO
2005033524 Apr 2005 WO
2005033574 Apr 2005 WO
2005117690 Dec 2005 WO
2005117733 Dec 2005 WO
2006074509 Jul 2006 WO
2006074510 Jul 2006 WO
2006078677 Jul 2006 WO
2006103661 Oct 2006 WO
2006111056 Oct 2006 WO
2007002541 Jan 2007 WO
2007005976 Jan 2007 WO
2007014447 Feb 2007 WO
2007034196 Mar 2007 WO
2007067324 Jun 2007 WO
2007069168 Jun 2007 WO
2007109123 Sep 2007 WO
2007126536 Nov 2007 WO
2007144894 Dec 2007 WO
2008005480 Jan 2008 WO
2008024596 Feb 2008 WO
2008028253 Mar 2008 WO
2008083111 Jul 2008 WO
2008097767 Aug 2008 WO
2008118992 Oct 2008 WO
2008126074 Oct 2008 WO
2008129326 Oct 2008 WO
2008131017 Oct 2008 WO
2008136008 Nov 2008 WO
2009000439 Dec 2008 WO
2009002514 Dec 2008 WO
2009003138 Dec 2008 WO
2009009064 Jan 2009 WO
2009057774 May 2009 WO
2009063166 May 2009 WO
2009067654 May 2009 WO
2009070616 Jun 2009 WO
2009100158 Aug 2009 WO
2009123819 Oct 2009 WO
2009126340 Oct 2009 WO
2009129475 Oct 2009 WO
2009129477 Oct 2009 WO
2009134605 Nov 2009 WO
2009137262 Nov 2009 WO
2010002313 Jan 2010 WO
2010018500 Feb 2010 WO
2010022370 Feb 2010 WO
2010027349 Mar 2010 WO
2010027471 Mar 2010 WO
2010029906 Mar 2010 WO
2010030820 Mar 2010 WO
2010132857 Nov 2010 WO
2010132985 Nov 2010 WO
2010143196 Dec 2010 WO
2010144922 Dec 2010 WO
2011019760 Feb 2011 WO
2011041450 Apr 2011 WO
2011044421 Apr 2011 WO
2011057289 May 2011 WO
2011064209 Jun 2011 WO
2011084593 Jul 2011 WO
2011097312 Aug 2011 WO
2011128052 Oct 2011 WO
2011150358 Dec 2011 WO
2011150376 Dec 2011 WO
2012021542 Feb 2012 WO
2012024577 Feb 2012 WO
2012039866 Mar 2012 WO
2012040487 Mar 2012 WO
2012058461 May 2012 WO
2012083245 Jun 2012 WO
2012088535 Jun 2012 WO
2012110955 Aug 2012 WO
2012173697 Dec 2012 WO
2013006713 Jan 2013 WO
2013006817 Jan 2013 WO
2013034175 Mar 2013 WO
2014052894 Apr 2014 WO
2014062728 Apr 2014 WO
2014138652 Sep 2014 WO
2014138918 Sep 2014 WO
2015120256 Aug 2015 WO
Non-Patent Literature Citations (411)
Entry
VasoNova Inc, Vascular navigation system for accurate placement of PICCs, Start-Up Emerging Medical Ventures, pp. 44-45, vol. 14 No. 7, Jul.-Aug. 2009.
Vesely, Thomas M. et al., Central Venous Catheter Tip Position: A Continuing Controversy, J Vasc Intery Radiol 2003; 14:527-534.
VIASYS Health Care Inc. Cortrak© Fact Sheet, 2005.
VIASYS Healthcare MedSystems, Navigator® Benefits, 2008.
VIASYS Healthcare MedSystems, Navigator® Research in Cost Justification, 2008.
VIASYS MedSystems, Cortrak™ Systems Brochure, 2005.
Volcano ComboMap Features and Benefits/Technical Specifications, 2 pages, 2011.
Watters, et al. “Use of Electrocardiogram to Position Right Atrial Catheters During Surgery.” Annals of Surgery, vol. 225, No. 2, pp. 165-171, 1997.
Welch Allyn Cardioperfect® PC-Based Resting ECG, 2003.
Wilson, R. G. et al, Right Atrial Electrocardiography in Placement of Central Venous Catheters, The Lancet, pp. 462-463, Feb. 27, 1988.
Wong, Jeffrey J. et al., Azygos Tip Placement for Hemodialysis Catheters in Patients with Superior Vena Cava Occlusion, Cardiovasc Intervent Radiol (2006) 29:143-146.
Worley, Seth J. “Use of a Real-Time Three-Dimensional Magenetic Navigation System for Radiofrequency Ablation of Accessory Pathways.” PACE, vol. 21 pp. 1636-1643, Aug. 1998.
Yilmazlar A et al, Complications of 1303 Central Venous Cannulations, J R Soc Med, pp. 319-321, vol. 90 No. 6, Jun. 1997 (Abstract only).
Yoon, SZ et al, Usefulness of the Carina as a Radiographic Landmark for Central Venous Catheter Placement in Paediatric Patients, Br J Anaesth, Jul. 2005.
Yoshida, Teruhisa et al, Detection of Concealed Left Sided Accessory Atrioventricular Pathway by P Wave Signal Averaged Electrocardiogram, J Am Coll Cardiol, pp. 55-62, 1999.
Zaaroor, et al. “Novel Magnetic Technology for Intraoperative Intracranial Frameless Navigation: In Vivo and in Vitro Results.” Neurosurgery, vol. 48, No. 5. pp. 1100-1107, May 2001.
Zachariou, Zacharias et al., Intra-atrial ECG recording: a new and safe method for implantation of Broviac catheters in children, Pediatr Surg Int (1994) 9: 457-458.
PCT/US2012/045814 filed Jul. 6, 2012 International Search Report and Written Opinion dated Oct. 1, 2012.
PCT/US2013/065121 filed Oct. 15, 2013 International Search Report and Written Opinion dated Jan. 16, 2014.
Pennington, C.R., Right Atrial Thrombus: a Complication of Total Parenteral Nutrition, British Medical Journal, pp. 446-447, vol. 295, Aug. 15, 1987.
Petersen, J et al, Silicone Venous Access Devices Positioned with their Tip High in the Superior Vena Cava are More Likely to Malfunction, Am J Surg, pp. 38-41, vol. 178 No. 1, Jul. 1999.
Pittiruti, et al, Intracavitary EKG Monitoring: A reliable method for controlling tip position during and after PICC Insertion presentation in Catholic University, Rome, Italy in 2008.
Pittiruti, et al. “The EKG Method for Positioning the Tip of PICCs: Results from Two Preliminary Studies.” JAVA, vol. 13, No. 4, pp. 179-185, 2008.
Polos, PG et al, Tips for Monitoring the Position of a Central Venous Catheter—How Placement can go awry—even when the anatomy is normal, J Crit Illn, pp. 660-674, vol. 8 No. 6, Jun. 1993 (Abstract only).
Pop, Gheorghe A. et al., Catheter-based impedance measurements in the right atrium for continuously monitoring hematocrit and estimating blood viscosity changes; an in vivo feasibility study in swine, Biosensors and Bioelectronics 19 (2004) 1685-1693.
Popp, M. B. et al., Accuracy of implanted port placement with the use of the electromagnetic CathTrack® catheter locator system, The Journal of Vascular Access 2005; 6: 9-12.
Randolph AG et al, Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature, Critcal Care Medicine, pp. 2053-2058, vol. 24, Dec. 1996.
Reece, A et al, Posititioning Long Lines: Contrast Versus Plain Radiography, Arch Dis Child Fetal Neonatal Ed, pp. 129-130, vol. 84 No. 2, Mar. 2001.
Reynolds, N et al, Assessment of Distal Tip Position of Long Term Central Venous Feeding Catheters using Transesophageal Echocardiology, JPEN J Parenter Enteral Nutr, pp. 39-41, vol. 25 No. 1, Jan.-Feb. 2001.
Ruschulte, Heiner et al, Prevention of Central Venous Catheter related infections with chlorhex idine gluconate impregnated wound dressings: A randomized controlled trial, presented as an abstract at the Annual meeting of the European Society of Anaesthesiologists (ESA) in Madrid, Spain in Jun. 2006, 12 pages, Annals of Hematology, Jul. 14, 2008.
Rutherford, J. S. et al., Depth of Central Venous Catheterization: An Audit of Practice in a Cardiac Surgical Unit, Anaesth Intens Care 1994; 22: 267-271.
Sacolick, et al. “Electromagnetically Tracked Placement of a Peripherally Inserted Central Catheter.” SPIE Medical Imaging, 2004 Proceedings.
Salem, et al. “A New Peripherally Implanted Subcutaneous Permanent Central Venous Access Device for Patients Requiring Chemotherapy.” Journal of Clinical Oncology, vol. 11, No. 11, pp. 2181-2185, Nov. 1993.
Savary, D et al, Intra-atrial Monitoring to Add Insertion of a Central Venous Line in Pre-Hospital Emergency Care Journal Europeen des Urgences, pp. 75-78, vol. 17 No. 2, 2004.
Schafer et al. “Incorrect placement of a vena cava catheter and its prevention by intra-atrial ECG.” Anaesthesist. Jan. 1988;37(1):49-51.
Schummer, et al. “Central Venous Catheters—The inability of ‘intra-atrial ECG’ to prove adequate positioning.” British Journal of Anaesthesia, vol. 93, No. 2, pp. 193-198, 2004.
Schummer, W et al, ECG-guided Central Venous Catheter Positioning: Does it detect the Pericardial Reflection rather than the Right Atrium?, Eur J Anaesthesiol, pp. 600-605, vol. 21 No. 8, Aug. 2004 (Abstract only).
Schummer, W et al, Intra-Atrial ECG is not a Reliable Method for Positioning Left Internal Jugular Vein Catheters, Br J Anaesth, pp. 481-486, vol. 91 No. 4, Oct. 2003.
Schummer, W, Central Venous Catheter—The Inability of “Intra-Atrial ECG” to prove Adequate Positioning, Br J Anaesth, pp. 193-198, vol. 93 No. 2, Aug. 2004.
Schuster, M. et al., The carina as a landmark in central venous catheter placement, British Journal of Anaesthesia 85 (2): 192-4 (2000).
Siela, Debra, Using Chest Radiography in the Intensive Care Unit, Crit Care Nurse Aug. 1, 2002 vol. 22 No. 4, pp. 18-27.
Simon, et al., “Central Venous Catheter Placement in Children: Evaluation of Electrocardiography Using J-Wire.” Paediatric Anaesthesia vol. 9, pp. 501-504, 1999.
Smith, Brigham, et al., Intravenous electrocardiographic guidance for placement of peripherally inserted central catheters, Journal of Electrocardiology 43 (2010) 274-278.
Stark, DD et al, Radiographic Assessment of Venous Catheter Position in Children: Value of the Lateral View, Pediatric Radiology, pp. 76-80, vol. 14 No. 2, 1984.
Starkhammar et al. “Cath-Finder Catheter Tracking System: A New Device for Positioning of Central Venous Catheters. Early Experience from Implantation of Brachial portal Systems.” Acta Anaesthesiol Scandinavia, vol. 34, No. 4 pp. 296-300, May 1990.
Starkhammer, H et al, Central Venous Catheter Placement using Electromagnetic Position Sensing: A Clinical Evaluation, Biomed. Instrum Technol, vol. 30 No. 2, pp. 164-170; Mar.-Apr. 1996.
Starr, David S et al, EKG Guided Placement of Subclavian CVP Catheters Using J-Wire, pp. 673-676, Ann. Surg, Dec. 1986.
Stas, M et al, Peroperative Intravasal Electrographic Control of Catheter Tip Position in Access Ports Placed by Venous Cut-Down Technique, EJSO, pp. 316-320, vol. 27, 2001.
STEREOTAXIS Magetic Navigation System with Navigant™ User Interface, 2005 Brochure.
STEREOTAXIS, Expanding the Possibilites of Interventional Medicine: Remote Navigation and Automation, pp. 1-8, Apr. 2011.
Tepa® Health Innovation PC based ECG System Introduction and Technical Specifications, EKG Master USB, 2 pages, Nov. 2003.
The FloWire Doppler Guide Wire located <http://www.volcanocorp.com/products/flowire-doppler-guide-wire.php>, 2011.
TRAXAL Technologies, Tracking Technology website overview: www.traxal.com/rd/rd—classroom—trackingtechnology.htm, last accessed Dec. 1, 2006.
UAB Health Systems, Arrhythmias, retrieved from http://www.health,uab.edu/14564/ on Nov. 15, 2007, 12 pages.
U.S. Appl. No. 11/466,602, filed Aug. 23, 2006 Advisory Action dated Jun. 22, 2009.
U.S. Appl. No. 11/466,602, filed Aug. 23, 2006 Appeal Board Decision dated Sep. 17, 2012.
U.S. Appl. No. 11/466,602, filed Aug. 23, 2006 Final Office Action dated Apr. 8, 2010.
U.S. Appl. No. 11/466,602, filed Aug. 23, 2006 Final Office Action dated Jan. 30, 2009.
U.S. Appl. No. 11/466,602, filed Aug. 23, 2006 Final Office Action dated Oct. 28, 2013.
U.S. Appl. No. 11/466,602, filed Aug. 23, 2006 Non-Final Office Action dated Mar. 28, 2013.
U.S. Appl. No. 11/466,602, filed Aug. 23, 2006 Non-Final Office Action dated Sep. 25, 2009.
U.S. Appl. No. 11/466,602, filed Aug. 23, 2006 Notice of Allowance dated Dec. 3, 2012.
U.S. Appl. No. 11/466,602, filed Aug. 23, 2006 Notice of Allowance dated Mar. 14, 2014.
U.S. Appl. No. 11/552,094, filed Oct. 23, 2006 Notice of Allowability dated Apr. 2, 2010.
U.S. Appl. No. 11/552,094, filed Oct. 23, 2006 Non-Final Office Action dated Apr. 27, 2009.
U.S. Appl. No. 11/552,094, filed Oct. 23, 2006 Notice of Allowance dated May 20, 2010.
U.S. Appl. No. 12/104,253, filed Apr. 16, 2008 Final Office Action dated Jul. 27, 2011.
CN 200980144663.8 filed May 9, 2011 Fourth Office Action dated Nov. 15, 2014.
CN 201080035659.0 filed Feb. 10, 2012 Second Office Action dated Oct. 9, 2014.
CN 201080053838.7 filed May 28, 2012 Third Office Action dated Dec. 4, 2014.
CN 201180016462.7 filed Sep. 27, 2012 Second Office Action dated Dec. 9, 2014.
CN 201180037065.8 filed Jan. 28, 2013 First Office Action dated Sep. 28, 2014.
CN 201180037068.1 filed Jan. 28, 2013 First Office Action dated Sep. 9, 2014.
CN 201180040151.4 filed Feb. 19, 2013 First Office Action dated Oct. 28, 2014.
CN 201180068309.9 filed Aug. 22, 2013 First Office Action dated Oct. 16, 2014.
EP 11 818 828.3 filed Mar. 18, 2013 Extended European Search Report dated Dec. 10, 2014.
EP 12177438.4 filed Jul. 23, 2012 Examination Report dated Dec. 5, 2014.
EP 12807886.2 filed Jan. 15, 2014 Extended European Search Report dated Feb. 6, 2015.
JP 2012-552060 filed Aug. 1, 2012 Office Action dated Nov. 12, 2014.
MX/a/2012/013858 filed Nov. 28, 2012 First Office Action dated Sep. 26, 2014.
U.S. Appl. No. 12/426,175, filed Apr. 17, 2009 Examiners Answer dated Oct. 7, 2014.
U.S. Appl. No. 12/545,762, filed Aug. 21, 2009 Non-Final Office Action dated Nov. 7, 2014.
U.S. Appl. No. 12/815,331, filed Jun. 14, 2010 Final Office Action dated Dec. 23, 2014.
U.S. Appl. No. 12/893,916, filed Sep. 29, 2010 Final Office Action dated Jan. 15, 2015.
U.S. Appl. No. 13/240,171, filed Sep. 22, 2011 Non-Final Office Action dated Dec. 26, 2014.
U.S. Appl. No. 13/336,919, filed Dec. 23, 2011 Final Office Action dated Dec. 19, 2014.
U.S. Appl. No. 13/665,420, filed Oct. 31, 2012 Non-Final Office Action dated Oct. 9, 2014.
Gonzales, et al. “Peripherally Inserted Central Catheter Placement in Swine Using Magnet Detection.” Journal of Intravenous Nursing, vol. 22, No. 3, May/Jun. 1999.
Greenall, M.J. et al, Cardiac Tamponade and Central Venous Catheters, British Medical Journal, pp. 595-597, Jun. 14, 1975.
Guillory, “Basic Principles of Technologies for Catheter Localization.” C.R. Bard internal paper, Oct. 20, 2004.
Guth, AA, Routine Chest X-rays after Insertion of Implantable Long-Term Venous Catheters: Necessary or Not?, Am Surg, pp. 26-29, vol. 67 No. 1, Jan. 2001 (Abstract only).
Hill, Bradley et al, Abstract of article discussing VasaNova VPS as guide for placement of PICCs. 2009.
Hill, Bradley, Identifying the Caval-Atrial Junction Using Smart-Catheter Technology presentation, 22nd Annual Scientific Meeting of the AVA in Savannah, Georgia, Sep. 13, 2008.
Hoffman, Thomas et al, Simultaneous Measurement of Pulmonary Venous Flow by Intravascular Catheter Doppler Velocimetry and Transesophageal Doppler Echocardiography: Relation to Left Atrial Pressure and Left Atrial and Left Ventricular Function, pp. 239-249, J Am Coll Cardiol, Jul. 1995.
Hoffmann, et al. “New Procedure in Transesophageal Echocardiography: Multiplane Transesophageal Echocardiography and Transesophageal Stress Echocardiography.” Herz, vol. 18, No. 5, pp. 269-277, Oct. 1993.
Iacopino, Domenico Gerardo et al, Intraoperative Microvascular Doppler Monitoring of Blood Flow within a Spinal Dural Arteriovenous Fistula: A Precious Surgical Tool, vol. 10, 5 pages, Neurosurg. Focus, Feb. 2001.
Jeon, Yunseok et al., “Transesophageal Echocardiographic Evaluation of ECG-guided Central Venous Catheter Placement,” Canadian Journal of Anesthesia, vol. 53, No. 10, Oct. 1, 2006, pp. 978-983.
Joosting, Jean-Pierre, “Dual-interface RFID-compatible EEPROM enables remote access to electronic device parameters,” EE Times, Mar. 8, 2010.
JP 2008-528151 filed Aug 24, 2006 Notice of Grant dated May 6, 2012.
JP 2010-504220 filed Sep. 3, 2009 Final Office Action dated Apr. 18, 2013.
JP 2010-504220 filed Sep. 3, 2009 Office Action dated May 21, 2012.
JP 2010-535117 filed May 26, 2011 First Office Action dated Aug. 5, 2013.
Kim, Ko et al, Positioning Internal Jugular Venous Catheters using the Right Third Intercostal Space in Children, Acta Anaesthesiol Scand, pp. 1284-1286, vol. 47 No. 10, Nov. 2003.
Kjelstrup T et al, Positioning of Central Venous Catheters using ECG, Tidssk Nor Laegeforen, pp. 599-601, vol. 111 No. 5, Feb. 1999 (Abstract only).
Kofler, Julia, et al., Epinephrine application via an endotracheal airway and via the Combitube in esophageal position, Critical Care Medicine: May 2000, vol. 28: Issue 5, pp. 1445-1449.
Konings, MK, et al., Development of an intravascular impedance catheter for detection of fatty lesions in arteries, IEEE Trans Med Imaging Aug. 1997; 16(4):439-46.
Kowalski, CM et al, Migration of Central Venous Catheters: Implications for Initial Catheter Tip Positioning, J Vasc Intery Radiol, pp. 443-447, vol. 8 No. 3, May-Jun. 1997.
Leowenthal, MR et al, The Peripherally Inserted Central Catheter (PICC): A Prospective Study of its Natural History after Fossa Insertion, Anaesth Intensive Care, pp. 21-24; vol. 30 No. 1, Feb. 2002.
Lepage Ronan et al. ECG Segmentation and P-wave Feature Extraction: Application to Patients Prone to Atrial Fibrillation, IEEE/EMBS Proceedings, 23rd Annual Conference, Istanbul, Turkey, Oct. 25-28, 2001.
Liu , Ji-Bin et al, Catheter-Based Intralumincal Sonography, J Ultrasound Med, pp. 145-160, vol. 23, 2004.
Lucey, B et al, Routine Chest Radiographs after Central Line Insertion: Mandatory Postprocedural Evaluation or Unnecessary Waste of Resources?, Cardiovasc Intervent Radiol, pp. 381-384, vol. 22 No. 5, Sep.-Oct. 1999.
Lum, Phillip, A New Formula-Based Measurement Guide for Optimal Positioning of Central Venous Catheters, JAVA, vol. 9, No. 2, pp. 80-85, 2004.
Lynch, RE et al, A Procedure for Placing Pediatric Femoral Venous Catheter Tips near the Right Atrium, Pediatr Emerg Care, pp. 130-132, vol. 18 No. 2, Apr. 2002.
Madan, et al. “Right Atrial Electrocardiography: A Technique for the Placement of Central Venous Catheters for Chemotherapy or Intravenous Nutrition.” British Journal of Surgery, vol. B1, pp. 1604-1605, 1994.
Madias, John E, Intracardiac (Superior Vena Cava/Right Atrial) ECGs using Saline Solution as the Conductive Medium for the Proper Positioning of the Shiley Hemodialysis Catheter: Is it Not Time to Forego the Postinsertion Chest Radiograph?, pp. 2363-2367, CHEST, 2003.
Markovich, Mary B., Central Venous Catheter Tip Placement: Determination of Posterior Malposition—A Case Study, JAVA, vol. 11, No. 2, pp. 85-89, 2006.
Martin, Roy W, An Ultrasoundic Catheter for Intravascular Measurement of Blood Flow: Technical Details, IEEE Transactions on Sonics and Ultrasonics, vol. SU-27, No. 6, pp. 277-286, Nov. 1980.
McDonnall, “Intra-Atrial Electrocardiography (ECG) for Catheter Placement.” Literature review prepared for Bard Access Systems, Oct. 2007.
McGee et al., “Accurate Placement of Central Venous Catheters: A Prospective, Randomize, Multicenter Trail.” Critical Care Medicine, vol. 21 No. 8, Aug. 1993.
MedGraphics, CardioPerfect® Resting/Stress ECG System, 3 pages, 2001.
Michenfelder, John et al, Air Embolism During Neurosurgery—An Evaluation of Right-Atrial Catheters for Diagnosis and Treatment, JAMA, pp. 1353-1358, vol. 208, No. 8, May 26, 1969.
Michenfelder, John et al, Air Embolism During Neurosurgery. A New Method of Treatment, Anesthesia and Analgesia. Current Researches, pp. 390-395, vol. 45, No. 4, Jul.-Aug. 1966.
MICROBIRD™ Miniaturized DC Magnetic Sensors for Intra-body Navigation and Localization, Specifications, 2005.
MICRONIX CathRite™ Cardiac Access Device Brochure. Jun. 2004.
Micronix Pty Ltd “CathRite” Guiding Styled Core Manufacturing, Jun. 15, 2006.
Murthy, Vrudhula et al, Analysis of Power Spectral Densities of Electrocardiograms, Mathematical Biosciences, pp. 41-51, vol. 12 No. 1-2, Oct. 1971.
Nadroo, AM et al, Changes in Upper Extremity Position Cause Migration of Peripherally Inserted Central Catheters in Neonates, Pediatrics, pp. 131-136, vol. 110, Jul. 2002.
Nakatani, K et al, Accurate Placement of Central Venous Catheters—ECG-guided method vs Patient Height Method, MASUI, pp. 34-38, vol. 51 No. 1, Jan. 2002.
Nazarian, GK et al, Changes in Tunneled Catheter Tip Position when a patient is Upright, J Vasc Interv Radiol, pp. 437-441, vol. 8 No. 3, May-Jun. 1997.
NEUROMETER® CPT, Clinical Applications. Neurotron , Inc. website: www.neurotron.com/CLINAPS.html, last accessed Oct. 23, 2006.
NEUROMETER® CPT, Frequently Asked Questions. Neurotron , Inc. website: www.neurotron.com/CPTFAQ/html, last accessed Oct. 23, 2006.
NEUROMETER® CPT, Products Page. Neurotron , Inc. website: www.neurotron.com/products.html, last accessed Oct. 23, 2006.
NEUROMETER® Electrodiagnostic Neuroselective Sensory Nerve Evaluation: Charts, Tables, Documents & Downloads. Neurotron , Inc. website: www.neurotron.com/downloads.html, last accessed Oct. 23, 2006.
Odd, De et al, Does Radio-opaque Contrast Improve Radiographic localisation of Percutaneous Central Venous Lines?, Arch Dis Child Fetal Neonatal Ed, pp. 41-43, vol. 89 No. 1, Jan. 2004.
Palesty, JA et al, Routine Chest Radiographs Following Central Venous Recatherization over a Wire are not Justified, Am J Surg, pp. 618-621, vol. 176 No. 6, Dec. 1998.
Paliotti, Roberta P. et al, Intravascular Doppler Technique for Monitoring Renal Venous Blood Flow in Man, J Nephrol, pp. 57-62, 2003.
Parker, K.H. et al, Cardiovascular Fluid Dynamics, Department of Bioengineering, National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, Cardiovascular Haemodynamics, pp. 1-28, Sep. 26, 2005.
Pawlik, et al., “Central Venous Catheter Placement: Comparison of the Intravascular Guidewire and the Fluid Column Electrocardiograms.” European Journal of Anaesthesiology, vol. 41, pp. 594-599, 2004.
PCT/US13/62409 filed Sep. 27, 2013 International Search Report and Written Opinion dated Feb. 24, 2014.
PCT/US2006/033079 filed Aug. 24, 2006 International Preliminary Report on Patentability dated Feb. 26, 2008.
PCT/US2006/033079 filed Aug. 24, 2006 Search Report dated Dec. 19, 2006.
PCT/US2006/033079 filed Aug. 24, 2006 Written Opinion dated Dec. 19, 2006.
PCT/US2008/060502 filed Apr. 16, 2008 International Search Report and Written Opinion dated Oct. 16, 2008.
PCT/US2008/084751 filed Nov. 25, 2008 International Preliminary Report on Patentability dated Jun. 1, 2010.
PCT/US2008/084751 filed Nov. 25, 2008 Search Report dated May 20, 2009.
PCT/US2008/084751 filed Nov. 25, 2008 Written Opinion dated May 20, 2009.
PCT/US2009/033116 filed Feb. 4, 2009 International Preliminary Report on Patentability dated Aug. 10, 2010.
PCT/US2009/033116 filed Feb. 4, 2009 Search Report dated Mar. 13, 2009.
PCT/US2009/033116 filed Feb. 4, 2009 Written Opinion dated Mar. 13, 2009.
PCT/US2009/041051 filed Apr. 17, 2009 International Preliminary Report on Patentability dated Apr. 8, 2014.
PCT/US2009/041051 filed Apr. 17, 2009 Search Report dated Jul. 28, 2009.
PCT/US2009/041051 filed Apr. 17, 2009 Written Opinion dated Jul. 28, 2009.
PCT/US2009/054687 filed Aug. 21, 2009 International Preliminary Report on Patentability dated Feb. 22, 2011.
PCT/US2009/054687 filed Aug. 21, 2009 Search Report dated Oct. 6, 2009.
PCT/US2009/054687 filed Aug. 21, 2009 Written Opinion dated Oct. 6, 2009.
PCT/US2009/056567 filed Sep. 10, 2009 International Preliminary Report on Patentability dated Mar. 15, 2011.
PCT/US2009/056567 filed Sep. 10, 2009 Search Report dated Nov. 6, 2009.
PCT/US2009/056567 filed Sep. 10, 2009 Written Opinion dated Nov. 6, 2009.
PCT/US2010/038555 filed Jun. 14, 2010 Search Report dated Oct. 5, 2010.
PCT/US2010/038555 filed Jun. 14, 2010 Written Opinion dated Oct. 5, 2010.
PCT/US2010/045084 filed Aug. 10, 2010 International Preliminary Report on Patentability dated Feb. 23, 2012.
PCT/US2010/045084 filed Aug. 10, 2010 Search Report dated Apr. 14, 2011.
PCT/US2010/045084 filed Aug. 10, 2010 Written Opinion dated Apr. 14, 2011.
PCT/US2010/050773 filed Sep. 29, 2010 Search Report dated Jan. 24, 2011.
PCT/US2010/050773 filed Sep. 29, 2010 Written Opinion dated Jan. 24, 2011.
PCT/US2010/051917 filed Oct. 8, 2010 Search Report dated Nov. 29, 2010.
PCT/US2010/051917 filed Oct. 8, 2010 Written Opinion dated Nov. 29, 2010.
PCT/US2011/023497 filed Feb. 2, 2011 Search Report dated Jun. 6, 2011.
PCT/US2011/023497 filed Feb. 2, 2011 Written Opinion dated Jun. 6, 2011.
PCT/US2011/038391 filed May 27, 2011 International Preliminary Report on Patentability and Written Opinion dated Dec. 4, 2012.
PCT/US2011/038391 filed May 27, 2011 International Search Report dated Sep. 21, 2011.
PCT/US2011/038415 filed May 27, 2011 International Preliminary Report on Patentability dated Dec. 13, 2012.
PCT/US2011/038415 filed May 27, 2011 International Search Report dated Sep. 28, 2011.
PCT/US2011/038415 filed May 27, 2011 Written Opinion dated Sep. 28, 2011.
PCT/US2011/047127 filed Aug. 9, 2011 International Preliminary Report on Patentability dated Apr. 18, 2013.
PCT/US2011/047127 filed Aug. 9, 2011 International Search Report dated Feb. 29, 2012.
PCT/US2011/047127 filed Aug. 9, 2011 Written Opinion dated Feb. 29, 2012.
PCT/US2011/048403 filed Aug. 19, 2011 International Search Report dated Dec. 15, 2011.
PCT/US2011/048403 filed Aug. 19, 2011 Written Opinion dated Dec. 15, 2011.
PCT/US2011/052793 filed Sep. 22, 2011 International Preliminary Report on Patentability dated Apr. 4, 2013.
PCT/US2011/052793 filed Sep. 22, 2011 International Search Report dated Jan. 6, 2012.
PCT/US2011/052793 filed Sep. 22, 2011 Written Opinion dated Jan. 6, 2012.
PCT/US2011/058138 filed Oct. 27, 2011 International Preliminary Report on Patentability dated May 10, 2013.
PCT/US2011/058138 filed Oct. 27, 2011 International Search Report dated Feb. 7, 2012.
PCT/US2011/058138 filed Oct. 27, 2011 Written Opinion dated Feb. 7, 2012.
PCT/US2011/067268 filed Dec. 23, 2011 International Preliminary Report on Patentability dated Jul. 4, 2013.
PCT/US2011/067268 filed Dec. 23, 2011 International Search Report and Written Opinion dated Apr. 27, 2012.
U.S. Appl. No. 12/104,253, filed Apr. 16, 2008 Non-Final Office Action dated Nov. 29, 2010.
U.S. Appl. No. 12/323,273, filed Nov. 25, 2008 Non-Final Office Action dated Jun. 8, 2012.
U.S. Appl. No. 12/369,625, filed Feb. 11, 2009 Final Office Action dated Feb. 23, 2012.
U.S. Appl. No. 12/369,625, filed Feb. 11, 2009 Notice of Allowance dated Oct. 5, 2012.
U.S. Appl. No. 12/369,625, filed Feb. 11, 2009 Notice of Panel Decision dated Aug. 1, 2012.
U.S. Appl. No. 12/369,625, filed Feb. 11, 2009 Non-Final Office Action dated Jul. 20, 2011.
U.S. Appl. No. 12/426,175, filed Apr. 17, 2009 Advisory Action dated Nov. 26, 2013.
U.S. Appl. No. 12/426,175, filed Apr. 17, 2009 Final Office Action dated Aug. 2, 2013.
U.S. Appl. No. 12/426,175, filed Apr. 17, 2009 Final Office Action dated Jan. 31, 2014.
U.S. Appl. No. 12/426,175, filed Apr. 17, 2009 Non-Final Office Action dated Dec. 3, 2012.
U.S. Appl. No. 12/427,244, filed Apr. 21, 2009 Non-Final Office Action dated Jan. 19, 2012.
U.S. Appl. No. 12/545,762, filed Aug. 21, 2009 Final Office Action dated Mar. 7, 2013.
U.S. Appl. No. 12/545,762, filed Aug. 21, 2009 Non-Final Office Action dated Aug. 1, 2012.
U.S. Appl. No. 12/545,762, filed Aug. 21, 2009 Non-Final Office Action dated Dec. 13, 2013.
U.S. Appl. No. 12/557,401, filed Sep. 10, 2009 Non-Final Office Action dated Apr. 24, 2012.
U.S. Appl. No. 12/557,401, filed Sep. 10, 2009 Non-Final Office Action dated Jan. 6, 2014.
U.S. Appl. No. 12/575,456, filed Oct. 7, 2009 Non-Final Office Action dated Oct. 5, 2012.
U.S. Appl. No. 12/715,556, filed Mar. 2, 2010 Final Office Action dated Oct. 2, 2013.
U.S. Appl. No. 12/715,556, filed Mar. 2, 2010 Non-Final Office Action dated Sep. 13, 2012.
U.S. Appl. No. 12/815,331, filed Jun. 14, 2010 Advisory Action dated Oct. 4, 2013.
U.S. Appl. No. 12/815,331, filed Jun. 14, 2010 Final Office Action dated Jul. 26, 2013.
U.S. Appl. No. 12/815,331, filed Jun. 14, 2010 Non-Final Office Action dated Jan. 22, 2013.
U.S. Appl. No. 12/854,083, filed Aug. 10, 2010 Final Office Action dated Aug. 15, 2013.
U.S. Appl. No. 12/854,083, filed Aug. 10, 2010 Non-Final Office Action dated Jan. 29, 2013.
U.S. Appl. No. 12/854,083, filed Aug. 10, 2010 Non-Final Office Action dated Jan. 29, 2014.
U.S. Appl. No. 12/878,915, filed Sep. 9, 2010 Final Office Action dated Sep. 26, 2012.
U.S. Appl. No. 12/878,915, filed Sep. 9, 2010 Non-Final Office Action dated Mar. 15, 2012.
U.S. Appl. No. 12/878,915, filed Sep. 9, 2010 Notice of Allowance dated Jan. 8, 2013.
U.S. Appl. No. 12/893,916, filed Sep. 29, 2010 Non-Final Office Action dated Dec. 24, 2013.
U.S. Appl. No. 12/900,750, filed Oct. 8, 2010 Non-Final Office Action dated Jun. 3, 2013.
U.S. Appl. No. 13/019,939, filed Feb. 2, 2011 Final Office Action dated Apr. 2, 2014.
U.S. Appl. No. 13/019,939, filed Feb. 2, 2011 Non-Final Office Action dated Oct. 11, 2013.
U.S. Appl. No. 13/118,138, filed May 27, 2011 Final Office Action dated Apr. 3, 2013.
U.S. Appl. No. 13/118,138, filed May 27, 2011 Final Office Action dated Aug. 1, 2013.
U.S. Appl. No. 13/118,138, filed May 27, 2011 Non-Final Office Action dated Oct. 3, 2012.
U.S. Appl. No. 13/213,622, filed Aug. 19, 2011 Final Office Action dated Feb. 19, 2013.
U.S. Appl. No. 13/213,622, filed Aug. 19, 2011 Non-Final Office Action dated Jul. 31, 2012.
U.S. Appl. No. 13/283,395, filed Oct. 27, 2011 Non-Final Office Action dated Apr. 23, 2013.
U.S. Appl. No. 13/336,919, filed Dec. 23, 2011 Advisory Action dated May 23, 2013.
U.S. Appl. No. 13/336,919, filed Dec. 23, 2011 Final Office Action dated Mar. 1, 2013.
U.S. Appl. No. 13/336,919, filed Dec. 23, 2011 Non-Final Office Action dated Dec. 27, 2013.
U.S. Appl. No. 13/336,919, filed Dec. 23, 2011 Non-Final Office Action dated Oct. 16, 2012.
U.S. Appl. No. 13/337,987, filed Dec. 27, 2011 Non-Final Office Action dated Mar. 15, 2013.
U.S. Appl. No. 13/469,932, filed May 11, 2012 Non-Final Office Action dated Jan. 3, 2014.
U.S. Appl. No. 13/665,420, filed Oct. 31, 2012 Non-Final Office Action dated Jan. 6, 2014.
U.S. Appl. No. 13/737,806, filed Jan. 9, 2013 Notice of Allowance dated Oct. 31, 2013.
U.S. Appl. No. 13/887,166, filed May 3, 2013 Non-Final Office Action dated Jan. 7, 2014.
U.S. Appl. No. 13/969,265, filed Aug. 16, 2013 Non-Final Office Action dated Dec. 19, 2013.
U.S. Appl. No. 29/428,649, filed Aug. 1, 2012 Notice of Allowance dated Jul. 5, 2013.
Valdivieso, J.R. Perez, et al., Evaluation of a formula for optimal positioning of a central venous catheter inserted through the right internal jugular vein, Rev. Esp. Anestesiol. Reanim. 2003; 50: 77-79.
Claasz, Antonia et al, A Study of the Relationship of the Superior Vena Cava to the Bony Landmarks of the Sternum in the Supine Adult: Implications for Magnetic Guidance Systems, Journal, vol. 12 No. 3, JAVA, Jul. 24, 2007.
Clifford, et al. “Assessment of Hepatic Motion Secondary to Respiration for Computer Assisted Interventions.” Computer Aided Surgery, vol. 7, pp. 291-299, 2002.
CN 200880012117.4 filed Apr. 16, 2008 First Office Action dated Dec. 23, 2011.
CN 200880012117.4 filed Apr. 16, 2008 Second Office Action dated Oct. 8, 2012.
CN 200880012117.4 filed Apr. 16, 2008 Third Office Action dated Apr. 27, 2013.
CN 200880125528.4 filed Nov. 25, 2008 First Office Action dated Jun. 5, 2012.
CN 200880125528.4 filed Nov. 25, 2008 Second Office Action dated Mar. 6, 2013.
CN 200880125528.4 filed Nov. 25, 2008 Third Office Action dated Jul. 1, 2013.
CN 200980123021.X filed Dec. 17, 2010 First Office Action dated Nov. 19, 2012.
CN 200980123021.X filed Dec. 17, 2010 Second Office Action dated Aug. 13, 2013.
CN 200980144663.8 filed May 9, 2011 First Office Action dated Dec. 5, 2012.
CN 200980144663.8 filed May 9, 2011 Second Office Action dated Aug. 22, 2013.
CN 201080035659.0 filed Feb. 10, 2012 First Office Action dated Jan. 26, 2014.
CN 201080053838.7 filed May 28, 2012 First Office Action dated Jan. 6, 2014.
Colley, Peter S et al, ECG-Guided Placement of Sorenson CVP Catheters via Arm Veins, Anesthesia and Analgesia, pp. 953-956, vol. 63, 1984.
Collier, PE et al, Cardiac Tamponade from Central Venous Catheters, Am J Surg, pp. 212-214, vol. 176 No. 2, Aug. 1998.
ComboWire® Pressure/Flow Guide Wire Ref 9500 Series, Instructions for Use, Apr. 2011.
Corsten, et al., “Central Placement Catheter Placement Using the ECG-Guided Cavafix-Certodyn SD Catheter.” Journal of Clinical Anesthesiology, vol. 6, Nov./Dec. 1994.
Cucchiara, Roy et al, Time Required and Success Rate of Percantaneous Right Atrial Catherization: Description of a Technique, Canad. Anaesth. Soc. J., pp. 572-573, vol. 27, No. 6, Nov. 1980.
Cullinane, DC et al, The Futility of Chest Roentgenograms Following Routine Central Venous Line Changes, Am J Surg, pp. 283-285, vol. 176 No. 3, Sep. 1998.
Curet, Myriam J. et al., University and Practice-based Physicians' Input on the Content of a Surgical Curriculum, The American Journal of Surgery® vol. 178 Jul. 1999, 78-84.
David, et al., “Is ECG-Guidance a Helpful Method to Correctly Position a Central Venous Catheter During Prehospital Emergency Care?” ACTA Anaesthesiologica Scandinavica, vol. 49, pp. 1010-1014, 2005.
DELTEC Oath-Finder® Tracking System Operation Manual, 1994.
Egelhof, Petra, Effects of Somatostatin on Portal Blood Flow and Portal Vein Pressure in Patients with Portal Hypertension due to Liver Cirrhosis Invasive Monitoring during TIPSS Procedures, Dissertation submitted to: Technical University of Munich, Faculty of Medicine, May 13, 2002; Date of examination: Feb. 26, 2003.
Engelhardt, W et al, ECG-Controlled Placement of Central Venous Catheters in Patients with Atrial Fibrallation, Anaesthesist, pp. 476-479, vol. 38 No. 9, Sep. 1989 (Abstract only).
EP 08855396.1 filed Jun. 15, 2010 European Search Report dated Jul. 31, 2012.
EP 08855396.1 filed Jun. 15, 2010 Intent to Grant dated Jul. 5, 2013.
EP 09707467.8 supplemental European search report dated Jun. 18, 2013.
EP 09808901.4 filed Aug. 21, 2009 European Search Report dated May 23, 2012.
EP 09808901.4 filed Aug. 21, 2009 Examination Report dated May 10, 2013.
EP 09813632.8 filed Apr. 5, 2011 European Search Report dated Jul. 4, 2012.
EP 09813632.8 filed Apr. 5, 2011 Office Action dated Apr. 30, 2013.
EP 09813632.8 filed Apr. 5, 2011 Summons to Attend Oral Proceedings dated Apr. 16, 2014.
EP 10786978.6 filed Dec. 19, 2011 Extended European Search Report dated Mar. 7, 2014.
EP 12177438.4 filed Jul. 23, 2012 Communication dated Jan. 13, 2014.
EP 12177438.4 filed Jul. 23, 2012 European Search Report dated Dec. 4, 2012.
EP 12177438.4 filed Jul. 23, 2012 extended European Search Report dated Mar. 25, 2013.
EP 14151268.1 filed Jan. 15, 2014 European Search Report dated Feb. 21, 2014.
Fearon, William F et al, Evaluating Intermediate Coronary Lesions in the Cardiac Catheterization Laboratory, vol. 4, No. 1, 7 pages, Reviews in Cardiovascular Medicine, 2003.
Felleiter P et al, Use of Electrocardiographic Placement Control of Central Venous Catheters in Austria, Acta Med Austriaca, pp. 109-113, vol. 26 No. 3, 1999 (Abstract only).
Forauer, AR et al, Change in Peripherally Inserted Central Catheter Tip Location with Abduction and Adduction of the Upper Extremity, J Vasc Interv Radiol, pp. 1315-1318, vol. 11 No. 10, Nov.-Dec. 2000.
Frassinelli, P et al, Utility of Chest Radiographs after Guidewire Exchanges of Central Venous Catheters, Crit Care Med, pp. 611-615, vol. 26 No. 3, Mar. 1998.
Frazin L et al, A Doppler Guided Retrograde Catheterization System, Cathet. Cardiovasc Diagn, pp. 41-50, May 1992.
French, PJ et al, Sensors for Catheter Applications, Sensors Update, vol. 13 Issue 1 pp. 107-153, Dec. 2003.
GB Application 0800474.9 filed Aug. 24, 2006 Office Action dated Aug. 9, 2010.
GB Application 0800474.9 filed Aug. 24, 2006 Office Action dated Mar. 17, 2010.
Gebauer, B et al, Ultrasound and Fluoroscopy-guided Implantation of Peripherally Inserted Central Venous Catheters (PICCs), ROFO, pp. 386-391, vol. 176 No. 3, Mar. 2004 (Abstract only).
Gebhard, et al., “The accuracy of Electrocardiogram-Controlled Central Line Placement.” The International Anesthesia Research Society, vol. 104, No. 1 Jan. 2007.
Gjendemsjo, Anders, et al., Energy and Power, The Connexions Project, Version 1.2, Feb. 20, 2004.
Gladwin, MT et al, Cannulation of the Internal Jugular Vein: is postpocedural chest radiography always necessary?, Crit Care Med, 33 pages, Oct. 2000.
CN 200980123021.X filed Dec. 17, 2010 Third Office Action dated Apr. 22, 2014.
CN 200980144663.8 filed May 9, 2011 Third Office Action dated May 4, 2014.
CN 201080053838.7 filed May 28, 2012 Second Office Action dated Jun. 17, 2014.
CN 201180016462.7 filed Sep. 27, 2012 First Office Action dated Mar. 21, 2014.
CN 201180043512.0 filed Mar. 8, 2013 First Office Action dated Jul. 31, 2014.
EP 10 808 660.4 filed Feb. 15, 2012 Extended European Search Report dated Mar. 4, 2014.
EP 13194818.4 filed Nov. 28, 2013 extended European search report dated Feb. 28, 2014.
JP 2012-515222 filed Dec. 9, 2011 Office Action dated Mar. 24, 2014.
PCT/US2011/048403 filed Aug. 19, 2011 International Preliminary Report on Patentability dated Jul. 30, 2013.
PCT/US2014/022019 filed Mar. 7, 2014 International Search Report and Written Opinion dated Jun. 11, 2014.
RU 2011150917 filed Dec. 15, 2011 First Office Action dated Apr. 24, 2014.
RU 2011150917 filed Dec. 15, 2011 Second Office Action dated Aug. 28, 2014.
U.S. Appl. No. 12/815,331, filed Jun. 14, 2010 Non-Final Office Action dated Jul. 2, 2014.
U.S. Appl. No. 12/854,083, filed Aug. 10, 2010 Advisory Action dated Sep. 8, 2014.
U.S. Appl. No. 12/854,083, filed Aug. 10, 2010 Final Office Action dated Jul. 1, 2014.
U.S. Appl. No. 12/893,916, filed Sep. 29, 2010 Advisory Action dated Aug. 15, 2014.
U.S. Appl. No. 12/893,916, filed Sep. 29, 2010 Final Office Action dated Jun. 18, 2014.
U.S. Appl. No. 12/893,916, filed Sep. 29, 2010 Non-Final Office Action dated Sep. 25, 2014.
U.S. Appl. No. 13/118,033, filed May 27, 2011 Non-Final Office Action dated May 22, 2014.
U.S. Appl. No. 13/118,138, filed May 27, 2011 Non-Final Office Action dated Oct. 9, 2014.
U.S. Appl. No. 13/213,622, filed Aug. 19, 2011 Non-Final Office Action dated May 22, 2014.
U.S. Appl. No. 13/469,932, filed May 11, 2012 Non-Final Office Action dated Jul. 31, 2014.
U.S. Appl. No. 13/887,166, filed May 3, 2013 Advisory Action dated Aug. 27, 2014.
U.S. Appl. No. 13/887,166, filed May 3, 2013 Final Office Action dated Jun. 23, 2014.
U.S. Appl. No. 13/890,158, filed May 8, 2013 Non-Final Office Action dated Aug. 15, 2014.
U.S. Appl. No. 13/969,265, filed Aug. 16, 2013 Notice of Allowance dated Jun. 23, 2014.
U.S. Appl. No. 14/141,046, filed Dec. 26, 2013 Non-Final Office Action dated Jun. 20, 2014.
U.S. Appl. No. 14/317,501, filed Jun. 27, 2014 Non-Final Office Action dated Sep. 12, 2014.
Zaidi, Naveed A., et al. “Room temperature magnetic order in an organic magnet derived from polyaniline.” 2004, Polymer, vol. 45, pp. 5683-5689.
“Ascension to Launch New 3D Guidance™ Tracker at TCT 2006.” Press Releases from Ascension website: www.ascension-tech.com/news/press—101106.php, last accessed Dec. 1, 2006.
Acuson—The Value of Vision, AcuNav Diagnostic Ultrasound Catheter, 2000.
Advertising flyer for GAVECELT—The Italian Group for Long Term Venous Access Devices, for program on International Meeting on PICC's, Midline Catheters and Long Term Venous Access Devices in Catholic University, Rome, Italy on Dec. 3, 4, 5, 2008.
Alexander, GD et al, The Role of Nitrous Oxide in Postoperative Nausea and Vomiting, Collection of Abstracts Presented at the International Anesthesia Research Society by various speakers, 58th Congress, Mar. 12-14, 1984, Anesthesia and Analgesia, pp. 175-284, vol. 63, 1984.
Allan, P.L. et al, Role of Ultrsound in the Assessment of Chronic Venous Insufficiency, Ultrasound Quarterly, vol. 17, No. 1, pp. 3-10, 2001.
Andropoulos, et al. “A Controlled Study of the Transesophageal Echocardiography to Guide Central Venous Catheter Placement in Congetital Heart Surgery Patients.” The International Anesthesia Research Society, vol. 89, pp. 65-70, 1999.
Anonymous author, Correct Catheter Placement with a low-impact, reliable and economical method, <http://www.cvc-partner.com/index.cfm?103A955CC6844BF58ACFE3C9C1471959>, last accessed Dec. 22, 2011.
Arai, J et al, Detection of Peripherally Inserted Central Catheter Occlusion by in-line Pressure Monitoring, Paediatr Anaesth, pp. 621-624, vol. 12 No. 7, Sep. 2002.
Arrow International, Inc., The Arrow-Johans RAECG Adapter-Making Proper Central Venous Catheter Placement More Reliable (Modle No. EG-04900), Technical Report 1987, USA.
Aslamy, et al. “MRI of Central Venous Anatomy: Implications for Central Venous Catheter Insertion.” American College of Chest Physicians, Jun. 8, 2009.
AU 2006283022 filed Aug. 24, 2006 Office Action dated Dec. 22, 2010.
AU 2008329807 exam requested Aug. 13, 2012 Examination Report No. 1 dated Feb. 15, 2013.
AU 2008329807 exam requested Aug. 13, 2012 Notice of Acceptance dated Feb. 14, 2014.
AU 2010300677 filed Mar. 12, 2012 First Examination Report dated Mar. 9, 2014.
AU 2011289513 filed Jan. 21, 2013 Examiner's Report dated Jul. 5, 2013.
AU 2012202293 filed Apr. 19, 2012 Examination Report No. 1 dated Apr. 24, 2013.
AU 2013201648 filed Mar. 19, 2013 Examiner's Report dated Mar. 5, 2014.
AU 2013201648 filed Mar. 19, 2013 Examiner's Report dated Oct. 14, 2013.
AU 2013202824 filed Apr. 6, 2013 First Examiner's Report dated Mar. 10, 2014.
AU 2013204243 filed Apr. 12, 2013 Examiner's Report dated Jun. 5, 2013.
AURORA® System Technical Specifications, Oct. 2003.
B. Braun Website, “The Optimal Position of the Central Venous Catheter.” http://www.cvcpartner.com/index.cfm18F1BDEA1310466194960A39F4E90968 (2009).
B. Braun, Certofix Central Venous Catheter for Placement Using the Seldinger Technique with Simultaneous ECG Lead Option, Feb. 2010.
Bailey, SH et al, Is Immediate Chest Radiograph Necessary after Central Venous Catheter Placement in a Surgical Intensive Care Unit?, Am J Surg, pp. 517-522, vol. 180 No. 6, Dec. 2000.
Bankier, Alexander A., Azygos Arch Cannulation by Central Venous Catheters: Radiographic Detection of Malposition and Subsequent Complications, Journal of Thoracic Imaging 12:64-69 (1997).
Barber, JM et al, A Nurse led Peripherally Inserted Central Catheter Line Insertion Service is Effective with Radiological Support, Clin Radiol, pp. 352-354, vol. 57 No. 5, May 2002.
Bard Access Systems, Sherlock Tip Location System, 5 pages, 2006.
Bard Access Systems, Site Rite Vascular Acess Ultrasound System, 4 pages, 2005.
Benchimol, Alberto at al, Right Atrium and Superior Vena Cava Flow Velocity in Man Measured with the Doppler-Catheter Flowmeter-Telemetry System, The Amer Journal of Medicine, pp. 303-309, vol. 48, Mar. 1970.
Benzadon, M. N. et al: “Comparison of the Amplitude of the P-Wave from Intracardiac Electrocardiogram Obtained by Means of a Central Venous Catheter Filled With Saline Solution to That Obtained Via Esophageal Electrocardiogram”, American Journal of Cardiology, Cahners Publishing Co., Newton, MA, US, vol. 98, No. 7, Oct. 1, 2006, pp. 978-981.
BioAdvance Lumen Vu, Greenhouse Fund Feb. 2004 Recipient, www.bioadvance.com <http://www.bioadvance.com>, 2005.
Borgobello, Bridget, App allows users to view electrocardiograms on smartphones dated Oct. 15, 2010; printed from http://www.gizmag.com/app-to-view-electrocardiograms-on-smartphones/16664/ on Feb. 4, 2011.
Buehrle, Douglas, PICC Placement in Humans using Electromagnetic Detection, <http://www.corpakmedsystems.com/supplement—material/supplementpages/navigator/navarticle.html>, 2008.
C.R. Bard, CathTrack™ Catheter Location System at www.bardaccess.com <http://www.bardaccess.com>, last accessed Apr. 28, 2011.
C.R. Bard, Inc., Bard Electrophysiology Product Catalogue, Bard Catheters, pp. 74-75 (2002), USA.
CA 2,619,909 filed Aug. 24, 2006 Examiner's Report dated Oct. 26, 2012.
Cadman, A et al, To Clot or Not to Clot? That is the question in Central Venous Catheters, Clinical Radiology, pp. 349-355, vol. 59 No. 4, Apr. 2004.
Calvert, N et al, The Effectiveness and Cost-effectiveness of Ultrasound Locating Devices for Central Venous Access: A Systematic Review and Economic Evaluation, Health Technology Assessment, vol. 7, No. 12, 2003.
Cardella, John F. et al., Interventinal Radiologic Placement of Peripherally Inserted Central Catheters, Journal of Vascular and Interventional Radiology 1993; 4:653-660.
Carlon, R et al, Secondary Migration of a Central Venous Catheter—A Case Report, Minerva Anestesiol, pp. 927-931, vol. 69 No. 12, Dec. 2003.
Caruso, LJ et al, A Better Landmark for Positioning a Central Venous Catheter, J Clinical Monitoring and Computing, pp. 331-334, vol. 17 No. 6, Aug. 2002.
Cavatorta, et al., “Central Venous Catheter Placement in Hemodialysis: Evaluation of Electrocardiography Using a Guidewire.” The Journal of Vascular Access, vol. 2, pp. 45-50, 2001.
Chalkiadis, GA et al, Depth of Central Venous Catheter Insertion in Adults: An Audit and Assessment of a Technique to Improve Tip Position, Anaesth Intensive Care, pp. 61-66, vol. 26 No. 1, Feb. 1998.
Chamsi-Pasha, Hassan et al, Cardiac Complications of Total Parenteral Nutrition: The Role of Two-Dimensional Echocardiography in Diagnosis, Annals of the Royal College of Surgeons of England, pp. 120-123, vol. 71, 1989.
Chang, Thomas C. et al., Are Routine Ch Ladiographs Necessary After Image-Guided Placement of Internal Jugular Central Venous Access Devices?, AJR Feb. 1998;170:335-337.
Chaturvedi et al., “Catheter Malplacement During Central Venous Cannulation Through Arm Veins in Pediatric Patients.” Journal of Neurosurgical Anesthesiology, vol. 15, No. 3 pp. 170-175, Jan. 2003.
Chen, Zhongping et al, Optical Doppler Tomography: Imaging in vivo Blood Flow Dynamics Following Pharmacological Intervention and Photodynamic Therapy, 7 pages, vol. 67, Photochemistry and Photobiology, 1998.
Cheng, Ki et al, A Novel Approach of Intravenous Electrocardiograph Technique in Correct Position the Long-Term Central Venous Catheter, Kaohsiung J Med Sci, pp. 241-247, vol. 16 No. 5, May 2000 (Abstract only).
Cheung, P., et al., The Effect of a Disposable Probe Cover on Pulse Oximetry, Anaesth Intensive Care 2002; 30: 211-214.
Chu, et al., “Accurate Central Venous Port—A Catheter Placement: Intravenous Electrocardiography and Surface Landmark Techniques Compared by Using Transesophageal Echocardiography.” The International Anesthesia Research Society, vol. 98, pp. 910-914, 2004.
CN 200980144663.8 filed May 9, 2011 Fifth Office Action dated May 26, 2015.
CN 201080035659.0 filed Feb. 10, 2012 Third Office Action dated Mar. 19, 2015.
CN 201080053838.7 filed May 28, 2012 Fourth Office Action dated Jun. 2, 2015.
CN 201180037065.8 filed Jan. 28, 2013 First Office Action dated Jun. 2, 2015.
CN 201180037068.1 filed Jan. 28, 2013 First Office Action dated Apr. 20, 2015.
CN 201180043512.0 filed Mar. 8, 2013 Second Office Action dated Apr. 14, 2015.
CN 201180068309.9 filed Aug. 22, 2013 Second Office Action dated May 6, 2015.
EP 11787515.3 filed Dec. 12, 2012 partial European search report dated Jun. 23, 2015.
EP 11787527.8 filed Dec. 19, 2012 partial European search report dated May 26, 2015.
EP 12177438.4 filed Jul. 23, 2012 European Search Report dated Jun. 7, 2015.
EP14197136.6 filed Dec. 10, 2014 Extended European Search Report dated May 26, 2015.
JP 2012-515222 filed Dec. 9, 2011 Office Action dated Feb. 23, 2015.
JP 2013-512046 filed Nov. 26, 2012 First Office Action dated Mar. 23, 2015.
JP 2013-512051 filed Nov. 26, 2012 First Office Action dated Mar. 23, 2015.
JP 2013-524999 filed Jan. 22, 2013 First Office Action dated Jun. 1, 2015.
Moureau, Nancy L. et al., “Electrocardiogram (EKG) Guided Peripherally Inserted Central Catheter Placement and Tip Position: Results of a Trial to Replace Radiological Confirmation,” Journal of the Association for Vascular Access, pp. 8-14, vol. 15, No. 1, 2010.
Pittiruti, et al, “The intracavitary ECG method for positioning the tip of central venous catheters: results of an Italian multicenter study,” J Vasc Access, pp. 1-9, Nov. 21, 2011.
Pittiruti, et al. “The electrocardiographic method for positioning the tip of central venous catheters.” JAVA, pp. 1-12, Feb. 12, 2011.
U.S. Appl. No. 1/118,033, filed May 27, 2011 Non-Final Office Action dated Jul. 8, 2015.
U.S. Appl. No. 12/815,331, filed Jun. 14, 2010 Advisory Action dated Mar. 5, 2015.
U.S. Appl. No. 12/815,331, filed Jun. 14, 2010 Non-Final Office Action dated Jun. 1, 2015.
U.S. Appl. No. 12/854,083, filed Aug. 10, 2010 Non-Final Office Action dated Mar. 16, 2015.
U.S. Appl. No. 13/019,939, filed Feb. 2, 2011 Non-Final Office Action dated Feb. 9. 2015.
U.S. Appl. No. 13/118,033, filed May 27, 2011 Non-Final Office Action dated Feb. 3, 2015.
U.S. Appl. No. 13/118,138, filed May 27, 2011 Non-Final Office Action dated Jul. 15, 2015.
U.S. Appl. No. 13/240,171, filed Sep. 22, 2011 Final Office Action dated Jun. 10, 2015.
U.S. Appl. No. 13/336,919, filed Dec. 23, 2011 Non-Final Office Action dated Jul. 9, 2015.
U.S. Appl. No. 13/887,166, filed May 3, 2013 Examiner's Answer dated Jul. 16, 2015.
U.S. Appl. No. 14/141,046, filed Dec. 26, 2013 Non-Final Office Action dated Feb. 11, 2015.
U.S. Appl. No. 14/317,501, filed Jun. 27, 2014 Final Office Action dated Jul. 1, 2015.
U.S. Appl. No. 14/317,501, filed Jun. 27, 2014 Non-Final Office Action dated Mar. 3, 2015.
U.S. Appl. No. 14/548,151, filed Nov. 19, 2014 Non-Final Office Action dated Jun. 5, 2015.
CA 2,721,715 filed Apr. 17, 2009 Examiner's Report dated Aug. 18, 2015.
CN 201180052587.5 filed Apr. 28, 2013 Second Office Action dated Aug. 19, 2015.
EP 10821193.9 filed Mar. 27, 2012 Partial European Search Report dated Oct. 9, 2015.
EP 11787527.8 filed Dec. 19, 2012 Extended European Search Report dated Oct. 9, 2015.
MX/a/2012/013672 filed Nov. 23, 2012 First Office Action dated Aug. 10, 2015.
U.S. Appl No. 12/545,762, filed Aug. 21, 2009 Non-Final Office Action dated Sep. 11, 2015.
U.S. Appl. No. 12/854,083, filed Aug. 10, 2010 Final Office Action dated Aug. 21, 2015.
U.S. Appl. No. 12/893,916, filed Sep. 29, 2010 Non-Final Office Action dated Sep. 10, 2015.
U.S. Appl. No. 13/240,171, filed Sep. 22, 2011 Advisory Action dated Aug. 18, 2015.
U.S. Appl. No. 13/469,932, filed May 11, 2012 Non-Final Office Action dated Sep. 4, 2015.
U.S. Appl. No. 14/309,511, filed Jun. 19, 2014 Non-Final Office Action, dated Sep. 24, 2015.
U.S. Appl. No. 14/317,501, filed Jun. 27, 2014 Advisory Action dated Sep. 16, 2015.
U.S. Appl. No. 14/506,552, filed Oct. 3, 2014 Non-Final Office Action dated Oct. 1, 2015.
Related Publications (1)
Number Date Country
20140243659 A1 Aug 2014 US
Provisional Applications (1)
Number Date Country
61026372 Feb 2008 US
Divisions (2)
Number Date Country
Parent 13737806 Jan 2013 US
Child 14270241 US
Parent 12427244 Apr 2009 US
Child 13737806 US
Continuations (1)
Number Date Country
Parent PCT/US2009/033116 Feb 2009 US
Child 11552094 US
Continuation in Parts (1)
Number Date Country
Parent 11552094 Oct 2006 US
Child 12427244 US